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SUMMARY 
Depending on the requirement of calcium for their hemagglutination activity, the 
animal lectins have been divided into two major types, the S type (calcium-
independent) and C type (calcium-dependent). The S-type lectins are soluble, 
P-galactoside-specific, evolutionarily conserved proteins widely distributed in nature 
from lower invertebrates to mammals. In addition, they require the presence of thiol 
reducing reagents to retain their carbohydrate-binding activity. So far, P-galactoside 
binding proteins or galectins have been implicated in various fundamental processes 
such as embryonic development, cell-cell interactions, cell migration, immune 
regulation and organization of nervous system. Moreover, these proteins are very well 
expressed in mammalian nervous system but its exact role is still obscure. 
P-galactoside binding lectin from buffalo brain was purified to homogeneity by using 
a combination of 40-70% ammonium sulphate fractionation and gel filtration 
chromatography on sephadex G50-80 column. The purification resulted in 1716 fold 
enrichment of specific activity with a yield of 0.04 %. The molecular weight of 
buffalo brain lectin (BBL) as determined by SDS-PAGE under reducing and non-
reducing conditions was 14.5 kDa, however, with gel filtration under native 
conditions, it was 28.5 kDa, revealing the dimeric form of the protein. The stokes 
radius calculated from gel filtration data was 25 A and diffusion coefficient 
corresponded to 8.91 x 10"15 cm2/s. 
The neutral sugar content of the soluble lectin was estimated to be 3.3 %, whereas 
thiol analysis indicated the presence of 3 sulphydryl groups per mole of BBL. 
Alkylation of sulphydryl groups of brain lectin by iodoacetate and iodoacetamide 
resulted in inactivation of hemagglutinating activity, suggesting the need of reducing 
agent to maintain BBL in its active form. The specificity of BBL for various 
saccharides was determined by hemagglutination inhibition assay. BBL displayed 
affinity for lactose and other sugar moieties in glycosidic form, suggesting it to be a 
P-galactoside binding lectin. Moreover, BBL preferentially agglutinated trypsinized 
human type A as well O erythrocytes. The temperature and pH activity profile 
displayed the maximum hemagglutination activity of BBL between a temperature 
range of 30-45 °C and a pi I range of 7-7.5. Binding parameters of BBL for lactose 
was determined by equilibrium dialysis, with 6.6 x 103 M'1 association constant (K^) 
and two binding sites per lectin molecule. 
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The effect of various denaturing agents like GdnHCl, urea and thiourea on BBL was 
studied and it was found that BBL considerably lost its activity at 6 M concentration 
of denaturants. Similarly, SDS also abolished the lectin activity but at very low 
concentration, while non-ionic detergents like Tween-20 and Triton X-100 exhibited a 
mild inhibitory behavior against BBL. However, pre-incubation of BBL with lactose 
largely prevented the detergent induced denaturation of the protein. 
The purified lectin was investigated for its brain cell aggregation properties by testing 
its ability to agglutinate cells isolated from buffalo and goat brains. Rate of 
aggregation of buffalo brain cells by purified protein was more than the goat brain 
cells. 
The treatment of BBL with oxidizing agent (H2O2) abolished its agglutination activity 
and shifted its UV absorption maxima from 282 to 250 nm, suggesting the oxidation 
of tryptophan residue present in BBL. In addition, conformational changes in BBL 
induced by H202 were also monitored by fluorescence, circular dichroism and FTIR 
spectroscopy. Fluorescence spectra of BBL in presence of oxidizing agent displayed a 
quenching in the fluorescence intensity profile, confirming the oxidation of aromatic 
acid residues. However, the presence of lactose was protective against oxidative 
structural perturbations as the fluorescence intensity of BBL pre-incubated with 
lactose displayed a lesser degree of H202 induced quenching. Similarly, circular 
dichroism and FTIR analysis revealed that the presence of oxidizing agent completely 
destroyed the native conformation of BBL. Far UV and FTIR spectra of oxidized 
BBL suggested the loss of secondary state, thereby changing the p-pleated (native) 
into a-helical structures, whereas the near-UV spectra confirmed the oxidant induced 
perturbations in the native tertiary structure of BBL. However, pre-incubation of BBL 
with lactose did not bring any change in the native conformation of BBL both at 
secondary and tertiary levels. Moreover, a protective effect of lactose against 
oxidizing action of H202 on BBL was also demonstrated by both CD and FTIR 
spectroscopy. 
The purified lectin from buffalo brain revealed the presence of 3.3 % sugar residues. 
Thus, the possible role of carbohydrate moiety in the stabilization of the protein was 
investigated by deglycosylating the lectin using periodate oxidation method. 
Deglycosylated and glycosylated forms of brain lectin were subjected to a 
comparative analysis using protein activity and fluorescence as probes over a wide 
range of temperature, pH and in the presence of various detergents and chaotropic 
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agents. The native form of lectin retained greater fraction of hemagglutinating activity 
against various physical and chemical denaturants. The unfolding of both the forms of 
lectin in the presence of GdnHCl, urea and thiourea studied by fluorescence indicated 
greater perturbations in the conformation of deglycosylated lectin than the native 
protein. The different properties examined thus indicated that glycosylation plays an 
important role in the stabilization of native conformation of protein against the 
inactivation caused by various denaturants. 
Antibodies raised against pure BBL gave a single precipitin band with BBL and the 
titre determined by direct binding ELISA was found to be more than 12800 
suggesting the high immunogenic nature of the protein. Moreover, anti-BBL 
antibodies also cross reacted with purified goat and sheep brain lectins, displaying 
antigenic relationship between them. Dot blot analysis revealed the presence of 
similar lectin in lung, heart and liver of buffalo which cross reacted with antibodies 
raised against buffalo brain lectin. 
The effect of soluble p-galactoside specific lectin from buffalo brain on the fragility 
and permeability of bio-membranes was examined using erythrocyte as model. 
Osmotic fragility of erythrocytes was considerably enhanced in the presence of BBL. 
The lytic activity of BBL was temperature, pH and incubation period dependent with 
maximum activity displayed between 30-40°C, pH 6.4-7.5 and 6 hours, respectively. 
Modulation of membrane integrity under oxidative stress in the presence and absence 
of P-galactoside binding protein was also investigated. Exogenous brain lectin 
considerably enhanced the susceptibility of erythrocyte membranes to free radical 
injury and hypochlorous acid induced oxidative assault, indicating the property of 
lectin to affect membrane dynamics and functions by overall reorganization of 
membrane components and making it more vulnerable to toxic assaults. 
BBL was also used as a diagnostics tool to reveal the expression pattern of 
p-galactoside residues on the erythrocyte membranes of prostate and breast cancer 
patients. It was found that breast cancer causes a marked decrease in the expression of 
p-galactoside residues whereas, no change in the sugar moieties was exhibited in 
patients with prostate cancer. 
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PREFACE 
Animal lectins are a unique class of proteins generally defined as non-enzymatic, 
non-immunoglobulin molecules recognizing specific carbohydrate structures. This 
category of sugar binding proteins is widespread in all taxa of the animal world 
ranging from nematodes to human beings, where they are involved in a number of 
fundamental processes. On the basis of location, vertebrates possess two types of 
lectins, one is membrane integrated lectin apparently involved in translocation of 
glycoconjugates in cells and the other is soluble lectin that plays a role in the secretion 
or organization of extracellular glycoconjugates. Depending upon their metal 
requirement nature, lectins belonging to kingdom animalia can be classified into 
C-type (Ca2+ dependent) and S-type lectins (sulphydryl dependent). Soluble 
p-galactoside binding lectins are a category of metal independent S-type lectins that 
binds specifically to p-galactoside residues present in cellular glycoproteins and 
glycolipids. Recent nomenclature classify these P-galactoside binding proteins as 
'galectins' which are defined as highly evolutionarily conserved family of proteins 
that share structural similarities in the carbohydrate recognition domain in addition to 
specificity for polylactosamine-enriched glycoconjugates. They are further classified 
on the basis of subunit structure into prototype (single domain), tandem repeat type 
(two homologous domains) and chimera type (galectin domain combined with 
unrelated protein domain). 
The localization of P-galactoside lectins is generally varied ranging from inside to 
outside the cells. In the former case, both the cytoplasm and nucleus are the sites of 
location, whereas in the latter case, they are either attached to the cell surface or 
localized in the intracellular spaces between closely packed cells. Thus, galectins have 
distinct biological roles depending on their sites of location. The versatility of lectins 
in animal tissues and their capacity for multiple interactions with carbohydrates as 
well as non-carbohydrate ligands, makes them potentially important factors for the 
interaction of cells with their environment. For example, galectins play a key role in 
linking extracellular and intercellular signals to control survival and motility in 
lymphocytes and epithelial cells (Hernandez and Baum, 2002; Rabinovich et al., 
2002; Stillman et al., 2005; Elola et al., 2007). In addition, role of galectins in normal 
epithelial and hematopoietic development, as well as in the epithelial carcinogenesis 
and lymphomagenesis, have been clearly demonstrated by several workers 
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(Hughes, 2001; Hoyer et al., 2004; Hasan et al., 2007). They also regulate cell cycle 
progression and apoptosis, serve as adhesion and deadhesion molecules and are 
actively involved in RNA splicing (Allione et al., 1998; Kim et al., 1999; Cooper, 
2002; Rabinovich and Gruppi, 2005). Precisely, they serve an overwhelming variety 
of essential physiological and .pathological functions including tumorigenesis, cancer 
progression and metastasis. 
Galectins have been isolated and studied from such diverse sources starting from 
electric eel (Levi and Teichberg, 1981), amphibians (Bols et al., 1986), reptiles 
(Gartner et al., 1980), aves (Beyer et al., 1980) and mammals (Harrison et al., 1984), 
expressed in an array of different tissues like skin, muscles, heart, lungs, kidney, 
intestines and nervous system carrying out diverse activities owing to their multivalent 
sugar binding property. The presence of galectins in mammalian nervous system has 
been reported by several workers, which are expressed in a sub-population of dorsal 
root ganglion neurons, astrocytes, perivascular cells and microvessels (Sango et al., 
2004; Stillman et al., 2005; Mok et al., 2007) and form the neural network of the 
olfactory bulb (Puche et al., 1996; John and Key, 1999; Imbe et al., 2003; Horie et al., 
2004). Although, various function of soluble lectin in mammalian nervous system in 
terms of physiological and pathological parameters have been suggested, but its exact 
role is still obscure. However, recent findings suggest its involvement in stimulation 
of axonal regeneration, neurite outgrowth, synaptic connectivity and establishment of 
neuropathic pain after the peripheral nerve injury (Imbe et al., 2003; Horie et al., 
2004; Stillman et al., 2005; Stillman et al., 2006). To add to the list of roles played by 
galectin in mammalian nervous system, latest inclusions are its neuroprotective and 
therapeutic effect during amyotrophic lateral sclerosis (Chang-Hong et al., 2005), 
neurodegenerating effect in scrapie infected central nervous system (Mok et al., 2007) 
and a pleiotropic role during glioblastoma cell motility (Debray et al., 2004). 
P-galactoside binding lectins have been previously purified and characterized from 
brain tissues of various mammals like rat, cow, human, goat and sheep (Caron et al., 
1987; Bladier et al., 1989; Ola et al., 2001; Shahwan et al., 2004). In view.of the fact 
that the purification of this protein has not been reported from buffalo brain and its 
physicochemical properties have not been fully investigated, we have done a detailed 
study of this soluble lectin, hoping that the intimate knowledge of this protein may 
help in understanding its physiological functions in mammalian nervous system. 
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Moreover, buffalo brain has been used as it is a cheaper and easily available source 
for investigation of lectins from mammalian nervous system. 
In the present study lectin having an affinity for p-galactosides has been purified from 
water buffalo {Bubalus bubalis) brain by a combination of ammonium sulphate 
precipitation and gel permeation technique. A detailed study of physicochemical 
properties and the effect of various inactivating agents on the functional and structural 
aspects of purified brain lectin have been sketched down. Till date, all the mammalian 
brain lectin (Caron et al., 1987; Bladier et al., 1989; Ola et al., 2001) isolated are 
found to be devoid of any carbohydrate moiety. Therefore, it was interesting to 
explore the glycosylated nature of the purified protein and study the role of 
glycosylation on the structure and functions of lectin by a co-operative analysis of its 
activity and structural stability in both glycosylated and deglycosylated forms over a 
wide range of temperature, pH, detergents and in the presence of various denaturing 
agents. 
Since these lectins remain in active conformation in the presence of a reducing agent, 
it led us to believe that they contain an oxidizable residue whose integrity is quite 
crucial for its activity. Therefore, a detailed evaluation of modification of brain lectin 
in the presence of H202 in terms of functional and structural parameters has been 
undertaken. 
Moreover, immunological studies have also been carried out to elucidate the antigenic 
relationship of buffalo brain lectin (BBL) with other similar brain lectins of different 
species and the presence of same lectin in different organs of buffalo by dot blot 
assay. 
The hemolytic and cytolytic action of purified lectin has been studied by monitoring 
its effect on erythrocytes cell membrane integrity and permeability. This would shed 
light on the role of lectin in cytolytic destruction of foreign cells in mammalian 
nervous system. 
Since erythrocytes of various carcinoma cells show a distinct pattern of glycosylation 
which becomes a diagnostic index to examine the presence and proliferation of well 
known cancers, we also intended to study the presence and absence of (3-galactoside 
sugar residues on erythrocyte membrane of different cancer patients using brain lectin 
as a tool. To sum up, the objectives and the overall aim of the present study is to 
contribute to the existing repertoire of the diversity, structure and biological role of 
p-galactoside binding lectins in mammalian nervous system. 
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REVIEW OF LITERATURE 
Milestones in discovery of lectins 
The term lectin (latin word means 'legre' or 'to choose') was first coined by Boyd and 
Shapleigh (1954) to describe a class of proteins of plant origin which agglutinates 
cells and exhibit antibody like sugar binding specificity. However, the existence of 
lectin in biological materials especially in plant seeds can be traced far back into 
history with the discovery of ricin (Tschrich, 1912; Olsnes and Phil, 1982) and abrin 
(Tschrich, 1925; Olsnes and Phil, 1982). Infact, the original lectin saga begins in 1888 
with the finding of Herman Stillmark during his doctoral research in Kobert's 
laboratory where he partially isolated proteinacious preparations called 'ricin' from 
castor beans (Barondes, 1997). His work initiated a series of discoveries that unveiled 
the presence of lectins in all spheres of biological kingdoms including virus, fungi, 
lichens, chordates, invertebrates and vertebrates. Animal lectins, including 
mammalian lectins, have been discovered much before than plant lectins, although the 
contexts of their discoveries were often rather different and some were discovered 
long before their identification as carbohydrate binding proteins (Kilpatrick, 2002). 
The first animal lectin observed was probably found in snakes when Flexner and 
Noguchi (1902), discovered the agglutinating and lytic activity of snake venoms. 
Infact, this idea was originally prompted by S. Weir Mitchell in 1886, two years 
before the Stillmark's discovery of plant lectin activity, so we may conclude that 
Mitchell was the first researcher to observe animal lectin activity and probably the 
first to observe lectin activity per se, whether of plant and animal origin (Kilpatrick, 
2002). Later, Stockert et al., (1974) discovered the first mammalian lectin from rabbit 
liver which was a major milestone in the history of lectin research in animal kingdom. 
Apart from liver, lectins were also isolated and purified from electric organ of electric 
eel (Levi and Teichberg, 1981), calf heart and lungs (De Waard et al., 1976). These 
lectins are dimers with subunit molecular weight of 14,000 dalton, requires reducing 
agents for their activity and bear specificity for P-galactoside binding. Later years till 
date witnessed the discovery of innumerable specific lectins from a variety of novel 
animal sources expressed in a wide array of different tissues ranging from muscle 
(Nowak et al., 1977) through brain (Kobiler and Barondes, 1977; Caron et al., 1987; 
Bladier et al., 1989; Ola et al., 2001; Shahwan et al., 2004), pancreas (Beyer et 
al.,1979), colon (Schoeppner, 1995), intestines (Tardy et al., 1995), retina (Uehara et 
al., 2001) , skin (Marschal et al.,1992) , serum (Colley et al.,1988), placenta 
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(Visegrady et al., 2001; Than et al., 2004), oocytes (Perillo et al., 1998; Rabinovich, 
1999) and uterus (Gray et al., 2004). 
Classification of animal lectins 
On the basis of the primary structure of animal lectins, Drickamer classified animal 
lectins into two structural families: the C-type (requiring Ca2+ for activity) lectins and 
S-type (sulfydryl-dependent or P-galactoside binding) lectins (Drickamer, 1988). Both 
families had a conserved carbohydrate recognition (CRD) domain of approximately 
130 amino acids residues, although the C-type and S-type domains are completely 
unrelated to each other. The few exceptions known at that time were a heterogenous 
group referred to as N type (not C or S) (Kilpatrick, 2002). However, the present day 
perception is very different with vastly more structural knowledge available (Gabius 
et al., 2002, Loris et al., 2002; Ahmed and Vasta, 2008), it is possible to list at least 15 
such families in addition to the C-type and S-type (Table I). Out of these 15 families 
only five major classes have been discussed below. 
C-type lectins 
C-type lectins are the most diverse family of animal lectins. These lectins are 
generally multidomain proteins, in which C-type homologous CRDs provide Ca 
dependent sugar recognition activity and a variety of other modules initiates a broad 
range of biological activities such as cell adhesion, endocytosis and pathogen 
neutralization (Dodd and Drickamer, 2001). The sugar binding sites in vertebrates 
C-type CRDs are formed in part by a bound Ca2+ which must be present for the sugar 
binding to occur (Dodd and Drickamer, 2001). The majority of C-type lectins bind to 
D- mannose, D-glucose and related sugars (Man-type ligands), or to D-galactose and 
its derivatives (Gal-type ligands) (Kolatkar and Weis, 1996). C type lectins with high 
affinity for glycoconjugates bearing terminal galactose residues have been identified 
on the surfaces of peritoneal macrophages, Kupffer cells (Hoyle et al., 1988; Ii et al., 
1990) and appear to mediate recognition of tumor cells (Sato et al., 1992), whereas 
C.-lectins with lower affinity for Gal-type ligands are found in proteoglycan core 
proteins of cartilage and other tissues and are presumed to contribute to the 
organization of the extracellular matrix (Drickamer and Taylor, 1993). The genuine 
C-type lectins are more varied than thought and can be classified into subgroups e.g. 
Hyalectans, asialoglycoprotein receptor, collectins, selectins, transmembrane 
receptors, macrophage mannose receptor and single domain lectins (Kilpatrick, 2002), 
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Table I 
The different families of animal lectin with known three dimensional structures 
Family Carbohydrate specificity range Fold 
Galectins 
Pentraxins 
C-type lectins 
I-type lectins 
P-type lectins 
Cys-MR and FGF2 
Tachylectin 
Yml 
HGF/SF(NK1) 
Lectin from spider toxin 
Cobra venom cardiotoxin 
Spermadesins 
TNF 
Calnexins 
ERGIC-53 
Strict galactose/lactose 
Variable, often non carbohydrates 
Highly variable 
Sialic acid 
Mannose -6-phophate 
Sulfated carbohydrates 
GlcNAc/GalNAc 
Heparin/heparin sulfate 
Heparin/heparin sulfate 
Heparin 
Mannosamine 
Heparin, often non carbohydrate 
Chitobiose 
Glucose 
Mannose 
Beta sandwich 
Beta sandwich 
C-type lectin 
Immunoglobulin 
M6P- P-sandwich 
- p-trefoil 
Five-bladed - P-
propeller 
Chitinase 
Unique 
Unique 
Hevein 
CUB 
TNF - p-sandwich 
- P-sandwich 
- P-sandwich 
0te*iUewo£SkfetcUttw 
depending upon gene structure and the nature of additional non-lectin domain. Wide 
range of functions carried out by these lectins include catabolism of partially degraded 
glycoproteins containing terminal galactose or N-acetylgalactosamine residues 
(Schwartz, 1984), clearance of galactose terminal glycoproteins, desialyted 
erythrocytes and other blood cells (Sharon and Lis, 1989), cell-cell interaction during 
spermatogenesis and fertilization (Goluboff et al., 1995), targeting of hydrolytic 
enzymes to lysosomes (Sahagian, 1984), regulation of blood clotting (Stockert, 1995) 
and as a protein that guides leukocytes (Crottet et al., 1996) and also plays major roles 
in chronic rejection process of transplanted tissues (Russell et al., 1994). 
P-type (phosphomannosyl receptors) 
P-type lectins are mannose-6-phosphate recognizing, calcium independent group of 
lectins which have unique repeating motif in the carbohydrate recognition domain 
(Dahms, 1996). These lectins play an essential role in the generation of functional 
lysosomes within the cells of higher eukaryotes by directing newly synthesized 
lysosomal enzymes bearing the mannose 6-phosphate signal to lysosomes (Dahms 
and Hancock, 2002). The two members of the P-type lectin family, the 
cation-dependent mannose 6-phosphate receptor (CD-MPR) and the insulin-like 
growth factor II/mannose 6-phosphate receptor (IGF-II/MPR) are distinguished from 
all other lectins by their ability to recognize phosphorylated mannose residues 
(Drickamer and Taylor, 1993). Although the reported subcellular distribution of the P 
type lectins varies among cell types (Waguri et al., 2001), in general about 10% of the 
receptors are present at the cell surface while the remainder of the MPRs are found 
predominantly in late endosomal compartments and the trans golgi network. The 
ability of the IGF-II/MPR to recognize many functionally distinct ligands illustrates 
the multifunctional nature of this receptor and its involvement in a myriad of 
important physiological pathways including its crucial role in mammalian growth, 
including heart development by influencing fetal cell division and differentiation 
(Dell and Day, 1998). Over-expression of IGF-II is observed in various human 
cancers (Ellis et al., 1998), overgrowth syndromes (Sperandeo et al., 2000) and 
development of atherosclerosis (Zaina et al., 2002), thus suggesting its role in various 
pathological conditions. 
I- type lectins 
I-type lectin is a collective term introduced by Powell and Varki (1995) to describe 
carbohydrate-recognizing proteins that belong to the immunoglobulin (Ig) 
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superfamily. According to their specificity and binding affinities, these lectins are 
classified into many subclasses. Thus, there are I-type proteins recognizing sialic 
acids, other sugars and glycosaminoglycans. Among the I-type lectins recognizing 
sialic acids are the Siglecs (Sialic acid-binding immunoglobulin superfamily lectins), 
CD-83 (Scholler et al., 2001) and cell adhesion molecule LI (Kleene et al., 2001). 
Each Siglec has a distinct expression pattern in different cell types, indicating that 
they perform highly specific functions including critical roles in neural development, 
such as neural cell adhesion, positive and/or negative regulation of neurite outgrowth 
and myelin sheath formation (Filbin, 1995). 
CD-83 is a 45 kDa glycoprotein expressed on mature dendritic cells (Zhou and 
Tedder, 1995), thus suggesting its involvement in the interaction between dendritic 
cells and circulating monocytes as well as activated and/or stressed T cells. 
Cell adhesion molecule LI is a homophilic and heterophilic adhesion molecule of 
200 kDa found in the nervous system, CD4+ T cells, monocytes and B cells (Ebeling 
etal., 1996) where it plays an important role in axon guidance, cell migration and 
neurogenesis (Angata and Linden, 2002). 
I-type lectins bearing specificity towards other sugars than sialic acids includes neural 
cell adhesion molecules (NCAM), Myelin Protein Zero (P0), ICAM-1/CD54 
(Intracellular adhesion molecules), CD 2 and hemolin. They are present in a wide 
array of tissues including nervous system, vascular endothelium, certain lymphocytes 
and monocytes where they are involved in T cell development and myelination of 
peripheral neurons (Warner et al., 1996), inflammation and wound healing (Angata 
and Linden, 2002). I-type proteins interacting with sulfated glycosaminoglycans 
(GAGs) show selectivity towards the type of GAGs they interact with (in many cases 
heparin/heparan sulfate are the favored ligands). This category includes vertebrate 
fibroblast growth factor receptors (FGFR), Perlecan (heparan sulfate proteoglycan-
2/HSPG2) and CD48 and are essential to mammalian embryonic development 
(Arikawa et al., 2001) and CD4+ T cell activation (Hopf et al., 2001). 
Pentraxins 
The term 'pentraxins' was applied to C-reactive proteins (CRP) and its homologue, 
serum amyloid P component (SAP), to reflect their unusual quarternary structure in 
which five identical polypeptide subunits combine to form a ring with a central hole, 
loosely resembling a doughnut (Kilpatrick, 2002). These proteins are complement 
activating molecule with high affinity for phosphorylcholine, however, CRP has also 
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been found to bind to galactans and galactose phosphate but using a different binding 
site (Kilpatrick, 2002). Pentraxins are expressed in vertebrate species, where the 
division into CRP or SAP is not made on the basis of primary structural homology to 
the human examples, but rather on a preference for phosphorylcholine (CRP) or 
phosphoethanolamine (SAP) (Iwaki et al., 1999; Kilpatrick, 2002). 
S-Type lectins or p-galactoside binding lectins 
S-type lectins refer to soluble vertebrate tissue lectins which require thiol reducing 
agents to maintain their activity. However, this property is not shared by all of the 
S-type lectins but specificity towards P-galactosides is a common characteristic 
among this class of lectins, therefore a consensus was reached that the term 
'p-galactoside binding' or galectin would be more apt for the nomenclature of these 
specific proteins (Kilpatrick, 2002). In 1973, P-galactoside binding lectins were first 
discovered in Dictyostellium discoidium, a popular slime mould species during the 
study of eukaryotic development and differentiation, which was inhibited by lactose, 
galactose and related sachharides (Kilpatrick, 2002). This agglutinin, first named 
discoidin, then discoidin-1, exhibited a 400-fold increase in specific activity during 
aggregation of amoebae and was originally thought to mediate the adhesive contacts 
between the cells. Within a few years, several rather similar lectins were discovered in 
related or indeed the same (discoidin) species (Barondes, 1986). All were readily 
inhibited by lactose, but differed in fine specificity, including relative affinities for 
galactose and N-acetylgalactosamine. An apparently similar lactose specific was 
reported from the electric organ tissue of the electric eel (Teichberg et al., .1975). The 
discovery of electrolectin prompted the researchers to survey various tissues of higher 
animals for lactose specific agglutinins. Such activity was found to be very widely 
distributed amongst the numerous rat organs examined, but the highest specific 
activity was found in pectoral muscle of chicken embryos. All the lectins isolated 
were dimers exhibiting subunit molecular weights of about 15 kDa with the exception 
for intestine lectin (subunit molecular weight 14 kDa) which behaved as monomer 
and had a somewhat different carbohydrate binding site. Later soluble lectins were 
isolated from several mammalian tissues including human heart (Child and Feizi, 
1979), muscles (Child and Feizi, 1979) as well as rabbit bone marrow (Harrison et al., 
1984). Thus, it was apparent that these 'soluble lectins', 'endogenous lectins, 
'galaptins' or p-galactoside-binding proteins occurred universally in vertebrate tissue 
(Harrison, 1991). Many of the vertebrate lectins are structurally homologous; 
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however, the term "galectin" is now preferred to denote members of this family 
(Kilpatrick, 2002). Recent survey of literature shows that work on galectin is not only 
limited to purification and characterization, but has rather spread to more wide arrays 
like artificial synthesizing galectin using recombinant DNA technique (Timoshenko et 
al., 2003; Leffler et al., 2004; Ahmed and Vasta, 2008; Nagae et al., 2008). Studies on 
galectin are mainly related to their functional roles and their structural changes upon 
binding to sugar residues (Patnaik et al., 2006; Mok et al., 2007). Analysis of 
Genebank databases has led to the identification of more galectin-like proteins in 
mammals, invertebrates, plants and microorganisms, confirming that these 
carbohydrate binding proteins are highly conserved throughout the evolution (Cooper 
2002; Leffler et al., 2004). Almost of them appear in human genomic DNA and their 
mRNA is also expressed, suggesting that they are not pseudogenes (Cooper and 
Barondes, 1999; Leffler et al., 2004). As sequence databases continue to explode, 
many more galectin relatives will be discovered and fill the gaps in the galectin family 
tree. In fact, soon, genomics and proteomics may advance to the point that specific 
interactions of galectin subunits with each other, carbohydrate ligands, or other 
proteins could be accurately predicted from sequence alone (Cooper, 2002). Most 
galectins have been proposed to exert discrete biologic effects, according to 
subcellular compartmentalization, developmentally regulated expression and cell 
activation status (Zuniga et al., 2001). The v/ealth of new information promises a 
future scenario in which galectins or their antagonists will be targeted in respect to 
their fine structure and detailed mechanism of crucial roles played by them in every 
aspect of living system. 
Structural diversity of galectins 
All galectins contain conserved carbohydrate-recognition domains that are responsible 
for carbohydrate binding (Ahmed and Vasta, 1994; Ahmed et al., 2004; Ahmed and 
Vasta, 2008). Till date, 15 different galectins (galectin-1 to -15) have been identified 
(Table II) in mammals (Houzelstein et al., 2004; Ahmed and Vasta, 2008; Nagae et 
al., 2008) based on different sequence homology of CRDs. Overall structures of 
Gal-1, -2, -3 and -4 is shown in Fig. 1. 
Galectin -1 
Galectin-1 is a homodimer protein composed of two non-covalently linked 14-kDa 
subunits with one carbohydrate recognition domain of 134 amino acids (Houzelstein 
et al., 2004; Kiss et al., 2007). Since each dimeric molecule possesses two galactoside 
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binding sites, galectin-1 can mediate either intramolecular or intermolecular 
crosslinking by binding to more than one sugar residue (Gabius, 2002; Kilpatrick, 
2002; Imbe et al., 2003). This protein is found on the cell surface and the extracellular 
matrix, as well as in the cytoplasm and the nucleus of the cells in various tissues, 
including skin, muscle, lymph node, dorsal root ganglion (DRG), thymus, lung, 
spleen and placenta (Imbe et al., 2003; Leffler et al., 2004). Expression of galectin-1 
has been also identified in immune privileged sites such as placenta and cornea, 
suggesting an important role in generating and maintaining immune tolerance 
(Ilarregui et al., 2005; Rabinovich and Gruppi, 2005; Rabinovich et al., 2007). In-vitro 
gal-1 induces cell cycle arrest and apoptosis of activated T cells or T cell lines 
(Matarrese et al., 2005; Ion et al., 2005; Ion et al., 2006). However, the in-vivo 
functions of gal-1 are currently unclear because targeted disruption of the gal-1 gene 
in null mutant mice results in the absence of major phenotypic abnormalities, perhaps 
because of compensation by other family members (Kiss et al., 2007). Moreover, it 
has been also shown that Gal-1 inhibits chemotaxis and trans-endothelial migration of 
polymorphonuclear leukocytes in in-vitro studies (La et al., 2003). Expression of Gal-
1 in bone marrow-derived mesenchymal (stromal) cells has been implicated in bone 
marrow (BM) cell differentiation (Panepucci, 2004; Kadri et al., 2005). Gal-1 has also 
been shown to be a positive growth regulator towards other cell types, such as 
vascular endothelial cells (Sanford et al., 1990; Rabinovich et al., 2002). It has been 
speculated that growth inhibitory or stimulatory properties of this lectin are highly 
dependent on the cell types, cell activation status and concomitant environmental 
signals (Rabinovich et al., 2002; Rabinovich and Gruppi, 2005). In addition, these 
effects might be regulated alternatively by the relative levels of Gal-1 in the extra 
cellular milieu and the equilibrium between its monomeric and dimeric forms, 
because dimeric gal-1 is required to induce some, but not all, of the biological effects 
mediated by this carbohydrate-binding protein (Rabinovich et al., 2002, Rabinovich et 
al., 2007). 
Galectin-2 
Galectin-2 is structurally closely related to galectin-1 (non-covalent dimer with 
subunits of about 14 kDa), but has a distinct and a restricted expression profile (Sturm 
et al., 2004; Rabinovich et al., 2007). Structurally, Gal-2 shares 43% amino acid 
sequence identity with Gal-1 and the analysis of expression in rat tissues and human 
tumor cell lines had revealed its presence to be confined to the gastrointestinal tract 
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Table II 
Characteristics and functions of mammalian 0-gaIactoside binding lectin family. 
Type Tissue distribution Functions 
Galectin-1 Proto Ubiquitous expression 
Galectin-2 Proto Small intestine, stomach 
Galectin-3 Chimera Ubiquitous expression 
Galectin-4 
Galectin-5 
Galectin-6 
Galectin-7 
Galectin-8 
Galectin-9 
Tandem Gastrointestinal tract 
Proto Erythrocytes (rat) 
„ , Gastrointestinal tract Tandem (mouse) 
Keratinocytes (stratified 
epithelium) 
Tandem Ubiquitous expression 
Proto 
„ , Immune cells, lung, 
Tandem _ .
 t t- , *\ 
gastrointestinal tract 
Galectin-10 Proto Eosinophils, basophils 
Galectin 11 
Galectin-12 
Galectin-13 
Galectin-14 
Galectin-15/ 
OVGAL11 
Proto Eye lens 
Tandem Adipose tissue 
Proto Placenta 
Proto Eosinophils (sheep) 
Sheep stomach with 
Proto parasitic infection 
Uterus 
Apoptosis induction in activated T cells 
Cell growth, mRNA splicing 
Regeneration of nerve axon (oxidized galectin-1) 
Aberrant neurite outgrowth of the olfactory neuron 
Risk factor of myocardial infarction 
cell adhesion, mRNA splicing 
Inhibition of T cell apoptosis 
Macrophage chemotactic factor 
AGE receptor 
Reduced intraperitoneal inflammatory response 
Accelerated progression of diabetic nephropathy 
Activation of intestinal CD4+ T cells 
Erythroblast maturation 
High homology to the C-terminal CRD of galectin-9 
High homology to galectin-4 
Marker of all subtypes of keratinocytes 
Cell adhesion 
Regulation of neutrophil function 
Apoptosis induction in activated T cells 
Eosinophil chemotactic factor 
Apoptosis induction in cancer cells 
Cell adhesion 
Charcot-Leyden crystal 
Affinity for mannose 
Also called GRIFIN, lacks affinity for p-galactosides, 
Apoptosis induction in adipocytes 
Pregnancy-related protein 
High homology to galectin-10 
Possible involvement in allergic reaction 
Relatively high homology to the N-terminal CRD of 
galectin-9 
Endometrial interactions, uterine immune and 
inflammatory responses and placental morphogenesis. 
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Figure 1. Schematic representation of the overall structures of galectin-1, -2, -3 
and-4. 
The proteins are shown schematically as linear diagrams corresponding to 
single peptide chains (top) and as assembled proteins (bottom). The 
carbohydrate- binding domains of about 130 amino acid residues are blue, the 
proline-, glycine- and tyrosine-rich repeating domain of galectin-3 (about 100 
residues) and link peptide of galectin-4 (about 30 residues) are orange and the 
N-terminal domain of galectin-3 (about 30 residues) is black. (Barondes et al., 
1994) 
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(Lahm, 2001; Ahmed and Vasta, 2008). Thus, Gal-2 is likely to encounter T cells, 
especially in inflammatory bowel disease, shedding light on its immunomodulatory 
capacity (Lahm et al., 2004; Sturm et al., 2004). In contrast to Gal-1, it lacks 
reactivity towards CD3 and CD7. However, it is a potent inducer of apoptosis of 
activated T cells, probably mediated by binding to Pi integrin (a closely associated 
glycoprotein) (Lahm et al., 2004; Sturm et al., 2004). 
Galectin-3 
Galectin-3 is a 29 kDa- 35kDa member of the galectin family which promotes cell 
growth and proliferation and acts as a mitogenic signal towards several types (Liu et 
al , 2002; Bozice et al., 2004; Ahmed and Vasta, 2008). Galectin-3 consists of an 
N-terminal domain (about 130 amino acids) made of tandem repeats of short stretches 
of amino acids connected to a C-terminal carbohydrate recognition domain (Dumic et 
al., 2006). It is ubiquitously expressed in a wide range of tissues and by inflammatory 
cells like neutrophils, dendritic cells, macrophages and monocytes (Liu et al., 1995; 
Dietz et al., 2000; Joo et a l , 2001; Acosta et al., 2004). In the peripheral and central 
nervous system, galectin-3 has been expressed in neurons, Schwann cells and 
astrocytes including gliomas and microglia (Yang et al., 2006). Gene expression 
profiling and immunohistochemical analysis has identified galectin-3 expression as 
highly up regulated in prion-infected brain tissue on the mRNA and protein level 
(Reimer et al., 2004; Mok et al., 2006), thus suggesting its role in chronic 
neurodegeneration in prion infected nervous tissue (Mok et al., 2007). Galectin-3 has 
been implicated in a variety of inflammatory conditions mostly involving innate 
immune reactions (Bernandes et al., 2006). Extra cellular galectin-3 can also function 
as an inducer of T-cell apoptosis through binding to CD7 and CD29 on the T cell 
surface (Fukumori et al., 2003; Fukumori et al., 2004), as well as a positive or a 
negative growth factor, depending on the target cells (Marer, 2000). In addition, 
galectin-3 plays a critical role in host protection against infection (Kleshchenko et al., 
2004; Vray et al., 2004), for example it displays a direct fungicidal activity by 
inducing death of Candida species containing specific 0-1-2 linked oligomannans 
(Kohatsu et al., 2006) and also binds to wide variety of mammalian pathogens (Beatty 
et al., 2002; John et al., 2002; Pelletier and Sato, 2002; van der Berg et al., 2004; 
Levroney et al., 2005; Ouellet et al., 2005; Barboni et al., 2005). Galectin-3 is also 
strongly expressed in wide variety of cancers (Danguy et al., 2002; Liu et al., 2002; 
Plazk et al., 2004), thus implicating its role in prognosis and malignancy of tumors 
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and also inhibits apoptosis in response to chemotherapeutic drugs (Plazk et al., 2004; 
Debray et a l , 2004; Takenaka et al., 2004; Fukomori et a l , 2007). 
Other galectins 
Galectin-4 was the first mammalian lectin consisting of a single polypeptide chain 
that forms two distinct but homologous CRDs, separated by an un-conserved linker 
sequence of upto 70 amino acids (Dumic et al., 2006). Thus two CRDs type galectins 
can bind two individual carbohydrate epitopes. This galectin is a monomer with 
molecular weight of 36 kDa and is abundantly present in intestinal epithelium 
(Barondes et al., 1994). 
Gal-5 was first discovered as a lactose binding protein isolated from rat lung (Cerra et 
al., 1985) and erythrocytes (Rabinovich et al., 2007) which consists of one CRD with 
little additional sequence and has upto 40% identity with galectin-3 and -4 (Leffler et 
al., 2004; Ahmed and Vasta, 2008). 
Galectin-6 has two CRDs that are about 80% identical with those of galectin-4, but 
the link peptide joining them is 24 amino acids shorter than galectin-4 (Gitt et al., 
1998). Galectin -4 and -6 are so similar that they cannot be distinguished in most 
localization assays such as immunohistochemical and northern blots, but their 
combined expression can be easily detected and distinguished from other proteins. 
Possibly galectin-6 is also expressed in small intestine of several mammalian species 
(Gitt et al., 1997; Leffler et al., 2004). 
Gal-7 is a 14 kDa member of the lectin family present in stratified epithelia, 
interfollicular epidermis and the outer root sheath of the hair follicle (Magnaldo et al., 
1995; Leonidas et al., 1998). Thus, galectin-7 is considered as a marker of all 
subtypes of keratinocytes and its expression does not seem to be influenced by the 
stages of differentiation (Magnaldo et al., 1995; Bernerd et al., 1999; Saussez and 
Kiss, 2006). In addition, galectin-7 is also reported to increase the efficacy of 
chemotherapeutic drugs in urothelial cancer mediated via intracellular reactive 
oxygen species (Matsui et al., 2007). 
Galectin -8 also known as prostate carcinoma tumor antigen 1 (PCTA-1) is a 35 kDa 
protein made up of tandem repeat CRDs joined by link peptide ((Bidon-Wagner and 
Le Pennec, 2004) and structurally related to galectin-4 (34% identity). However, 
unlike galectin-4, which is confined to the intestine and stomach, gal-8 is expressed in 
liver, kidney, cardiac muscle, lung and brain (Hadari et al., 1995, Hadari et al., 2000). 
Native gal-8 exists as a monomer and its two CRDs are structurally different with 
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different specificities for sugar residues which does not require complex N-Glycans 
for binding (Patnaik et al., 2006) 
Galectin-9 is a 40 kDa protein consisting of 353 amino acids. The sequence identity 
between the N- and C-terminal CRDs is 35% (Nagae et al., 2006; Cao et al., 2007; 
Nagae et al., 2008). Galectin 9 is a lactose binding protein reported to be expressed in 
a subpopuation of cells present in peripheral blood leukocytes, lymphoid tissues 
(Sahin et al., 1995; Tureci et al., 1997; Nagae et al., 2008), kidney, intestine and 
thymus (Wada et al., 1997) controlling wide range of activities like T-cell 
development (Wada and Kanwar, 1997; Wada et al., 1997), chemo-attraction of 
eosinophils, induction of apoptosis and down-regulating of effector THi responses 
(Matsushita, 2000; Kageshita et al., 2002; Zhu et al., 2005; Nagae et al., 2008). 
Galectin-10 has been originally isolated as Charcot-Leyden crystal because of its 
unusual solubility properties and spontaneously crystallization in eosinophil mediated 
inflammatory tissues (Charcot and Robin, 1853; Leyden, 1872; Kilpatrick, 2002). 
It constitutes >7% of the total protein content of a typical eosinophils 
(Ackerman et al., 1993) and displays weak lactose and mannose binding specificity in 
soluble and crystalline state, respectively (Swaminathan et al., 1999; Kilpatrick, 
2002). 
Very little information is available on gal-11 and 13, except that they contain one 
carbohydrate recognition domain (Kilpatrick, 2002). Galectin-11 (also called GRIFIN 
for "galectin related interfiber protein") was found to be present in the lens of the 
eye, suggesting a role for this protein in the maintenance of immune privilege in this 
vulnerable tissue (Rabinovich et al., 2002; Rabinovich et al., 2007). 
Galectin-12, a recently identified member of this family, contains two CRDs and has 
shown growth inhibitory properties (Yang et al., 2001; Hotta, 2001). Expression of 
galectin-12 is high in peripheral blood leukocytes and adipocytes, but very low or 
undetectable in many tissue and cell lines, except in those of myeloid origin with the 
potential to undergo terminal differentiation (Yang and Liu, 2003). 
Gal-14 is a novel sheep galectin specifically expressed in eosinophils, but this galectin 
is similar in sequence to the first galectin domain of galectin-9. It has been shown to 
have galactoside-binding activity and has been named galectin-14 (Dunphy et al., 
2000; Dunphy et al., 2002). Galectin-14 seems to be released into the airway lumen in 
response to allergen challenge; therefore a possible role in immune defense (Dunphy 
et al., 2002) is suggested. 
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Galectin-15, also known as OVGAL11 and a previously uncharacterized member of 
the galectin family of secreted P-galactoside lectins containing a conserved 
carbohydrate recognition domain and a separate putative integrin binding domain, 
was discovered in the uterus of sheep (Gray et al., 2004; Gray et al., 2005). It is 
concentrated near and on the apical surface of the endometrial luminal epithelia and 
localized within discrete cytoplasmic crystalline structures of conceptus 
trophectoderm (Tr) (Gray et al., 2004; Rabinovich et al., 2007). Galectin-15 protein is 
functional in binding lactose and mannose sugars and immunologically identical to 
the unnamed Mv 14,000 (14 kDa) protein from the ovine uterus that forms crystalline 
inclusion bodies in endometrial epithelia and conceptus Tr (Gray et al., 2004). 
Structural Classes of p-galactoside binding lectins 
Based on protein architecture and its ability to function as a cross linker, the galectin 
family has been divided into three subgroups as shown in Fig. 2 (Vasta et al., 2004). 
Prototype 
The proto-type galectins (galectin-1, 2, 5, 7, 10, 11, 13, 15 and 14) consist of a single 
CRD per subunit with a short N-terminal sequence and a single core protein domain 
(Houzelstein et al., 2004; Rabinovich et al , 2007; Nagae et al., 2008). Most of these 
galectins are homodimers or multimers as in the case of sponge galectins (Miarons 
and Fresno, 2000), but some others, such as mammalian galectin-5, -7 and -10 
(Kopitz et al., 2003) exists in monomeric form. They also show distinct tissue specific 
and developmentally regulated expression in a variety of different sources (Cooper, 
2002). Dimerization of prototype galectins involves self-association of monomer 
subunits at sides opposite their CRDs through non-covalent interactions to create 
bivalent lectins (Brewer et al., 2002; Rabinovich et al , 2007). Thus, the CRD pockets 
and any bound ligands face away from each other, an arrangement unlikely to allow 
multivalent binding to closely clustered ligands (Brewer, 2002; Brewer, 2004; Dam et 
al., 2005). However, these dimers can very effectively crosslink separated ligands, 
even forming chains or crystalline networks of the divalent lectin bound to di- or 
multivalent ligands (Sacchettini, 2001; Liu and Rabinovich, 2005). 
Tandem-repeat 
These galectins (Galectin-4,-6,-8,-9 and 12) are composed of two non identical core 
galectin domains joined either directly or via a linker peptide of variable length 
(Toscano et al., 2007). Their CRDs are positioned in such a way that they can 
simultaneously bind to multivalent ligands, greatly enhancing the binding avidity 
17 
gR&iHewofiSflU&uUate' 
(Arata et al.,1997; Hirabayashi et al., 2002) as opposed to homo-functional cross-
linking by dimeric prototype galectins (Cooper, 2002). 
Chimeric type (Galectin-3) 
These galectin types are composed of a protein domain joined to a distinct 
N-or-C-terminal domain (Rabinovich et al, 2007) which is responsible for 
interactions between subunits, thus facilitating its oligomerization (Liu and 
Rabinovich, 2005). In vertebrates, the only chimeric galectin yet discovered is 
galectin-3, but several other chimeric galectins are apparent in invertebrates (Dumic et 
al., 2006). Galectin-3 is composed of an N-terminal domain with several repeats of a 
peptide sequence rich in proline, glycine and tyrosine residues followed by a 
C-terminal galectin domain (Dumic et al., 2006). The intact C-terminal galectin 
domain remains with its lectin activity intact, but loses much of its propensity to 
multimerize (Kuklinski and Probstmeir, 1998). Galectin-3 monomers are in 
equilibrium with higher order oligomers in solution and galectin-3 precipitates as a 
pentamer with multivalent oligosaccharides (Ahmed et al., 2004). This lectin binds to 
multi-glycosylated proteins with positive co-operativity, suggesting that galectin-3 
monomers, after ligand binding, recruit additional lectin molecules to form a complex 
of multivalent interactions (Brewer et al, 2002; Ahmed et al., 2004). The biologic 
functions attributed to galectin-3 are thus likely to depend upon both ligand 
crosslinking and oligomerization (Nieminen et al., 2005; Stillman et al., 2005; Chen et 
al., 2006; Toscano et al., 2007; Nieminen et al., 2007). 
Secretion and biosynthesis of (3-galactoside binding lectins 
Although galectins are often reported to be present on cell surfaces or in extracellular 
matrix, they lack recognizable secretion signal sequences and do not pass through the 
standard Endoplasmic reticulum/Golgi pathway (Leffler, 2001; Cooper, 2002), with 
the possible exception of a sponge galectin (Miarons and Fresno, 2000). Instead, most 
galectins have characteristics typical of cytoplasmic proteins, such as an acetylated N-
terminus, free sulfhydryls and lack of glycosylation. Nevertheless, there is strong 
experimental evidence that at least some galectins are, indeed, secreted, albeit by 
novel non-classical mechanisms (Hughes, 1999; Boulianne et al., 2000; Leffler et al., 
2004). Galectin secretion from cells is tightly controlled during development and 
several unrelated factors, including cytokines as well as adhesive and membrane 
fusion can modulate secretion (Hughes, 1999). Pulse chase experiments also 
demonstrated that the lectin is actively secreted from cells, rather than leaked from 
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Figure 2. Pictorial representation of three types of lectins. 
The first group consists of proto-type galectins with one carbohydrate binding 
domain or carbohydrate recognition domain (CRD). The second group consists 
of chimera-type galectins that have one CRD and another non-
carbohydrate-binding domain linked together. The third group consists of 
tandem-repeat-type galectins with two CRDs. Although proto-type and 
chimera-type galectins have only one CRD, two molecules bind to each other 
(dimerization) so that they can actually bind to two carbohydrate chains as 
tandem-repeat-type galectins do (some proto-type galectins are unlikely to 
form a dimer) ( Stillman et al., 2005). 
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damaged cells (Cooper, 2002; Hughes, 2001). Upon secretion, galectins typically 
bind to and stay associated with glycoproteins and glycolipids on the cell surface, or 
within the surrounding extracellular matrix to complete its folding and stability 
(Stillman et al., 2005). Thus, while galectins are abundant in tissues where they are 
made, however, only low levels are found in serum and serum levels of galectins do 
not reflect the rates of synthesis in tissues (Iurisci et al., 2000; He and Baum, 2004). 
Purification strategies of p-galactoside binding lectins (Galectins) 
In general, soluble P-galactoside binding lectins have been isolated by affinity 
chromatography on asialofetuin or lactosyl-Sepharose 4 B columns (Ola et al., 2001; 
Ola et al., 2007). First, the fresh animal tissue is solubilized with phosphate buffer 
saline containing reducing agents and competing sugars in order to dissociate soluble 
P-galactoside binding lectin from insoluble substances of starting tissues (Kasai and 
Hirabayashi, 1996). The acetone powder prepared from animal tissue has been rarely 
used to extract lectin (Den and Malinzak, 1977). Then soluble P-galactoside binding 
lectin is isolated from crude extract by ammonium sulphate fractionation followed by 
affinity chromatography. The bound protein is eluted with lactose. The lectin activity 
is measured by hemagglutination assay using fresh rabbit and human erythrocytes 
treated with trypsin or neuraminidase (Muramoto et al., 1999; Ola et al., 2001). In 
addition, multiple forms of lectin have also been isolated from human and rat lung by 
employing ion exchange chromatography on DEAE-cellulose or sephadex column 
followed by chromatography on CM-sephadex column (Cerra et al, 1985; Sparrow et 
al., 1987) in the presence of protease inhibitors to minimize the proteolytic 
degradation of lectin. 
Physicochemical properties of P-galactoside binding lectins (Galectins) 
These lectins are soluble proteins bearing an affinity for P-galactoside containing 
moieties, besides possessing a carbohydrate recognition domain with conserved 
sequence elements that require a reducing environment for action but no divalent ions 
(Hasan et al., 2007). They are distinguishable from all other lectins by their low 
molecular weights, ranging from 14-36 kDa, dimeric nature and their variable 
sub-cellular location (Rabinovich et al., 2007). By virtue of their multivalency, 
galectins are able to cross link cell surface glycoconjugates and iniatiates cell 
biological response (Rabinovich et al., 2007). These lectins binds to 
N-acetyllactosamine with relatively low affinity (dissociation constant (Kd) in the 
range of 90-100 uM), but they bind to glycoproteins containing polylactosamine 
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sequences with a high affinity (Kd-luM) (Brewer et al., 2002; Dam et al., 2005). 
While CRDs of all galectins share affinity for N-acetyllactosamine found on many 
cellular glycoproteins, individual galectins can also recognize different modifications 
of this sugar, demonstrating the fine specificity of certain galectins for tissue or 
developmentally specific ligands (Brewer, 2004; Ahmed et al., 2004). 
In the isolectric focusing experiment, 90 % of rat lung lectin moved with the 
isoelectric point (pi) of pH 5.5. However, a faint band with pi of pH 5.5 was also 
observed (Clerch et al., 1988). Amino acid composition of galectins obtained from 
different sources of several mammals is found to be similar, if not identical (Shahwan 
et al., 2004). The total number of acidic amino acid residues is found to be 
significantly higher than the total number of basic amino acid residues. All lectins 
studied so far have blocked N-termini and an acetyl group is demonstrated to be the 
blocking group (Leffler et al., 2004; Rabinovich et al., 2007). Galectins occasionally 
contain cysteine residues, but no disulfide bond is formed and all SH groups are in a 
free state. Till date, no galectins are glycosylated with an exception of sponge galectin 
(Miarons and Fresno, 2000). Cloning of cDNAs revealed that galectins are 
synthesized without a signal sequence (Kasai and Hirabayashi, 1999), strongly 
suggesting that galectins are designed as intracellular proteins (Leffler et al., 2004). 
Ligands for Galectins 
Despite the large number of P-galactoside-containing glycoconjugates present in the 
cellular milieu, few glycoproteins from cell extracts bind to particular galectins 
in-vitro (Barondes et al., 1999) suggesting that these may be the interactions that are 
physiologically significant. Among naturally occurring glycoconjugates, 
glycoproteins that contain polylactosamines are especially good ligands for galectins 
(Liu, 2000; Rabinovich et al., 2007). Of these, laminin, a glycoprotein with many 
polylactosamine chains, has been implicated as a natural ligand for galectin- 1 
(Hughes, 2001) and is also bound by galectin-3 (Liu, 2000). Galectin- 1 has also been 
shown to bind to other glycoconjugates including polylactosamine-rich 
lysosome-associated membrane proteins (Imbe, 2003) that are sometimes found on 
the cell surface, a lactosamine-containing glycolipid on olfactory neurons (St John 
and Key, 1999; Horie and Kadoya, 2004) and integrin a7pi on skeletal muscle cells 
(Hadari et al., 2000). 
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Carbohydrate binding domain and specificity 
Galectins have in common a highly conserved carbohydrate binding site (CRD) with 
affinity for lactose and N-acetyllactosamine (Fig. 3) (Barondes et al., 1999; Vasta et 
al., 2004; Ahmed and Vasta, 2008), formed by part of the six stranded antiparallel 
P-pleated sheets that form an extended sandwich with a typical jellyroll topology and 
is around 130 amino acid long (Liao et al., 1994). The core sequence of this domain 
lies between the 30th and the 90th residues and is encoded by a single exon (Cooper 
and Barondes, 1999). The number and arrangement of the CRDs may vary and has 
been used as a basis of their classification. The galectin CRD has a concave side 
forming a groove long enough to hold a linear oligosaccharide made of up to four 
monosaccharide units (Loris, 2002; Leffler et al., 2004). The fine specificity of the 
two CRDs may differ (Hirabayashi et al., 2002; Ideo et al., 2003; Zick et al., 2004) 
displaying tightest interaction with galactose residue, but interaction with glucose is 
also significant, making the afiinity for lactose 50-150 folds higher compared to 
galactose for most galectins (Toscano et al., 2007). However the carbohydrate binding 
cleft can accommodate an additional one to three sachharide residues suggesting the 
reason for polylactosaminoglycans as good ligands for galectins (Cho and Cummings, 
1995; Stowell et al., 2004; Sorme et al., 2004). In fact polylactosaminoglycans are 
bound by the galectins more tightly than lactose/N-acetyllactosamine due to the 
presence of secondary sites for interaction with more extended oligosachharides 
(Leppanen et al., 2005) in addition to the primary site, which accommodates 
lactose/N-acetyllactosamine (Toscano et al., 2007). Each galectin has a unique 
specificity, for example the affinity of galectin-1 for blood group A tetrasaccharide is 
about 100 fold lower than that of galectin-3 and certain complex mucin derived 
saccharide that bind galectin-3 well, do not bind galectin-1 at all (Brewer, 2002). 
Galectin-1, -3 and -5 also differs in their affinity for certain disachharides such as 
Gal-pM-j3 GalNAc (Brewer, 2002). The two chicken galectins, CI4 and CI6, were 
shown to differ in their fine specificity for a panel of synthetic lactose derivative 
(Barboni et al.,2000). 
Mutivalency of P-galactoside binding lectins 
Most galectins are divalent, either by self-association or by including two CRDs in 
one protein (Gabius et al., 2002). All galectins identified till date can be structurally 
classified into three basic types (Vasta et al., 2004), which achieve di- or higher 
valency by distinct mechanisms. Multimerization is a common feature across various 
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Figure 3. Fine structure of interaction between galectin-2 and lactose. 
The sugar residues are shown in green with red oxygen atoms and position numbers. 
The amino acid side chains interacting with the saccharides are shown in light blue. 
The principal hydrogen bonds between amino acid side chains and the sugar residues 
are shown as yellow dotted lines (Barondes et al., 1999). 
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families of carbohydrate binding proteins, perhaps because binding interactions of 
individual CRDs with even their most favored carbohydrate ligands are of relatively 
low affinity and multimerization can greatly increase binding avidity for multivalent 
or clustered ligands (Rabinovich et al., 2007). However, in studies of a range of di- or 
multivalent galectins, only some show enhanced avidity for multivalent ligands 
(Hirabayashi et al., 2002). This may mean that for some galectins, the significance of 
di- or multivalency is to provide them the ability to crosslink ligands (Cooper, 2002). 
Indeed, there is considerable evidence that some galectins regulate association of their 
glycoconjugate ligands on cell surfaces, in extracellular matrices, or both (Brewer, 
2002; Rabinovich et al., 2007). Monovalent galectins might function to competitively 
block such cross-linking activity (Cooper, 2002). 
Crystal structure of fi-galactoside binding lectin 
The refined X- ray model of S- lectin consists of 133 amino acid residues in one 
monomer and 132 amino acid residues in the other monomer, two 
N-acetyllactosamine molecules and 154 water molecules (Liao et al., 1994). The 
S-lectin dimer forms a 22-strand anti-parallel P-sandwich, with the N and C termini of 
each monomer at the dimer interface (Fig. 4). The two molecules are related to each 
other by a non-crystallographic 2-fold rotation perpendicular to the P-sheets 
displaying a jelly roll topology containing a P-hairpin insertion with the first and 
second parallel P-strands omitted (Liao et al.,1994). The structure reveals that there is 
one carbohydrate-binding site per monomer, which is located on the same side of the 
P -sandwich and on the far ends of the dimer 46 A apart. The integrity of the dimer is 
maintained by the P-sheet interactions across the monomers and by the formation of a 
hydrophobic core common to both. In S-lectin the two P-sheets of the monomers 
extend continuously across the dimer interface and all direct protein carbohydrate 
interactions involve side chains located on p-strands (Liao et al., 1994). 
Carbohydrate Binding-Site Interactions 
The well-defined electron density of both carbohydrate molecules clearly indicates the 
a-anomeric form for the GlcNAc unit (Liao et al., 1994). Most amino acid residues 
involved in sugar binding are invariant in all sequences of S-lectins. The binding-site 
depression is shaped to complement the galactose moiety with extensive Van der 
Waals contacts and a network of electrostatic interactions (Fig. 5). In addition, a water 
molecule mediates the interactions of the side chain of Asn-46 with the 3-OH and 4-
OH of galactose. The aromatic side chain of the conserved Trp-68 stacks adjacent to 
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Figure 4. Fold of S-lectin: Highlighting secondary structure motifs of the 
dimmer. 
P strands are shown as ribbons and the N-acetyllactosamine molecules are 
shown as yellow stick models. The model was generated by the computer 
program RASTER 3 D written by David Bacon (University of Alberta, 
Canada) (Barondes et al.,1994). 
25 
0te^ie44^o^3^Ue^€Uu*e^ 
Figure 5. Stereoscopic representation of S-lectin carbohydrate binding site. 
Bonds between carbohydrate atoms are solid and those between protein atoms 
are open. The electrostatic interactions between protein and sugar atoms are 
shown in thin N46 lines. For clarity, protein-protein electrostatic interactions 
of residues involved in sugar binding are not indicated; these include the salt 
bridges between Arg-48 and Asp-54, Arg-73 and Asp-54 and Arg-73 and 
Glu-7 (Liao et al., 1994). 
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the galactose ring. Such Van der Waals interactions between sugar and aromatic side 
chains are quite common in protein-carbohydrate complexes (Vyas, 1991). The axial 
4-OH of galactose is the main determinant of the S-lectin specificity which forms two 
key electrostatic interactions i.e one with the N" atom of Arg-48 and the other with 
the Ne atom of His-44. The interactions of the GlcNAc moiety with the protein are 
less extensive than those of H 44 of galactose, whereas the binding of 
N-acetyllactosamine to S-lectin is 5-fold tighter than the binding of lactose (Ahmed et 
al., 1990; Vasta et al., 2004) which may be attributed to Van der Waals interactions 
between the N-acetyl group and the side chains of Arg-73 and Glu-71. The 
carbohydrate-protein interactions are supported by exquisite protein-protein 
electrostatic interactions, assuring optimal side-chain conformations (Fig. 5). Most 
striking is the spatial disposition of the charged residues Arg-48, Asp-54, Arg-73 and 
Glu-71, which together form a network of three salt bridges unprecedented in other 
sugar-binding proteins of known structure. Of these, Asn-46, Glu-71 and Arg-73 have 
been previously suggested as essential for binding by site-directed mutagenesis 
(Hirabayashi and Kasai, 1991). These structural data explain why those amino acid 
residues that are directly and indirectly associated with the carbohydrate binding are 
conserved. 
Environment of Thiol Groups. 
The crucial role that the oxidation states of the S-lectin thiol groups play in regulating 
function in vivo is still a mystery. According to the refined structure (Liao et al., 
1994), the thiol groups of Cys-42 and Cys-60 are reduced and buried whereas Cys-2 
thiol group is disordered and Cys-16, Cys-88 and Cys-130 sulphydryl moieties are 
oxidized and solvated. No thiol group is directly involved in sugar binding and all 
thiol groups bind heavy atoms without impairing sugar binding. Cys-60 is the only 
cysteine residue close to the binding site. Its main-chain atoms are involved in the 
formation of the active site depression and its side chain is buried and surrounded by 
hydrophobic residues (Liao et al., 1994). Site-directed mutagenesis studies of the 
14-kDa S-lectins, replacing Cys-60 and Cys-2 by serine residues, did not inhibit sugar 
binding, consistent with the structural information (Abbot and Feizi, 1991; 
Hiarabayashi and Kasai, 1991). 
Hemolytic and membrane perturbing action of p-galactoside binding protein 
Animal lectins have been of great interest recently, as their various important 
functions have been suggested. One of the most probable roles of P-galactoside 
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binding lectins is to act as humoral factors in the defense mechanism against various 
pathogenic agents. Moreover, gal-1 preferentially binds to ganglioside GMi on 
neuroblastoma cells to exert growth control (Kopitz et al., 2001; Seibert et al., 2003; 
Kopitz et al., 2003) and that it harbors a site to interact with hydrophobic tails of 
oncogenic H-Ras (Rotblat et al., 2004). The underlying mechanism to carry out this 
role is its glycan binding property present on the cell membranes, thereby causing 
lysis of the cells. Lytic action of some lectins have been ascribed to enzymatic activity 
(Hittelet et al., 2002), perturbation of the activities of membrane-associated enzymes 
(Lowe and Marth, 2003), or pore formation in the membranes (Yu et al., 2002).The 
lectin dependent association of glycans may affect membrane features such as 
fluidity, permeability and osmofragility (Gupta et al., 2006). In addition, lectin might 
also interact with hydrophobic membrane patches adding to its impact on membrane 
characteristics (Gupta et al., 2006). 
Functions of p-galactoside binding lectins 
Lectins bearing specificity towards galactoside residues are involved in wide array of 
functional activities owing to its potential of recognition and discrimination between 
potential glyco-substrates. Some of their principle roles are discussed below: 
Role of p-galactoside lectins in inflammatory and immunomodulatory responses 
Among the various functions of galectins, the role in the modulation of the immune 
response has been very well documented. Recent research indicated that gal-1 
ameliorates phospholipase A2 induced edema (Rabinovich et al., 2000; Rabinovich et 
al., 2002; Rabinovich and Gruppi, 2005), regulates the release of soluble mediators 
from lipopolysaccharide stimulated macrophages, blocks neutrophil extravasation 
(Elola et al., 2005), mast cell degranulation (Rubenstein et al., 2004) and nitric oxide 
synthesis (Rabinovich et al., 2004). Moreover, presence of Gal-1 in bone marrow 
derived mesenchymal (stromal) cells suggests its implications in bone marrow derived 
cell differentiation and mobilization (Panepucci et al., 2004; Kadri et al., 2005; Kiss et 
al., 2007). In addition, gal-1, displays pleiotropic immunomodulatory functions, 
including regulation of lymphocyte survival and cytokine secretion in autoimmune 
system, transplant diseases, parasitic and viral infection models (Santucci et al., 2000; 
Santucci et al., 2003; Baum et al., 2003, Rabinovich et al., 2004; Levroney et al., 
2005). 
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Role of p-galactoside lectin in cell-cell and cell matrix interactions 
Galectin plays a pivotal role in adhesion and migration of cell mediated by 
cross-linking a mosaic of extracellular matrix glycoproteins like laminin, fibronectin, 
lysosome associated membrane proteins and CD45 (Wada and Makino, 2001; 
Rabinovich et al., 2004). Despite specific binding of galectins to these 
glycoconjugates, its anti or pro-adhesive role still remains obscure. For example, gal-1 
promotes the adhesion of ovarian carcinoma cells to extracellular matrix (Rabinovich 
et al., 2004), whereas it inhibits the adhesion of myoblast to laminin by blocking the 
laminin receptor integrin a7pi from recognizing laminin (Matarrese et al., 2000a). 
Similarly, gal-3 preferably mediates adhesion of the neutrophils to laminin in 
comparison to melanoma (Sato et al., 2002). While gal-3 contributes to cell 
interactions between dendritic cells and naive T lymphocytes in lymph nodes 
(Rabinovich et al., 2002, Ilarregui et al., 2005), a recent study revealed that galectin-3 
even disrupts thymocyte interactions within the thymic microenvironment, thus acting 
as a de-adhesion molecule (Villa et al., 2002). 
Role of p-galactoside lectin in pre-mRNA splicing 
The process of deletion and reconstitution of splicing activity, assayed in cell free 
system, suggested that galectins are major factors involved in pre-mRNA processing 
(Park et al., 2001; Liu et al., 2002). Other techniques such as co-localisation studies 
(Vyakarnam et al., 1998; Wang et al., 2007) and immunofluorescence microscopy 
(Liu et al.,2002) also revealed nuclear speckled structures containing galectin and 
known splicing factors, thus providing additional evidence to confirm the role of 
galectins in mRNA splicing. The domain structure for gal-1 and gal-3 suggested that 
homologous CRD was necessary and sufficient for splicing activity (Park et al.,2001; 
Liu et al., 2002), which thereby interacts with various functional proteins constituting 
the spliceosome assembly (Pellizzoni et al., 1998; Park et al., 2001). 
Role of P-galactoside lectin in cell growth and apoptosis 
Several early studies provided correlative evidence for an association between 
galectin expression and cell proliferation. Galectin-3 is expressed at high levels in a 
wide range of neoplasms, including spontaneous, viral, ultraviolet and chemically 
induced tumors (Plazk et al., 2004; Dumic et al., 2006) suggesting the possibility that 
the galectins may have a role in regulation of cell growth (Liu et al., 2002; Dumic et 
al., 2006). Some pro-apototic galectins, such as gal-1 and gal-9, directly initiate death 
by cross-linking cell surface receptors, whereas intracellular expression of other 
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galectins, such as gal-7, potentiates other death signals (Rabinovich et al., 2004). 
Galectins affect cell fate decisions in a variety of tissues and cell types. For example, 
gal-1 kills T cells, B cells and prostate and breast cancer cell lines, suggesting that 
gal-1 may recognize a common carbohydrate ligand on diverse cell surface receptors 
to initiate a common intracellular death pathway (Hernandez and Baum, 2002; 
Stillman et al., 2005). Multiple galectins have also been shown to influence viability 
in a single cell type. Complex expression patterns of galectins and their carbohydrate 
ligands may allow temporal regulation of cell viability during development, tissue 
remodeling and inflammation (Hernandez and Baum, 2002; Leffler et al., 2004). In 
addition, some galectins can act extracellularly to induce apoptosis in concert with 
other stimuli. For example, addition of exogenous gal-8 induced apoptosis of serum-
starved carcinoma cells in a carbohydrate dependent manner (Hadari et al., 2000). 
Furthermore, galectin-1 also induces apoptosis of breast and prostate cancer cell lines 
(Yang and Liu, 2003) and melanoma cells (Stillman et al., 2005). 
Role of P-galactoside lectins in regulation of cell cycle 
Factors playing significant role in cell growth and apoptosis simultaneously function 
in controlling cell cycle, thus suggesting that galectins also play significant role in 
regulating cell cycle. For example, galectin-1 has also been shown to inhibit growth 
of mouse embryonic fibroblast at relatively low concentrations (Wells and Mallucci, 
1991; Rabinovich et al., 2001) and induce cell cycle arrest during the S-to G2 
transition of mammary cell lines (Wells et al., 1999; Novelli et al., 1999; Yang and 
Liu, 2003). It also inhibits the IL-2 induced proliferation of phytohemagglutinin 
activated T lymphocytes, IL-independent proliferation of T lymphoma cells, 
concavavalin A (Con A)-stimulated rat T cells (Rabinovich et al., 2004), human 
neuroblastoma cells (Rubinstein et al., 2004; Rabinovich and Gruppi, 2005), human 
leukemia T cells (Nakahara et al., 2005) and murine fibroblasts (Nakahara et al., 
2005). 
Role of p-galactoside lectins in cancer and metastasis 
The myriad critical roles played by galectins ranging from cell signaling to apoptosis 
make them potent tumirogenic molecules. Galectins are often overexpressed in 
cancerous cells and cancer-associated stromal cells (Danguy et al., 2002; Lahm et al., 
2004; van den Brule et al., 2004; Takenaya et al., 2004). In general, this altered 
expression correlates with the aggressiveness of the tumors and the acquisition of 
metastatic phenotype, indicating that galectins might modulate tumor progression and 
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influence disease outcome (Danguy et al., 2002; Greco et al., 2004). There is 
increasing evidence that galectins have important functions in several aspects of 
cancer biology (Rabinovich et al., 2005; Liu and Rabinovich, 2005), including tumor 
transformation (Paz et al., 2001), apoptosis (Matarrese et al., 2000b; Rabinovich et al., 
2002; Matarrese et al., 2005) and cell growth regulation (Yamaoka et al., 2000; 
Kopitz et al., 2001). In addition, galectins are also involved in various steps of tumor 
metastasis, including tumor cell adhesion (Levy et al., 2001; van den Brule et al., 
2003), homotypic cell aggregation (Tinari et al., 2001; Glinsky et al., 2003), 
invasiveness (Hittelet et al., 2002), angiogenesis (Nangia-Makker et al., 2000). Gal-3 
could be used as a prognostic marker for thyroid cancer, colon cancer and cancers of 
pancreas, bladders, head and neck squamous epithelial cells, stomach and kidneys 
(Plzak et al., 2004; van der Brule et al.,2004, Hasan et al., 2007). Similarly, galectin-1 
is also involved in cancer development as it anchors the molecule Ras, which is 
involved in cellular transformation (Paz et al., 2001). Increased malignant potential of 
human thyroid tumors (Xu et al., 1995), glioma (Rorive et al., 2001) and prostate 
adenocarcinoma (Ellerhorst et al., 1999; van der Brule et al., 2001; Rabinovich et al., 
2004) has been correlated with enhanced expression of galectin-1 both on the surface 
of the tumor cells as well as the stromal tissue surrounding the tumors (van der Brule 
et al., 2001; He and Baum, 2004; Stillman et al., 2005). 
Therapeutic applications of galectins 
The study of galectins has been an area of active research in biomedical sciences as 
these molecules play important roles in a variety of biological processes (Hasan et al., 
2007). Research over the past decade indicated that the local administration of 
galectin-1 prevented clinical and histopathological manifestations of many well 
known diseases such as Mysthania Gravis and experimental encephalomyelitis, 
(Santucci et al. 2000; Wada and Makino, 2001; Rabinovich et al., 2004; Rabinovich 
and Gruppi, 2005), autoimmnune encephalitis (Kilpatrick, 2002; Rabinovich and 
Gruppi, 2005), collagen induced arthritis (Rabinovich et al., 1999; Wada and Makino, 
2001), colitis (Santucci et al., 2000), hepatitis (Santucci et al., 2003), autoimmune 
uveitis (Toscano et al., 2007) and anti-glomerular basement membrane (GBM) 
glomerulonephritis (Tsuchiyama et al., 2000). In anti-GBM nephritis in experimental 
rats, the administration of gaelctin-9 induced apoptosis of activated CD 8 positive 
cells and ameliorated proteinuria and renal tissue injuries (Tsuchiyama et al., 2000). 
The ability of galectin-1 to suppress the allogeneic T-cell response through apoptotic 
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and non-apoptotic mechanisms (Rabinovich et al., 2002; Stillman et al., 2005) 
suggests its potential use for immunosuppression in organ transplantation and graft 
versus host diseases (Toscano et al., 2007; Rabinovich and Gruppi, 2005). For 
example, galectin-1 treatment significantly improved reconstitution of normal splenic 
architecture following hematopoietic stem-cell transplantation and, similar to its 
effects on autoimmune settings, this p-galactoside-binding protein reduced the 
production of Tl-type cytokines (Baum et al., 2003; Toscano et al., 2007). 
Possible usage of galectins in the therapy of atherosclerosis and diabetic vascular 
complications by modulating macrophage function and advanced end glycation 
products clearance is suggested by several studies (Nachtigal et al., 1998; Wada and 
Makino, 2001; Stillman et al., 2005). Galectin-7 is also reported to increase the 
chemotherapeutic efficacy of cisplatin in treatment of urothelial cancer through the 
accumulation of intracellular reactive oxygen species (Matsui et al., 2007). 
Furthermore, galectin display antimicrobial activity by acting as immunosuppressant 
during various infections caused by T. Cruzi, (Zuniga et al., 2001) Leismania major 
(Pelletier and Sato, 2002; Pelletier et al., 2003), HIV (Lanteri et al., 2003) and Nipah 
Virus (Levroney et al., 2005). 
Interestingly, the discovery of anti-galectin antibodies in pathological sera and 
autoimmune disorders like Chagas' cardiomiopathy (Giordanengo et al., 2001), 
non-endemic loiasis (Rabinovich et al., 2002; Rabinovich et al., 2004) and Hodgins's 
disease (Kilpatrick 2002; Rabinovich and Gruppi, 2005) opens new diagnostic and 
potentially therapeutic avenues for researchers in application of galectins as suitable 
target for novel drugs and pharmacological molecules. 
Detection of altered galectin expression also serves as excellent diagnostic markers in 
various carcinomas (Hasan et al., 2007; Stillman et al., 2005) and inflammatory cells 
(Rabinovich et al., 2005; Rabinovich and Gruppi, 2007). 
Direct administration of oxidized galectin has implication in axonal regeneration and 
functional recovery after peripheral nerve injury (Kadoya et al., 2005). Galectin 
especially gal-1 has innumerable direct therapeutic application in mammalian nervous 
system which has been discussed in detail in the next section. 
Presence and role of p-galactoside binding lectin in mammalian nervous system 
Localization 
P-galactoside binding lectin are ubiquitously distributed throughout the mammalian 
tissue including skin (Kuwabara et al., 2002; Rabinovich et al., 2004), muscle 
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(Rubenstein et al., 2004), lymph node (Stillman et al., 2005), thymus (Kuwabara et 
al., 2002) , lung, spleen and placenta (Rabinovich et al., 2004). They are present on 
the cell surface and the extracellular matrix as well as in the cytoplasm and the 
nucleus of the cells comprising these tissues (Imbe et al., 2003). In the mammalian 
nervous system, (3-galactoside binding lectins are highly expressed (Perillo et al., 
1998; Rabinovich, 1999; Stillman et al., 2005) particularly localized in neurons in the 
central nervous system (CNS) and peripheral nervous system (PNS) (Pesheva et al., 
2000; Yang et al., 2006; Mok et al., 2007) in developing animals, but its distribution 
is restricted to the peripheral nervous tissue in adults (Hynes et al., 1990; Perillo et al., 
1998; Horie et al., 1999; Imbe et al., 2003). In human brain, galectin-3 is expressed by 
fibroblasts, macrophages, activated microglial cells, a subpopulation of dorsal root 
ganglions (DRG) and Schwann cells following nerve injury (Woo et al., 1990; 
Reichert et al., 1994; Stillman et al., 2005). Galectin-1 expression has not been well 
characterized in human brain; however, in animal models, galectin-1 is expressed in a 
subpopulation of DRG, primary sensory neurons, olfactory and motor neurons (Horie 
and Kadoya, 2004) as well as astrocytes, perivacular cells and microvessels (Sango et 
al., 2004; Stillman et al., 2005; Mok et al., 2007). Galectin-1 mRNA persists in dorsal 
root ganglia neurons at later development stages and is maintained in adult sensory 
neurons (Horie and Kadoya, 2004). The mRNA is also expressed in motoneurons in 
the spinal cord and brain stem (Hynes et al., 1990). Immunohistochemical study for 
gal-1 in normal rats also showed immunoreactivity in DRG neurons and their axons 
as well as in the spinal cord, where motoneurons and their axons were specifically 
positive (Horie et al., 1999; Kadoya et al., 2005;). Galectin-1 immunoreactivity was 
observed in regions containing Schwann cells and regenerating axons (Horie et al., 
1999). In the olfactory system, galectin-1 is expressed by ensheathing cells both in 
olfactory bulb of the embryonic and adult rat. In the adult rat, galectin-1 was 
preferentially expressed by olfactory ensheathing cells in the nerve fiber layer of the 
ventromedial and lateral surfaces of the olfactory bulb (John and Key, 1999; Mok et 
al., 2007). 
In the central nervous tissue of adult mammal, galectin-1 seems to be expressed in the 
restricted sites like retinal pigment epithelium, outer limiting membrane and outer 
plexiform layer in bovine and rat retinas (Uhera et al., 2001). In the adult rat brain, 
galectin-1 mRNA is expressed in pineal gland and in neurons in nuclei of cranial 
nerves, red nucleus, locus ceruleus and cerebeller nucleus (Akazawa et al., 2004). The 
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expression level of the mRNA is up-regulated in motoneurons in facial nucleus after 
transfection of facial nerve (Akazawa et al., 2004; Kadoya et al., 2005). 
Functions 
Despite the high expression of galectins in mammalian brain, mystery regarding the 
functional activities of these proteins largely remains unfolded. However, galectin-1 
knockout mice demonstrate defects in olfactory neuron targeting (Puche et al., 1996; 
Kadoya et al., 2005), thus indicating its potential functions in nervous system. It is a 
well known fact that galectin-1 is a homodimer with a subunit molecular mass of 14.5 
kDa and exhibits (3-galactoside binding activity only in the reduced form. But 
surprisingly the axonal regeneration activity of this lectin is promoted by its oxidized 
form (Kadoya et al., 2005) containing three intermolecular disulfide bond (Cys -
Cys'30, Cys16-Cys88, Cys42-Cys60) (Inagaki et al., 2000). This has been proved by 
several experiments including purification of galectin-1 from oxidative environments 
and subjecting to axonal regeneration activity in a dose dependent manner in the DRG 
explant model and fluorogold tracer technique where recombinant oxidized galectin 
was administered locally to acellular autografts (Fukaya et al., 2003; Horie and 
Kadoya, 2004; Kadoya et al., 2005). The disulfide bond formation alters the structure 
of galectin-1 as to confer the novel ability to promote axonal regeneration (Kadoya et 
al., 2005). In contrast, reduced form of lectin did not promote axonal regeneration but 
induced marked hemagglutination (Inagaki et al., 2000). Thus it can be said that 
oxidized form of galectin-1 is not a member of gaelctin family, because it lacks 
P-galactoside binding ability and therefore it is more appropriate to term it as oxidised 
galectin in order to distinguish it from galectin-1 having lectin activity. In addition to 
axonal regeneration, oxidized gal-1 also advances the restoration of nerve function 
after peripheral nerve injury (Hori and Kadoya, 2004; Kadoya et al., 2005). The 
administration of recombinant oxidized galectin to the nerve injury site was found to 
increase both the number and diameter of regenerating myelinated fibers, especially 
of medium sized fibers (Kadoya et al., 2005). The mechanism behind the promotion 
of peripheral nerve regeneration is still obscure. But recent reports suggest that 
macrophages are the target cells and that the oxidized galectin-1 stimulates 
macrophages to secrete a factor that promotes axonal growth and Schwann cell 
migration (Horie et al., 2000). This essential function of oxidized gaelctin-1 for 
peripheral nerve regeneration is thought to be specifically different from other 
neurotrophic factors. Thus, it can be said that oxidized gaelctin-1 is potentially 
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therapeutic for functional restoration after peripheral nerve injury. In contrast, a study 
by Kopitz et al., (2004), suggested that galectin-1, acting as a lectin promotes axonal 
regeneration of hippocampal axons in vitro. The fact that hippocampal neurons are 
components of the central nervous system may be basic to explain this different 
behavior of galectin-1, considering the general physiological differences between 
peripheral and central nervous systems and, in particular, their distinct capacities for 
regeneration (Kopitz et al., 2004). 
The endogenous galectin-1 may also contribute to the establishment of neuropathic 
pain after the peripheral nerve injury by increasing some sensory excitatory 
neuropeptide receptor into the spinal cord which is responsible to the development of 
mechanical hypersensitivity in neuropathic pain (Imbe et al., 2003; Horie and Kadoya, 
2004). 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized 
by loss of motor neurons in the cerebral motor cortex, brainstem and spinal cord 
(Rowland and Schneider, 2001). Oxidized form of galectin-1 is reported to promote 
the survival of degenerating motor neurons in ALS (Hong et al., 2005), thus 
suggesting a potential therapeutic effect of galectin-1 for patients with ALS. 
Furthermore, galectin-3, which is over-expressed in scrapie-infected brain tissue 
(Reimer et al., 2004; Mok et al., 2006), is reported to play important role in chronic 
degeneration during prion infection of CNS (Mok et al., 2007), probably by 
interacting with the lysosomal membrane proteins which contribute to the lysosomal 
autophagy for degrading organelles and long lived proteins during scrapie infections 
(Mok et al., 2007). Thus, a detrimental role of galectin-3 is suggested in prion 
infection of central nervous system. 
Moreover, galectins play vital roles in the development and the potential treatment of 
brain tumors by directly regulating the balance between cell survival and cell death, 
modulating cell motlity and impacting signaling through Ras pathway (Hughes, 2001; 
Paz et al., 2001; Hernandez and Baum, 2002; Stillman et al., 2005). In addition, by 
regulating immune responses, galectins may also contribute the efficacy in brain 
tumor patients to a variety of experimental immuno and vaccine based chemotherapy 
(Stillman et al., 2005). Increased expression of galectin-1 mRNA and immunoreactive 
galectin-1 is reported in astrocytic tumors ranging from low grade astrocytoma to 
malignant glioma (Yamaoka et al., 2000; Camby et al., 2002; Stillman et al., 2005), 
thereby promoting tumor cell invasion and dissemination in in-vivo (Rorive et al., 
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2001). During tumor metastasis galectin-1 is suggested to increase cell motility 
associated with reorganization of the actin cytoskeleton and increased expression of 
RhoA, a protein that modulates actin polymerization and depolymerization (Stillman 
et al., 2005). It is also suggested that they promote detachment of tumor cells from the 
initial tumor site and facilitate migration into the surrounding brain parenchyma 
(Camby et al., 2002; Stillman et al., 2005). Galectin-3 is a useful diagnostic marker to 
distinguish subtypes of astrocytic and glial tumors (Neder et al., 2004) and may also 
have extracellular roles in brain cancer progression (Stillman et al., 2005). For 
example, due to defective tumor cell glycosylation, galectin-3 do not adhere to the 
glioma cell lines, thereby leading to decreased glioma cell adhesion at the primary 
tumor site which may contribute to gliomas cell invasion and migration (Kuklinski et 
al., 2000; Debray et al., 2004). Thus, the significance of galectins in brain tumors and 
its invasion is largely contributed to its ability to bind to neural cells and neural 
glycoconjugates, resulting in aggregation and formation of neurite bundles. 
As it is evident from the review of literature, the P-galactoside specific lectins are an 
important class of proteins expressed in mammalian tissues which carry out various 
important functional roles. These proteins isolated from different animals expressed in 
various tissues may differ significantly in structural and physiochemical properties. 
The studies on brain lectins carried out so far are primarily confined to bovine, rat, 
mouse and human brains. The possible occurrence of the lectins in other mammalian 
brains, their structure and functional relationship are yet to be studied. Keeping this in 
mind the present study was undertaken to investigate the P-galactoside specific lectins 
from buffalo brain. The purpose of this study was not only to look for lectins which 
display specific sugar specificity but to start a comprehensive study which will 
contribute to the pool of basic information necessary for the understanding of their 
biological functions. 
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OBJECTIVES OF THE PRESENT WORK 
1 Soluble P-galactoside binding lectins are an important group of proteins, which 
have assumed significance in recent years in view of their various roles in all 
spheres of mammalian nervous system. Thus, the present work was carried out to 
explore the possible occurrence of lectin in brain tissue from water buffalo and to 
study its functional and structural properties. Water buffalo was selected for this 
study as it is an easily available and an inexpensive source of mammalian lectin. 
2. Soluble P-galactoside binding lectin was purified by ammonium sulphate 
fractionation followed by gel filtration chromatography. A complete 
characterization of its properties such as molecular weight, stokes radius, 
carbohydrate specificity, temperature and pH optima etc were carried out. 
3. Since we obtained glycosylated form of soluble P-galactoside binding lectin, an 
effort was made to understand the role of glycosylation in first ever glycosylated 
brain lectin reported. Therefore, we have made an attempt to study the 
comparative stability of glycosylated and deglycosylated form of lectin against 
various denaturing agents. 
4. In addition, oxidized form of lectin has been reported to have several 
implications in mammalian nervous system. Therefore, we evaluated the effect of 
H202 on buffalo brain lectin in terms of its functional and structural parameters 
using UV, fluorescence and circular diochroism spectroscopy techniques. 
5. Lectins, irrespective of their source, owing to their glycan binding nature disrupt 
the organization and structure of biomembranes leading to lysis of the cells. 
Thus, an effort has also been undertaken to study the cytolytic nature of purified 
lectin using erythrocytes as a model. 
6. A change in the glycosylation pattern of erythrocytes membrane takes place 
during the onset and progression of various carcinomas. Therefore, we examined 
the appearance and disappearance of P-galactoside moieties on red blood cells 
from breast and prostate cancer patients using buffalo brain lectin as a diagnostic 
tool. 
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MATERIALS 
Chemicals and reagents used in the present study were obtained from the following 
sources as detailed below. Glass distilled water was used in all experiments. 
Genei Pvt. Ltd., Bangalore, India 
Molecular weight markers (medium range). 
Hi-Media, India 
Agar agar, agarose, Freund's complete adjuvant, Freund's incomplete adjuvant, 
sodium azide. 
Pharmacia Fine Chemicals, Sweden 
Blue Dextran. 
Qualigens Fine Chemicals, India 
Acetone, ammonium sulphate, ammonium persulphate, cupric sulphate, cupric 
chloride, ethyl alcohol, glacial acetic acid, hydrochloric acid, isopropanol, methanol, 
monosodium dihydrogen orthophosphate, di-sodium hydrogenorthophosphate, 
sodium carbonate, sodium chloride, sodium hydroxide, sodium lauryl sulfate, sodium 
potassium tartarate, sulphuric acid, thiourea, tris hydroxyl methyl amino acid 
methane, hydrogen peroxide, ethylene glycol, sodium periodate. 
Sigma Chemicals Co., USA 
Sephadex G.50-8o, sephadex G.100, coomassie brilliant blue R-250, iodoacetate, 
iodoacetamide, ovalbumin. 
Sisco Research Laboratories (SRL), India 
Acrylamide, N'N methylene bis-acrylamide, bovine serum albumin, comassie 
brilliant blue R-250, EDTA, Folin-ciocalteau'phenol reagent, glycine, phenol, N'N-
dithiobisnitro benzoic acid, cysteine, cytochrome C, D-galactosamine, galactose, 
methyl P-D-galactoside, trypsin, glutraldehyde, soyabean trypsin inhibitor. 
Fresh buffalo brain tissues were routinely collected from the slaughter house (within 
30 minutes after the animals were killed) in ice and processed for lectin purification 
within 2 hours of collection. Albino rabbits were used for collection of erythrocytes 
and raising of antibodies. 
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METHODS 
Isolation of p-galactoside binding lectin from buffalo brain 
Brain homogenization 
The freshly preleved brain was rinsed in normal saline solution. The meningeal 
membranes were carefully removed. Total brain was cut into small pieces and 
suspended in 75 mM sodium phosphate buffer saline pH 7.2, containing 0.15 M NaCl, 
5 mM P-ME, 150 mM lactose, 0.02 % sodium azide and 10 mM EDTA in the ratio of 
1 gm of brain tissue/2 ml of buffer. Homogenization was carried out at 4°C in a 
stainless steel vessel using mixer table homogenizer at full speed for three periods of 
1 min with 1 min. intervals. The homogenate was further centrifuged in a Beckman J 
2-21 cooling centrifuge (JA-20 rotor, 10000 rpm for 30 min) at 4° C and the 
supernatant was collected. 
Fractionation of brain homogenate 
The supernatant of homogenate obtained from above steps was re-centrifuged at 
40,000 rpm for 1 hour in Beckman L 8-60 M ultracentrifuge using Ti rotor. The 
supernatant was collected and kept on ice. To this soluble protein solution an 
equivalent weight of solid ammonium sulphate was slowly added to obtain a final 
40 % saturation and kept at 4°C for 3 hours. The precipitated proteins were removed 
by centrifugation at 10,000 rpm for 30 min. in a cooling centrifuge and the 
supernatant was further brought to 70% saturation with solid ammonium sulphate. 
After agitation for 3 hours at 4° C the precipitate was collected and dissolved in 
minimal amount of 75 mM sodium phosphate buffer, pH 7.2 containing 0.15 M NaCl 
(PBS), 0.02 % sodium azide, 30 mM lactose and 5 mM P-ME. After extensive 
dialysis against the same buffer, the sample was loaded on a sephadex G.50-80 column. 
Gel filtration chromatography 
Sephadex G-50-80 column was prepared as recommended by Peterson and Sober 
(1962) at room temperature. The gel was allowed to swell in sufficient amount of 
distilled water for 6 hours in boiling water bath. The gel fines were removed by 
suspending the gel in 75 mM PBS, pH 7.2 and allowing 90-95% of the gel to settle 
down. The remaining gel in supernatant was rapidly removed by suction. A 
previously cleaned glass column mounted on a sturdy vertical support was filled to 
one third of its length with the distilled water in order to check leaks and flush air 
bubbles from the dead space. The deareated gel slurry was then gently poured with 
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the help of a glass rod into the column with care to avoid generation of air bubbles. 
The column was left standing overnight. Flow rate was increased gradually and after 
accomplishing a constant flow rate higher than that required for final elution the 
column was adjusted to the required flow rate. The packed column was thoroughly 
washed with two bed volumes of 75 mM sodium phosphate buffer, pH 7.2 containing 
0.15 M NaCl and 5 mM p-ME (operating buffer). In order to check the uniform 
packing and to determine the void volume of the column, 0.2 % (w/v) solution of blue 
dextran in operating buffer was passed through the column. The volume of blue 
dextran or protein solution applied on the column was not more than 2-3% of the total 
bed volume. 
The column was thoroughly washed and equilibrated with 75 mM PBS, pH 7.2 
containing 5 mM P-ME and 30 mM lactose prior to application of the sample. The 
dialysed sample obtained after 40%-70% ammonium sulphate fractionation was 
applied at room temperature to the chromatographic column. Two ml fractions were 
collected and assayed for protein concentration and hemagglutinating activity. The 
fractions of protein peak were again dialyzed against 75 mM sodium phosphate 
buffer, pH 7.2 containing 0.15 M NaCl and 5 mM P-ME to remove lactose and tested 
for hemagglutination activity. Samples showing maximum activity were pooled and 
concentrated for study. The protein content was quantitated by Folin's phenol reagent 
by the method of Lowry et al. (1951). Homogeneity of the preparation was analysed 
by applying the sample on 10 % polyacrylamide gel electrophoresis (PAGE). 
Colorimetric analysis 
Determination of protein concentration 
Protein was estimated by the method of Lowry et al. (1951). Aliquots of protein 
solution were taken in a set of tubes and final volume was made up to 1 ml with 
75 mM sodium phosphate buffer (pH 7.2). Five ml of alkaline copper reagent 
(containing one part of 1 % (w/v) copper sulphate and 2 % (w/v) sodium potassium 
tartarate in 1% (w/v) sodium hydroxide and sodium carbonate) was added and then 
after 10 min of incubation at room temperature, 0.5 ml of 6 N Folin-Ciocalteau's 
phenol reagent was added. The tubes were instantly vortexed. The colour developed 
was read at 660 nm after 30 min against a reagent blank. A calibration curve was 
prepared using BSA standard. 
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Determination of carbohydrate content 
The procedure described by Dubois et al. (1956) was followed. Two ml of sugar 
solution containing 10 to 100 ug of carbohydrate was pipetted in test tubes and 0.5 ml 
of 80% phenol was added to it. This was followed by the addition of 5.0 ml 
concentrated sulphuric acid, the stream of acid being directed against the liquid 
surface rather than the side of the test tube in order to obtain good mixing. The tubes 
were vortexed and placed for 20 min. at room temperature to cool. The colour was 
stable for several hours. The absorbance of the characteristic yellow orange colour 
was measured at 490 nm for quantitation of hexose content against blank prepared by 
substituting buffer for sugar solution. 
Determination of sulphydryl groups 
The method used was essentially that described by Ellman (1959). For the 
determination of exposed -SH groups, appropriate amount of protein was added in 
100 mM Tris-EDTA buffer, pH 8.0 to give a total volume of 3.0 ml of the solution. 
0.1 ml DTNB solution (40 mg DTNB in 10 ml of 0.1 M Tris HC1, pH 8.0) was added 
and the colour developed was read at 412 nm after 15 min. A reagent blank was used 
to account for the absorption of the reagent at 412 nm. Cysteine (0.125 mM) was 
taken to obtain standard plot of SH groups. Thiol groups in u moles were calculated 
using the standard plot of cysteine per u mole of protein. 
Hemagglutination assay 
Hemagglutination activity was routinely assayed with rabbit erythrocytes by the 
methods of Lis and Sharon (1972) as described below. 
Preparation of RBC suspension 
A. Untreated erythrocytes 
A blood sample from a healthy rabbit was obtained by vein puncture in 3% trisodium 
citrate solution as an anticoagulant used in a ratio of 4:1. The erythrocytes were then 
centrifuged at room temperature in a clinical table top centrifuge (2000 rpm for 5 min) 
and washed three to four times with 75 mM PBS, pH 7.2 (5 ml per 1 ml packed cells). 
Washed erythrocytes were made 4 % (v/v); (3x 108 cells /ml) by adding 75 mM PBS, 
pH 7.2. 
B. Enzymatically modified erythrocytes: (Trypsinized erythrocytes) 
An 8 % (v/v) suspension of washed erythrocytes was prepared in 75 mM PBS, pH 
7.2. Trypsin was added to a final concentration of 100 ug /ml (0.1 ml of trypsin 
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solution to 1 ml of erythrocytes suspension) and incubated for 1 hour at 37°C. The 
trypsinized erythrocytes were washed four to five times with 75 mM PBS, pH 7.2 and 
4% (v/v) suspension was prepared for further use. 
Hemagglutination test 
A 50 ul of 75 mM PBS, pH 7.2 was added to each row of wells on a microtitre 
'V'plate, starting with the second well. To each of the first two wells 50 ul of the 
solution to be tested for activity was added and mixed by shaking the plate by hand. 
50 ul of a liquid from the second well was transferred to the adjacent one, mixed and 
transferred 50 p.1 from the latter well to the next one and so on up to the last well. This 
protocol produced two fold serial dilutions of the tested material i.e. 1:1, 1:2, 1:3, 1:4, 
1:5, 1:6, 1.8, etc. 50 ul of the 4% (v/v) erythrocyte suspension was added to each well, 
mixed and left for 1 hour at room temperature. Highest dilution giving agglutination 
was noted. A mat of erythrocytes covering the well showed the occurrence of 
agglutination. In absence of agglutination, erythrocytes appeared as a button at the tip 
of the well. One agglutinating unit was arbitrarily described as the minimal of 
material required to cause full agglutination under the above conditions. The titre of 
the tested solution was expressed as a reciprocal of the highest dilution showing 
agglutination. 
Determination of carbohydrate specificity by inhibition of 
hemagglutination 
Qualitative determination 
Two mM solutions of the sugars to be tested were prepared. The titre of the lectin 
preparation was determined and diluted such that 50 ul had its titre 4. In wells of a 
microtitre plate, 50 ul of the test carbohydrate solutions were mixed with 4 
agglutinating units of the lectin and kept for 5-10 min and 50 (il of a 4% suspension of 
erythrocytes were added. The degree of agglutination was determined in different 
wells after 1 hour. Absence of agglutination indicated that the lectin was specific for 
the sugar in the well. 
Quantitative determination 
Two fold serially diluted test sugar solutions were incubated for 5-10 min at room 
temperature with 4 agglutinating units of lectin in microtitre plates. Agglutination was 
observed after 1 hour of addition of 50 ul of 4% erythrocyte suspension to each well. 
JlcvfeuiilatultM&thvdi 
The highest dilution of the test sugar giving complete inhibition of hemagglutination 
was noted. 
Slab gel electrophoresis 
Polyacrylamide gel electrophoresis (PAGE) 
Native PAGE was performed by Tris-Glycine system of Laemmli (1970) using slab 
gel apparatus manufactured by Biotech, India. Routinely 10% and 12.5% acrylamide 
gels were used. Concentrated stock solution of 30% acrylamide containing 
0.8% bisacrylamide and 1.0 M Tris (pH 6.8 and 8.8) were prepared and mixed in 
appropriate amount to give the required final concentration. The solution was 
deareated and poured in the mould formed between the two glass plate (8.5 x 10 cm) 
separated by 1.5 mm thick spacers. Bubbles and leaks were avoided. A comb 
providing a template for 7 wells was inserted into the gel before the polymerization 
began. After polymerization the comb was removed and wells were overlaid with the 
running buffer. Protein samples were prepared to give final concentration of 0.0625 M 
in Tris HC1 (pH 6.8), 10 % glycerol and trace of bromophenol blue as a tracking dye. 
Electrophoresis was performed in electrode buffer containing 0.025 M Tris, 0.2 M 
glycine at 100 V till the tracking dye reached the bottom of the gel. 
SDS-Gel Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE was essentially performed by the method of Laemmli (1970). Stock 
solutions of 30% acrylamide containing 0.8% bisacrylmide, 1.0 M tris HC1 (pH 6.8) 
and 10% of SDS were mixed in specific proportion to give desired percentage of 
acrylamide. Protein samples were prepared to give a final concentration of 1% SDS 
(w/v), 0.5 % P-ME (v/v), 0.25 M tris HC1, pH 6.8 and 10 % glycerol (v/v) and a trace 
of bromophenol blue as a tracking dye. Samples were then heated in a boiling water 
bath for about 3-5 min; electrophoresis was carried out at 100 V for approximately 3 
hours in electrode buffer containing 0.025 M Tris, 0.2 M glycine and 0.02 % SDS. 
Coomassie blue staining 
After electrophoresis the gels were stained with five gel volumes of 0.25% coomassie 
brilliant blue R-250 in 5 % methanol and 10 % acetic acid for at least 4 hours. For 
destaining, the gels were incubated in 5 % methanol and 7.5 % acetic acid at room 
temperature with vigorous shaking. 
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Molecular weight determinations 
The molecular weight of the brain lectin was determined under the native conditions 
using gel filtration and under denaturing condition by SDS-PAGE. 
Gel filtration 
The molecular weight of the native buffalo brain lectin was computed from its elution 
volume in sephadex G.ioo column which was prepared as discussed before using the 
method of Peterson and Sober (1962). The column was calibrated by determining the 
elution volumes of several globular proteins of known molecular weights like Bovine 
serum albumin (68 kDa), ovalbumin (45 kDa), soyabean trypsin inhibitor (20.1 kDa) 
and cytochrome c (12.4 kDa). Purified buffalo brain lectin was applied to the column 
and 3 ml fractions were eluted with 75 mM PBS, pH 7.2 containing 30 mM lactose, at 
a flow rate of 15ml/hr. The data were analysed according to the theoretical treatment 
of Andrews (1964). The linear plot between VJV0 and log M was used for calculating 
the molecular weight of the lectin. 
SDS-PAGE 
The subunit molecular weight of BBL was calculated by the procedure of Weber and 
Osborn (1969) using its mobility on SDS-PAGE. The mobility of marker proteins 
determined under identical conditions was plotted against the logarithm of molecular 
weight. The analysis of data indicated a linear relationship between log M and relative 
mobility (Rm). The plot between log M and relative mobility was used for calculating 
molecular weight of the lectin. 
Determination of stokes radius 
The stokes radius of buffalo brain lectin was determined by the methods of Laurent 
and Killander (1964) using gel filtration data. The proteins bovine serum albumin 
(35.5A), ovalbumin (27.3 A), soyabean trypsin inhibitor (22.6 A) and cytochrome C 
(16.4 A) were taken as standards. The value of Kav of each marker protein was 
calculated from the formula Kav=Ve-Vo/Vt-Vo by substituting the values of Ve 
(elution volume), Vo (void volume) and Vt (total volume of column). A graph of the 
square root of the negative logarithm of Kav versus stokes radius gave a linear plot 
which was used for calculating stokes radius of the brain lectin. 
Thermal stability 
The temperature stability of the native and deglycosylated lectin (125ug/ml) was 
determined by incubating 100 u.1 samples in 75 mM PBS pH 7.2 containing 5 mM 
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P-ME at various temperature (30°C to 70°C) for 30 min, cooling it on wet ice and 
titrating with trypsinized rabbit erythrocytes using microtitre plate assay. 
pH stability 
To determine the optimal pH and stability of native and deglycosylated lectin activity, 
the proteins (125ug/ml) in 50 ul of normal saline containing 5 mM P-ME were 
incubated with 50 ul of following buffers, 0.1 M sodium acetate buffer (pH 6.5-7.5), 
0.1 M tris HC1 buffer (pH 8.5-9.5) and 0.1 M glycine-NaOH buffer (pH 10.5-11.5) for 
24 hours at 4°C. The hemagglutination activity of the lectin was then assayed using 
trypsinized rabbit erythrocytes on microtitre plates. 
Chemical modification of active groups of lectin 
The rate of the reactions with 70 mM alkylating agents like iodoacetate and 
iodoacetamide in 75 mM PBS pH 7.2 containing 1 mm P-ME and with oxidizing 
agents (5 mM H2O2 in the absence of P-ME) in the same buffer were determined at 
room temperature. After designated times the modified brain lectin was titrated for 
hemagglutination assay. 
Effect of detergents, denaturants and metal ions on lectin induced 
hemagglutination 
The effect of denaturants on native and deglycosylated lectin (125|Ag/ml) was 
determined by incubating protein with urea, guanidine HC1 and thiourea in the 
concentration range of 0.5 M to 8.0 M in 75 mM PBS, pH 7.2 containing 5 mM P-ME. 
Titre value of each sample was determined using microplate assay. Native BBL sample 
in 75 mM PBS, pH 7.2 containing 5 mM P-ME served as control (initial activity). 
The effect of different detergents was also monitored by incubating native and 
deglycosylated proteins (125ug/ml) with SDS (0.1-2 mg/ml), Triton-X (0.5-5 % (v/v)), 
and Tween 20 (0.5-5 % (v/v)) in 75 mM PBS, pH 7.2 containing 5 mM p-ME. Titre 
value of each sample was determined using microplate assay. Native BBL sample in 
75 mM PBS, pH 7.2 containing 5 mM p-ME served as control (initial activity). 
To examine the effect of divalent cations on lectin activity, demetallization of purified 
lectin was carried out using 0.1 M EDTA followed by remetallization of the sample 
with 0.1 M CaCl2 and MnCl2, [Sr(CH3COO)2], MgCl2, NiCl2 in 75 mM PBS, pH 7.2 
containing 5 mM p-ME. Hemagglutination activity of each sample was tested by 
microtitre plate assay using rabbit RBCs. Native BBL sample in 75 mM PBS, pH 7.2 
containing 5 mM P-ME served as control (initial activity). 
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Equilibrium dialysis 
The binding of lactose to BBL was quantitatively studied in 75mM PBS, pH 7.2 
containing 5 mM P-ME by equilibrium dialysis in a dialysis bag (3.0 ml capacity) 
made from Sigma cellulose membrane (inflated diameter 6 mm, width 10 mm). The 
dialysis bag containing 1ml (100 uM) of the lectin solution was placed in plastic vials 
containing 1.0 ml of lactose solution in the range of 40 uM-400 uM After capping the 
vials, the dialysis bag was mechanically shaken for 24 hours at 37°C. After attainment 
of equilibrium, the decrease in lactose concentration was estimated in the dialysate, 
outside the dialysis bag by the method of Dubois et al., (1956). The amount of lactose 
bound per mole of lectin was calculated according to Scatchard analysis. It should be 
noted that no detectable binding of lactose by the dialysis bag was observed. 
BBL readily reacted with the specific carbohydrate, according to the following 
reaction. 
L+nS — LSn (1) 
K„,-» _[LSn] (2) 
[L] [S]n 
u-nK^fSJ / l+IWS] (3) 
where n is the number of carbohydrate binding sites in the lectin dimer and K^, is the 
association constant for the interaction of S (or lactose) with L (or lectin). Equation 3 
can be arranged to Eq. 4. 
u/[S] — -Kw) + nKa,, (4) 
The amount of lactose bound per mole of lectin i.e., v, was determined in triplicate and 
plotted according to Eq. 4. 
Brain cell aggregation assay 
The brain cell aggregation activity was determined using dissociated cells from goat 
and buffalo brain without any chemical treatment. One-gram tissue was isolated from 
the telencephalon of each brain and mechanically dissolved into separate cells by 
standardized method using a dissociation chamber containing a magnetic stirrer 
(Bologna et al., 1982, Caron et al., 1987). Perfectly isolated cells were automatically 
and reproducibly obtained without adding any chemical substance. The cell suspension 
was fixed in 4% (v/v) glutraldehyde in 75 mM sodium phosphate buffer, pH 7.2 
containing 0.15 M NaCl. After one hour, the cells were washed in 75 mM PBS, pH 
7.2, rinsed twice in 0.2 M glycine, and dissociated again. Isolated cells were finally 
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suspended (6.25* 105 cells/ml) in 75 mM PBS, pH 7.2. 100 ul of purified lectin 
(lOug/ml) was added to tubes containing 100 ul of a suspension of isolated fixed cells. 
After rotation at 70 rpm for 60 min, small aliquots were carefully removed and the 
number of particles (single cells and clumps) per unit volume was determined using a 
Maleuzz hematocytometer. The rate of agglutination was expressed as the % decrease 
in particle number (Caron et al., 1987). Similarly, the effect of temperature and pH on 
brain cell aggregation by BBL was also measured by incubating BBL and isolated cells 
at different temperatures (20-80°C) and buffers of various pH values (3.5-11.5) and 
counting the number of cells as discussed above. 
Preparation of periodate oxidized Buffalo Brain Lectin 
Deglycosylation of lectin was carried out according to the method of Rasheedi, 
et al. (2003). Protein sample (lmg/ml)in 75 mM PBS pH 7.2 was prepared and treated 
with 10 mM sodium periodate solution in a molar ratio of 5:1. Reaction mixture was 
incubated for 15 min at room temperature in dark. The oxidation process was stopped 
by adding 0.5 ml ethylene glycol per ml of sample. The quenched sample was then 
dialysed at room temperature overnight against 75 mM sodium phosphate buffer pH 
7.2 containing 0.15 M NaCl and 5 mM 0-ME. 
Spectroscopy 
UV spectroscopy 
The UV spectra of native lectin in 75 mM PBS containing 5 mM P-ME and oxidized 
lectin by adding 5 mM H2O2 (in the absence of P-ME) were measured on a Beckman 
UV 640 spectrophotometer in the wavelength region 220-350 nm. 
Fluorescence spectroscopy 
The intrinsic fluorescence of the lectin was measured at 25±0.2° C in Hitachi-F 2000 
spectrofluorometer (Tokyo, Japan). The protein was excited (X ex) at 280 nm. 
Corrected emission spectra were recorded with excitation and emission band widths of 
10 nm. Appropriate control containing substances used for the treatment were run and 
correction made wherever necessary. 
The change in intrinsic fluorescence of native lectin in PBS (45ug/ml) containing 5 
mM P-ME and oxidized lectin by adding 5 mM H202 (in the absence of P-ME), in 
presence as well as in absence of 0.1 M lactose was followed by measuring the 
emission fluorescence in the wavelength region of 300-400 nm. Similarly, effects of 
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various denaturants (0.5-8 M of GdnHCl, urea and thiourea) on the fluorescence 
spectra of native and deglycosylated lectin were also measured. 
Circular diochroism spectroscopy 
Circular diochroism of native lectin and after various treatments were measured in a 
Jasco J-810 spectropolarimeter equipped with a temperature controlled sample cell 
holder. Spectra were recorded with scan speed of lOOnm/min and with a response time 
of 1 sec and 1 nm band width. Each spectrum was the average of four scans. 
Measurements in the far UV (200-250 nm) as well as in the near UV (250-350 nm) 
regions were taken using 250ug/ml and 1 mg/ml of BBL, respectively. 
Fourier Transform Infrared Spectroscopy 
Infrared spectroscopy was done to see the changes in the secondary structure 
components (conformational changes) in BBL in the presence of oxidizing agents. The 
spectra were truncated between 1740 and 1520 cm'1 and baseline recorded. The 
equipment used was NICOLET (ESP) 560 spectrophotometer (USA) equipped with a 
transmission OMNIC ESP 5.1 software and a DTGS detector. BBL solutions 
(0.15 mg/ml) were prepared in sodium phosphate buffer (10 mM, pH 7.2). 
Original spectra of native and treated BBL at 37"C were recorded with a resolution of 
4 cm'1 and 128 scans. The changes in peak frequency and intensity were then assigned 
to conformational change within the protein. Native BBL was taken as control. 
Immunological techniques 
Immunization 
Antibodies against BBL were raised in healthy adult male albino rabbits (New Zealand 
strain) weighing 1.5-2.0 kgs. Prior to immunization the rabbits were bled for obtaining 
serum that served as control in the studies. They received a primary immunization with 
300 ng of purified buffalo brain lectin emulsified in equal volume of complete 
Freund's adjuvant through a subcutaneous injection at several sites on the back. 
Weekly secondary immunization of 150 ug of protein in Freund's incomplete adjuvant 
was administered after 2 weeks. A similar second and third booster was given in the 
third and fourth weeks, respectively and the animal was bled after an additional one 
week. The blood collected was allowed to coagulate at 20°C for 3 hrs, the anti-sera 
was decomplemented at 37°C for 30 min, collected in small aliquots and kept frozen 
at -20°C until further used. 
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Ouchterlony immunodiffusion 
Immunodiffusion was performed essentially according to the method of 
Ouchterlony (1962). One percent molten agarose prepared in normal saline containing 
0.1% sodium azide and 30 mM lactose (to prevent the interaction of lectin with 
agarose or serum glycoproteins), was poured on clean petriplate and allowed to 
solidify at room temperature. Required number of wells were cut from agarose and 
stored at 4°C. Antisera 10 to 40 ul and required amount of antigen were added in the 
central and peripheral wells, respectively. The petriplate was incubated at 37 °C for 
4 hours and then at 4°C overnight in order to get a clear precipitin band. The petriplate 
was photographed under proper illumination. The cross reactivity of antibodies was 
also checked against sheep and goat brain lectin. 
Direct binding ELISA 
Elisa was performed essentially as described by Aotsuka et al., (1979). Polystyrene (96 
wells) microtitre plates coated with 100 ul of antigen at a concentration of 2.5 ug/ml in 
TBS (10 mM Tris, 150 mM NaCl, pH 7.4 ), kept for 2 hrs at room temperature and 
overnight at 4° C. The antigen coated wells were washed three times with TBS-T (20 
mM Tris, 144 mM NaCl, 2.68 mM KC1, pH 7.4 with 500 ul Tween-20) to remove 
unbound antigen. Unoccupied sites were blocked with 150 ul of 1.5 % BSA in TBS for 
3 hrs at room temperature. After washing the plates with TBS-T, the serially diluted 
antiserum (100 ul/well) were added to each well and plates were incubated for 2 hrs at 
room temperature. The bound antibodies were assayed by an appropriate anti-rabbit 
goat IgG labeled with horse radish peroxidase using hydrogen peroxide and 
tetramethylbenzidine as substrate. The plates were incubated for 1 hr and absorbance 
was read at 450 nm. Each sample was coated in duplicate. Results were expressed as a 
mean of A (test)- A (control). 
Competition ELISA 
The antigenic specificity of the induced antibodies was determined by competition 
inhibition experiments (Hasan et al., 1991). Varying amount of inhibitors (0-20 ug/ml) 
were mixed with a constant amount of antiserum (1:100 dilution), and the mixture was 
incubated at room temperature for 2 hrs and overnight at 4°C. The immune complex 
thus formed, was coated in the microtitre wells (instead of serum). The remaining steps 
were same as that of direct binding ELISA. The results thus obtained were expressed 
as % inhibition. 
Percent inhibition= 1-A (inhibited)/A (uninhibited) * 100 
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A (inhibited) = absorbance at 450 nm in presence of varying amounts of inhibitors. 
A (uninhibited) = absorbance at 450 nm in the absence of inhibitors. 
Dot blot analysis 
The specificity and the immunological cross reactivity of buffalo brain lectin antisera 
with other galactoside binding lectins present in liver, lung and heart was demonstrated 
by standard dot blot assay taking respective tissue homogenates. Two microlitres of the 
purified lectin sample was spotted on nitrocellulose paper and the blot was blocked by 
overnight incubation with 5% BSA solution. The blot was first incubated with rabbit 
anti-lectin antisera (1.50) and then with peroxidase coated goat anti-rabbit antibodies at 
the dilution of 1:1000 for 2 hrs at 37° C in a moist chamber. Extensive washings of the 
blot were carried out with 0.05 % Tween-PBS at every step to remove excess reagents. 
The binding of the BBL and of the tissue lectins with anti-buffalo brain lectin 
antibodies were visualized by developing the blot with a mixture of 0.1 % H2O2 
containing 1 mg/ml diaminobenzidine 
Interaction of BBL with erythrocyte membrane 
Preparation of erythrocyte suspension 
A blood sample from a healthy rabbit (adult, male, New Zealand white strain) was 
obtained by vein puncture in 3 % trisodium citrate solution as an anticoagulant used in 
a ratio of 4:1. The erythrocytes were then centrifuged 2000 rpm for 5 min, plasma and 
buffy coat were discarded and pelleted cells were washed three times with 75 mM 
sodium phosphate buffer, pH 7.4, containing 0.15 M NaCl. Finally, a 2 % erythrocyte 
suspension was made (2 ml of packed erythrocytes in 100 ml PBS). Trypsin was added 
to a final concentration of 100 fig /ml (0.1 ml of trypsin solution to 1ml of erythrocytes 
suspension) and incubated for 1 hour at 37eC. The trypsinized rabbit RBCs were 
washed four to five times with 75 mM PBS, pH 7.4 and finally 10% suspension was 
prepared. 
Determination of osmofragility of lectin agglutinated erythrocytes 
For the determination of osmofragility of erythrocytes (Raghuramulu et al., 1983); 
from the cell suspension prepared as above, aliquots of 200ul were taken in different 
tubes. To these aliquoted cell suspensions, 100 ul of either lectin in 75 mM PBS, pH 
7.4 were added and the mixture was incubated for a period of 1 h at room temperature 
(37°C) for the agglutination to take place. After this 1.5 ml of hypotonic solution of 
varying concentrations (i.e. 0.35-0.85% NaCl) was added to the above reaction. The 
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cells were then incubated for a period of 4 h at room temperature with intermittent 
gentle mixing. At the end of the incubation period, the tubes were centrifuged at 2000 
rpm for 5 min and the supernatant was collected. Extent of hemolysis was measured by 
taking absorbance at 540 nm. Results were reported as percent lysis where lysis of 
similar volume of RBC with the same amount of distilled water was taken as 100%. 
Effect of various colloids on the osmofragility of lectin agglutinated erythrocytes. 
For protection of osmotic lysis, the lectin agglutinated erythrocytes were incubated 
with 1.5 ml of 75 mM sodium phosphate buffer containing 0.15 M NaCl, pH 7.4 with 
30 mM of ribose, galactose, mannose or lactose. The cells were incubated at room 
temperature for 6 h with gentle mixing. Hemolysis was subsequently quantitated as 
described above. Erythrocytes without lectin, incubated at similar conditions, served as 
control. 
Effect of lectin on superoxide induced damage of erythrocytes membrane 
Red blood cell suspensions (200 ul) were taken in different test tubes. To these 
aliquoted cell suspensions 100 ul of lectin (lOOug/ml) was added and the mixtures 
were incubated for one hour at room temperature. After this, the agglutinated cells 
were exposed to superoxide radical (CV), generated from a pyrogallol auto-oxidation 
system by adding 10 u.1 of pyrogallol solution (0.02 M freshly made in H202) and 
incubated for a period of 20 min at room temperature, and the erythrocytes were 
recovered after centrifugation of the sample at 3000 rpm for 5 min. The cells were 
washed thrice with PBS and the supernatant was collected for analyzing the 
hemoglobin released. The released oxyhemoglobin concentration in supernatants was 
measured by the equation of Winterbourn (1990) using absorbance measurements at 
560, 577 and 630 nm, with the following equation: 
[Oxy Hb] = 119 A577- 39 A«o-89 A36o. 
The susceptibility of erythrocytes membranes to hypochlorous acid induced 
damage in the presence and absence of lectin 
Red blood cell suspensions (200 ul) was mixed with 100 ul (lOOug/ml) in 75 mM 
PBS, pH 7.4 containing 5 mM pVME and incubated for 1 hour for agglutination to 
take place. The agglutinated cells were treated with different concentrations of 
hypochlorous (HOG) acid at 22° C for 20 min. Then, the cells were washed three 
times with excess of cold PBS and re-suspended in PBS as 10% suspension. HOC1 
was added as a single bolus of 25 mM l"1 stock solution of sodium hypochlorite 
(NaOCl) in PBS buffer to RBC suspension and mixed by vortexing. At pH 7.4 this 
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solution contains a mixture of H0C1 and OCT at approximately 1:1 ratio and is 
subsequently referred to as HOC1 (Vissers et al., 1998). The concentrations of OCT1 
were determined spectro-photometrically using an absorbance coefficient of 350 M"1 
1 cm"1 at 292 nm and pH 9.0 (Morris, 1996). The susceptibility of erythrocytes to 
HOC1 induced oxidative damage was measured in terms % hemolysis. The process of 
hemolysis of agglutinated erythrocytes treated with HOC1 was monitored by 
hemoglobin release as discussed above. 
Preparation of human erythrocytes suspensions of cancer patients 
Both pre and post-operative venous blood was collected from breast and prostate 
cancer patients in tubes containing EDTA. Within 24 hours, blood samples were 
tested in our laboratory. Plasma was separated by centrifugation at 2000 rpm for 5 
min, and pellet containing red blood cells were washed thrice with cold phosphate 
buffered saline (75 mM PBS, pH 7.4) and finally 4% RBC suspension was prepared. 
Trypsin was added to a final concentration of 100 ug /ml (0.1 ml of trypsin solution to 
lml of erythrocytes suspension) and incubated for 1 hour at 3TC. The trypsinized 
RBCs were washed four to five times with PBS and finally 10% suspension was 
prepared. Percent hemolysis was determined as discussed above. 
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RESULTS 
Hemagglutinating activity of brain homogenate 
Buffalo brain extract readily agglutinated trypsinized rabbit erythrocytes. The best 
solubilizing buffer was found to be 75mM sodium phosphate buffer, pH 7.2 
containing 0.15 M NaCl, 150 mM lactose, and 5 mM P-mercaptoethanol (P-ME). 
Lactose was an essential competing saccharide in aqueous buffer for efficient 
solubilization. Moreover, the presence of reducing agent was critical during the 
purification procedure. If P-ME was eliminated from the aqueous buffer, no lectin 
activity was recovered. The lectin activity was unaffected by heat treatment up to 
45°C for 30 minutes. However, the activity was considerably reduced by the addition 
of high concentration (over 0.5 M) of sodium chloride. The lectin mediated 
hemagglutination of rabbit erythrocytes was inhibited by lactose at concentration of 5 
mM but glucose and mannose had no effect even at a concentration of 200 mM. 
Isolation and purification of p-galactoside binding lectin 
Purification 
Crude buffalo brain extract (150 g) solubilized in 75 mM sodium phosphate buffer, 
pH 7.2 containing 0.15 M NaCl, 150 mM lactose, 5 mM P-ME, 10 mM EDTA and 
0.02% sodium azide (w/v). BBL was further purified by a combination of ammonium 
sulphate fractionation and gel permeation chromatography on sephadex GJO- go 
(1.8 x 59 cm) column. A 40-70% ammonium sulphate fractionation resulted in about 
18% yield with five-fold purification with respect to soluble proteins in the 
homogenate. The high salt content was removed by extensive dialysis against 75 mM 
sodium phosphate buffer, pH 7.2 containing 30 mM lactose, 0.15 M NaCl and 5 mM 
P-ME. Lactose was added to the dialyzed sample before loading on to the column to 
inhibit the lectin and sephadex gel interaction. The salt fractionated protein was 
further chromatographed on sephadex G50-80 equilibrated with same buffer. Fig.6 
represents the elution profile with a well defined peak for the protein fraction 
containing the maximum lectin activity. The results of purification of 150 gm brain 
are shown in Table III. The yield of the purified protein was 560 ng (from 1350 mg) 
which represented 71.11% of total activity with fold purification of 1715.35. 
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Figure 6. Size exclusion chromatography of BBL 
The ammonium sulphate precipitate obtained from 150g of brain homogenate 
was dissolved and dialysed against several changes of 75 mM sodium 
phosphate buffer, pH 7.2 containing 0.15 M NaCl, 5 mM p-ME and 30 mM 
lactose at 4°C. The sample was applied on sephadex Gso-so column 
(1.8 x 59 cm), and eluted with same buffer at the flow rate of 20 ml/hr. 
Fractions of 2 ml were collected and assayed for hemagglutinating activity 
against trypsinized rabbit erythrocytes and for the protein concentration. 
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Step Fraction 
Brain extract 
40-70% cut 
Gel chromatography 
Table m . 
Purification of buffalo brain lectin 
Total 
Volume 
(ml) 
180 
20 
2 
Total Total Specific 
protein activity activity 
(rag)1 (Titrer (Titre/mg) 
1350 14400 10.66 
240 12800 53.33 
0.560 10240 18285.71 
Purification 
(Fold) 
1 
5.00 
1715.35 
Recovery 
(%) 
100 
88.88 
71.11 
Yield 
(%) 
100 
17.77 
0.041 
Values are mean of three different preparations from 150 gm fresh tissue 
a
 Determined by the method of Lowry et al (1951) 
The titre of the tested lectin is expressed as the reciprocal of the highest dilution 
showing agglutination of trypsinized rabbit erythrocytes 
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Charge homogeneity and Subunit structure 
Homogeneity of BBL eluted from gel filtration column was determined by 
polyacrylamide gel electrophoresis in the absence of SDS. The fraction containing the 
maximum hemagglutinating activity migrated as a single band in native PAGE 
(Fig. 7). Subunit structure was determined by SDS-PAGE under non-reducing (in the 
absence of 0-ME) and reducing conditions (in the presence of 0-ME) as shown in 
Fig.8. 
Physicochemical characterization of BBL 
Molecular weight determination 
The subunit molecular weight of BBL under denaturing condition was calculated 
from its mobility using SDS-PAGE according to the method of Weber and Osbom 
(1969). Relative mobilities (Rm) of the marker proteins were plotted against the 
logarithm of molecular weights using least square analysis (Fig.9). The relative 
mobility of BBL in the presence and absence of reducing agent corresponded to a 
molecular weight of 14.5 kDa (Fig. 10). 
The molecular weight of BBL under native condition was determined using gel 
filtration chromatography on sephadex G-ioo (1.8 * 45 cm) equilibrated with 75 mM 
PBS, pH 7.2 containing 5 mM 0-ME and 30 mM lactose to prevent lectin and gel 
interaction. The column was calibrated with marker proteins i.e. bovine serum 
albumin (68 kDa), ovalbumin (45 kDa), soyabean trypsin inhibitor (20.1) kDa and 
cytochrome c (12.4 kDa). The values of the ratio of elution volume to the void 
volume (Ve/Vo) for each marker proteins i.e. bovine serum albumin (68 kDa), 
ovalbumin (45 kDa) soyabean trypsin inhibitor (20.1) kDa and cytochrome c 
(12.4 kDa) including BBL were calculated as shown in the Table IV. Analysis of data 
indicated a linear relationship between log M and Ve/V0. The value of Ve/V0 for BBL 
was found to be 2.13 which corresponded to a molecular weight of 28.5 kDa (Fig. 11 
and Table IV). 
Stokes radius 
The stokes radius of BBL was determined from its elution volume on sephadex G-ioo 
column. The column was calibrated by determining the elution volume of several 
globular proteins with known stokes radii. The data was analyzed according to the 
theoretical treatment of Laurent and Killander (1964) equation for calculating the 
stokes radius of BBL under native conditions, and was found to be 25 A (Fig. 12). 
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Figure 7. Native electrophoresis of buffalo brain lectin during various stages of 
purification. 
PAGE was performed on 10 % acrylamide gel as described in materials and 
methods section. Lane (a) contains soluble brain extract (30 ug); Lane (b) 
contains 40-70% ammonium sulphate fraction (30 fig); Lane (c) contains 
purified protein (40 ug). 
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Figure 8. SDS-Gel electrophoresis of buffalo brain lectin during various stages of 
purification. 
SDS-PAGE was performed on 12.5% acrylamide gel under reducing 
conditions as described in materials and methods section. Lane (a) contains 
soluble brain extract (30ug); Lane (b) contains 40-70% ammonium sulphate 
fraction (30 ug); Lane (c) contains purified protein (40 ug). 
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Figure 9. Molecular weight determination of BBL: Samples were separated by 
12.5% SDS-PAGE under reducing condition and non-reducing 
conditions. 
Lane (a) purified protein (25 ug) under reducing conditions; Lane (b) 
molecular weight markers under reducing conditions; Lane (c) purified protein 
(25 ug) under non-reducing conditions; Lane (d) molecular weight markers 
under reducing conditions. The molecular weight markers are in the 
descending order; Phosphorylase b (97.4 kDa), BSA (68 kDa), ovalbumin (45 
kDa), Carbonic anhydrase (29 kDa), Soyabean trypsin inhibitor (20.1 kDa), 
Lysozyme (14.4 kDa). 
59 
@le*ulU 
2.0-
1.8-
1.6-
Q 
1.4-
1.2-
1.0 
Phosphorylase b 
(97.4 kDa) 
BSA (68 kDa) 
OA (45 kDa) 
Carbonic anhydrase (29 kDa) 
,STI(20.1 kDa) 
1 Lysozyme (14.4 kDa) 
- i — | — i — | — • — | — i — | — i — | — i — | — i — | — i — | — i — , 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 
Relative mobility (Rm) 
Figure 10. Molecular weight determination of BBL by SDS-PAGE. 
Electrophoresis was carried out using 12.5 % SDS-polyacrylamide gel. The 
relative mobility (Rm) of the marker proteins and BBL were plotted against 
their molecular weight using least square analysis of the data. Molecular 
weight of BBL is indicated by an arrow. 
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Table IV. 
Various parameters for marker proteins and buffalo brain lectin calculated 
from gel filtration chromatography 
Marker 
proteins 
Bovine serum 
albumin 
Ovalbumin 
Soyabean trypsin 
inhibitor 
Cytochrome C 
Buffalo brain lectin 
Stokes 
radius 
(A) 
35.5 
27.3 
22.6 
16.4 
25.0±1.5 
MW 
(kDa) 
68 
45 
20.1 
12.4 
28.5±1.2 
LogM 
1.82 
1.653 
1.303 
1.09 
1.45 
Elution 
volume 
(V.) 
52 
64 
88 
103 
79 
v«/v„ 
1.40 
1.72 
2.37 
2.78 
2.13 
(-logJCv)1'2 
0.846 
0.678 
0.430 
0.273 
0.518 
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Figure 11. Molecular weight determination of BBL using sephadex G.ioo gel 
filtration chromatography. 
Purified BBL was applied on a column of sephadex G.ioo (1.8 * 45 cm) and 
eluted with 75 mM PBS, pH 7.2 containing 5 raM p-ME and 30 mM lactose at 
a flow rate of 15 ml/hr. The molecular weight markers used were bovine 
serum albumin (BSA 68 kDa), ovalbumin (OA 45 kDa), soyabean trypsin 
inhibitor (STI 20.1 kDa) and cytochrome c (CC 12.4 lcDa). The elution 
position of the lectin molecule is indicated by an arrow. 
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Figure 12. Determination of Stokes radius of the purified BBL by Laurent and 
Killander plot. 
The purified BBL and marker proteins were subjected to gel filtration on 
sephadex G.ioo column as described in materials and methods section. The 
Kav values were computed from the elution volumes of marker proteins. 
Stokes radii for the marker proteins were: 35.5 A (bovine serum albumin, 
BSA), 27.3 A (ovalbumin, OA), soyabean trypsin inhibitor (22.6 A, STi), and 
cytochrome C (16.4 A, Cyt C). Stokes radius of BBL is indicated by an arrow. 
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Diffusion Coefficient 
The diffusion coefficient, D, of BBL corresponding to the value of stokes radius was 
computed to be 8.91 x 10"15 cm2/s with the help of the equation, D=KT/67tr|r, where, 
K is the Boltzman constant (1.386 x 10"16 erg/deg), T is the absolute temperature 
(303 K) and n, is the coefficient of viscosity of the medium [0.0100 P for water and 
dilute aqueous salt solutions at 20° C (Freidfelder, 1982)]. 
Carbohydrate binding specificity 
The carbohydrate binding affinities of BBL was studied by investigating the effect of 
various sugars and their derivatives on BBL mediated hemagglutination of trypsinized 
rabbit erythrocytes. The inhibitory effect of saccharides was tested by using 4 
hemagglutinating unit of BBL. Increasing concentration of a specific saccharide 
caused substantial decrease in hemagglutination. The most potent inhibitor of BBL 
was lactose giving complete inhibition of hemagglutination at 0.78 mM followed by 
p-nitropheyl-P-D-galactopyranoside (50mM), galactose (lOOmM), 
methyl-P-D-galactopyranoside (lOOmM) and methyl-a-D-galactapyranoside 
(lOOmM) as shown in Fig. 13 and Table V. Other sugars such as D-galactosamine, 
p-nitropheyl-a-D-galactopyranoside, D-glucose, L-fucose, sucrose, D-mannose, 
melibiose, and D-fructose were unable to inhibit the lectin mediated hemagglutination 
even at a concentration of 200mM. 
Blood group specificity 
The ability of purified BBL to agglutinate human erythrocytes (Blood groups A, B, 
and O) was assayed using trypsinized as well as untrypsinized preparations of red 
blood cells. The BBL was titrated against erythrocytes showing positive agglutination 
using microtitre plate assay. The results are shown in Table VI. The concentration of 
brain lectin required for agglutination varied markedly with the type of cells. The 
rabbit erythrocytes treated with trypsin were most sensitive requiring only 1-1.5 ng/ml 
of lectin for complete agglutination, while the concentration required for trypsinized 
human erythrocytes was rather high (10-15 u.g/ml). BBL agglutinated native human 
erythrocytes with marked preference for the blood group A, while trypsinized human 
erythrocytes were found to be more sensitive towards buffalo brain lectin in the order 
of blood group A=0>B. 
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Figure 13. Inhibition of hemagglutination activity of BBL due to various 
saccharides. 
Each well contained 50 ul of serially diluted tested sugar, 50 ul of lectin (4 
agglutinating unit) and 50 ul of 4 % suspension of trypsinized rabbit 
erythrocytes. The minimum inhibitory concentration was obtained by dividing 
the starting concentration of the carbohydrates i.e. A (lactose (100mM)), B 
(galactose (200mM)), C (methyl-P-D-galactopyranoside (200mM)), 
D (p-nitrophenyl-p-D-galactopyranoside (100mM)), E (p-nitrophenyl-a-D-
galactopyranoside (200mM)), F (D-galactosamine (200mM)), G (Methyl-a-D-
galactopyranoside (200mM)), H (glucose (200mM)) by the reciprocal of the 
highest inhibitory dilution, taking into account that due to the addition of BBL, 
the dilution of the test sugar is 1:2 in the first well. 
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TABLE V. 
Effect of various saccharides on the hemagglutinating activity of BBL 
Carbohydrates Minimum concentration of sugar giving 
complete hemagglutination inhibition* 
Lactose 0.78 
Galactose 100 
Methyl-pVD-galactopyranoside 100 
p-nitrophenyl-P-D-galactopyranoside 50 
p-nitrophenyl-a-D-galactopyranoside Nil 
D-galactosamine > 100 
Methyl-a-D-galactopyranoside 100 
Glucose Nil 
The following saccharides were also tested and showed no inhibitory activity even at 200mM 
concentration: D- mannose, L-fucose, sucrose, meiibiose, and D-fructose. 
•Each value represents the mean of three independent experiments performed in triplicates. 
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TABLE VI. 
Human blood type specificity of buffalo brain lectin 
Blood type 
A 
B 
0 
Untrypsinized 
8 
4 
8 
Titre 
Trypsinized 
32 
16 
32 
Titre* The reciprocal of the highest dilution giving visible hemagglutination 
Four hemagglutinating units per 50 ul were taken in each assay; the results shown are 
mean of three different preparations taken in triplicates. 
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Determination of binding parameters of lactose with lectin by equilibrium 
dialysis 
The Scatchard plot of the equilibrium dialysis data of binding of BBL in 75mM PBS 
pH 7.2 containing 5mM P-ME with lactose (40-400 uM) at 37°C is shown in Fig. 14. 
A linear plot was obtained, the slope of which gave the binding constant Kass as 
6.66 x 103 M1. The number of binding sites calculated from the X intercept was found 
to be 1.7 per lectin dimer suggesting the presence of one binding site per subunit. 
Carbohydrate moiety 
BBL was found to contain 3.3% carbohydrate content, which may correspond to 3 
residues of carbohydrate per lectin molecule. 
Sulphydryl groups 
Thiol group analysis of the lectin indicated a molar ratio of 2.8 suggesting the 
presence of three-sulphydryl groups per mole of protein. 
Thermal stability 
BBL retained full activity when maintained at temperatures up to 45°C (Fig. 15). A 
gradual decrease of activity was observed when it was heated between 45-65°C, while 
a sharp decline was observed at 70°C. 
pH stability 
The BBL showed maximum hemagglutinating activity at pH 7.5, with stability 
between 6.5-9.5 (Fig. 16). 
Functional modification of lectin with alkylating agents 
The extracted lectin showed activity only in the presence of reducing agents like 
P-ME and dithiothreitol. To examine the role of thiol groups in the sachharide 
binding, these groups were modified by iodoacetate and iodoacetamide. Treatment 
of alkylating agents resulted in a considerable loss of lectin activity, which was 
studied by measuring the time course of inactivation by 70 mM each of iodoacetate 
and iodoacetamide in 75 mM PBS, pH 7.2 containing ImM P-ME (Fig. 17). 
Iodoacetamide inactivated more than 75 % activity of buffalo brain lectin within 20 
minutes but no further significant loss of activity was observed, whereas, iodoacetate 
showed a much gradual decrease in the activity. This indicated the possible role of 
thiol groups of lectin in the saccharide binding and the need of a reducing agent to 
maintain the active form of lectin. 
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Binding coefficient 
Figure 14. Scatchard plot for the binding of lactose to BBL. 
A fixed concentration of BBL (lOOuM) in 75 mM sodium phosphate buffer 
pH 7.2 containing 0.15 M NaCl and 5 mM P-ME in a dialysis bag was 
incubated with 40-400 uM of lactose in the same buffer at 37°C for 24 hrs. 
After the attainment of equilibrium the decrease in lactose concentration was 
estimated in the dialysate. Analysis of results yielded the value of association 
constant and the number of sugar binding sites. 
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Figure 15. Thermal stability of BBL. 
Buffalo brain lectin (125ug/ml) was incubated for 30 min at various 
temperatures (30-70 °C). The hemagglutinating activity was measured by 
microtitre plate assay and the initial activity (100%) refers to the activity of 
the unincubated lectin. 
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Figure 16. The pH dependence of BBL. 
Native BBL (125 ug/ ml) were incubated in various buffers (0.1 M sodium 
acetate/sodium phosphate/Tris-HCl/ glycine NaOH) of different pH values 
(3.5-11.5) at 4°C for 24 hours. Hemagglutinating activity was assayed by 
microtitre plate assay. Initial activity refers to the activity of BBL in normal 
saline containing 5 mM P-ME. 
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Figure 17. Effect of alkylating agents on the activity of BBL. 
Buffalo brain lectin (125 ug/ml) having 256 hemagglutinating units (100% 
activity) was incubated at room temperature with 70 raM iodoacetate or 
iodoacetamide in 75 mM of sodium phosphate buffer containing 0.15 M NaCl 
and 1 mM 0-ME pH 7.2 at 37'C for different time intervals (0-50 min) and 
residual activity was measured by microtitre plate assay. The initial activity 
refers to the hemagglutinating activity of BBL in the absence of the alkylating 
agents. 
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Effect of detergents 
The effect of increasing concentration of SDS on the activity of native lectin is shown 
in Fig. 18. The activity of the lectin showed a steep decline with loss of 50 % activity 
at 0.5 mg % SDS. Complete inhibition was achieved at 2 mg % of SDS concentration. 
However, when native protein was treated with SDS in the presence of 10 mM 
lactose, effective protection was demonstrated against denaturation. Pre-incubation of 
BBL with varying concentration of non-ionic detergents i.e. Tween-20 and 
Triton X-100, resulted in a lesser loss of lectin activity (Fig. 19). Addition of 
Tween-20 showed a decline in the activity with 50 % decrease at 5 % (v/v) of Tween 
20. Similarly Triton X-100 lowered the agglutination activity of native lectin with 
reduction of 66.6 % at 5.0 % (v/v) Triton X-100 concentration. BBL pre-treated with 
10 mM lactose did not show any change in the activity at all inhibiting concentrations 
of Tween-20 and Triton X-100. 
Effect of metal ions 
Addition of metal cations (CaCl2, MnCl2, [Sr(CHCOO)2], MgCl2, NiCl2) showed no 
effect on hemagglutinating activity, suggesting that BBL activity was not dependent 
on metal ions. 
Brain aggregation assay 
The purified BBL preferentially agglutinated buffalo brain cells (75%; 45 x 104 
cells/ml) than goat brain cells (63%; 38 x 104 cells/ml) (Fig. 20). Optimum pH and 
temperature for brain cell aggregation activity of BBL was found to be 7.5 and 40°C, 
respectively (Fig 21, 22). The optimal pH and temperature did not change for goat 
brain cells and was same as that for buffalo brain cells. 
Spectroscopic properties of lectin 
UV spectra 
Ultraviolet absorption spectrum of purified protein was studied in 75 mM PBS pH 
7.2, containing 5 mM 0-ME in the wavelength of 220-320 nm. The lectin displayed 
an absorption maximum at 282 nm, and a minimum at 250 nm corresponding to the 
presence of single tryptophan residue and a large number of other aromatic residues 
(Fig.24). When excited at 280 nm, the native lectin showed fluorescence emission 
spectrum with a maximum at 335nm, typical of a tryptophan residue in a hydrophobic 
environment as shown in Fig. 25. 
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Figure 18. Effect of increasing concentrations of SDS on the activity of BBL. 
BBL (125 ug/ ml) having initial titre value of 256 (100% activity) was 
incubated with varying concentrations of SDS (0.1-2 mg/ml) in 75 mM of 
sodium phosphate buffer containing 0.15 M NaCl and 5 mM P-ME pH 7.2 at 
37°C for one hour. The residual activity was measured by microtitre plate 
assay. The initial activity refers to the hemagglutinating activity of the 
unincubated protein. 
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Figure 19. Effect of increasing concentrations of Tween-20 and Triton X-100 on 
BBL. 
BBL (125 fig/ ml) with initial titre value of 256 (100% activity) was incubated 
in varying concentrations of Tween-20 and Triton X-100 (1-5% v/v) in 75 mM 
of sodium phosphate buffer containing 0.15 M NaCl and 5 mM p-ME pH 7.2 
at 37"C for one hour. The residual activity was measured by microtitre plate 
assay. The initial activity refers to the hemagglutinating activity of the 
unincubated protein. 
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Figure. 20. Brain cell aggregation by BBL 
BBL induced aggregation of brain cells from adult buffalo (•) and goat (•) 
were detected by measuring the decrease in the number of total free particles 
by hematocytometer. 
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Figure 21. Effect of temperature on brain cell aggregation by BBL 
BBL induced aggregation of brain cells from adult buffalo (A) and goat (•) 
were detected by measuring the decrease in the number of total free particles 
by hematocytometer after incubating at different temperatures ( 20-80 °C) for 
30 min. 
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Figure 22. Effect of pH on brain cell aggregation by BBL. 
BBL induced aggregation of brain cells from adult buffalo (A) and goat (•) 
were detected by measuring the decrease in the number of total free particles 
by hematocytometer after incubating in various buffers (0.1 M sodium 
acetate/sodium phosphate/Tris-HCl/ glycine NaOH) of different pH values 
(3.5-11.5) at 4°C for 24 hours. 
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Circular dichroism Spectra 
The far-ultraviolet circular dichroism spectra of native lectin in 10 mM sodium 
phosphate buffer pH 7.5 are shown in Fig. 27. A low intensity spectrum was observed 
with a minimum in the range between 215-217 nm consistent with the large extent of 
P-sheet structure profile. The a-helical structure was found to be absent in BBL due to 
the absence of trough at 222 nm and 208 nm (characteristic feature of a-helix) The 
CD-spectra of BBL in the near UV range is depicted in Fig. 29 which gives a picture 
of tertiary structure of BBL. 
Modification of lectin in the presence of H202 and lactose 
The time course of inactivation of buffalo brain lectin in the presence of H2O2 was 
measured in 75 mM PBS pH 7.2 containing 1 mM |3-ME. The exposure of BBL to 
H202 showed a remarkable decrease in the hemagglutination activity with time 
(Fig.23). Functional modification of BBL in the presence of oxidizing agent was due 
to the conformational changes in the native structure of BBL. This was confirmed as 
UV spectrum (Fig.24) of native BBL showed a sharp decline in the maxima from 282 
to 250 nm in the presence of H202 typical as that of oxidation of tryptophan residue. 
Fluorescence spectroscopy shows a quenching of the intrinsic fluorescence of the 
native spectra in the presence of 5 mM of H2O2 as is evident in fluorescent profile 
(Fig. 25). The peak position of oxidized protein also showed a blue shift from 335 to 
332 nm accompanied by quenching of fluorescence intensity. Fig. 26 shows a rate of 
change of fluorescence intensity in the presence of 5 mM H2O2. This decrease of 
fluorescence intensity can be compared to the decrease in the activity profile and can 
be assessed that both the changes are concomitant to each other. When fluorescence 
experiments of the native protein were carried out in the presence of 0.1 M lactose 
solution a large enhancement in the fluorescence intensity was observed, suggesting 
that the flourophore is possibly present in the vicinity of the lactose-binding site. 
Exposure of lectin to 5 mM H2O2 in the presence of 0.1 M lactose showed less 
decrease of fluorescence (Fig. 25) as compared to the decrease in its absence. The 
changes in the secondary structure of the native BBL in the presence of H2O2 was also 
analyzed by CD and fluorescence tagged infra red (FTIR) spectroscopy analysis. The 
far-ultraviolet circular diochroism spectra (Fig. 27) of native BBL in 10 mM 
sodium phosphate buffer pH 7.2 containing 0.15 M NaCl and 5 mM p-ME revealed a 
low intensity spectrum with a minimum in the range between 215-217 nm. The CD-
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Figure 23. Effect of oxidant on the hemagglutination activity of BBL. 
Buffalo brain lectin with titre value of 256 (80 |xg/ml) was incubated with 
5mM H2O2 at room temperature for different time intervals (1-50 min) and 
residual activity was measured by microtitre plate assay. Initial (100%) 
activity refers to the activity of the unincubated lectin. 
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Figure 24. Ultraviolet spectra of native and oxidized BBL. 
Spectra of native buffalo brain lectin (150ug/ml) in 75 mM PBS, pH 7.2 
containing 5 mM 0-ME (•) and after adding 5 mM H2O2 in the absence of P-
ME(»). 
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Figure 25. Fluorescence spectra of BBL. 
Experiments were performed with BBL (45 ug/ml) in 75 mM sodium 
phosphate buffer pH 7.2. The spectra of native BBL alone (•), in the presence 
of 0.1 M lactose (a), oxidized BBL alone (by adding 5 mM H2O2) (•) and 
oxidized BBL in the presence of 0.1 M lactose (o) were measured between 
300-400 nm. 
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Figure 26. The rate of change in relative fluorescence of BBL. 
The rate of change of relative fluorescence of BBL (40ug/ml) at 340 nm on 
incubation with 5mM H202 was measured at 22°C after excitation at 280nm 
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spectra of BBL in the near UV range is depicted in Fig. 29 which gives a picture of 
tertiary structure of BBL. The effect of H2O2 on the secondary (Fig. 28) and tertiary 
structure (Fig. 30) of native lectin was also studied using circular diochroism 
spectroscopy. The CD spectral analysis revealed that oxidant exposure caused a 
remarkable change in the far UV CD spectra with alterations in the P-sheet towards 
predominantly a-helical structure (characterized by the minima around 208 and 222 
nm). Addition of H2O2 to the lectin also indicated changes in the near UV CD spectra 
of the native lectin, shedding light on the significant change in the tertiary structure of 
the lectin upon oxidation. Addition of lactose alone did not cause any significant 
change either to the secondary (Fig. 27) or tertiary structure (Fig. 29) of the native 
lectin as depicted by spectral analysis in far UV and near UV region respectively, 
while oxidation of BBL pre-incubated with lactose displayed a lesser change in 
secondary (Fig. 28) and tertiary (Fig. 30) structure of lectin as compared to its native 
form. 
FTIR analysis confirmed the conformational changes during BBL-lactose and 
BBL-H2O2 interactions as shown by circular diochroism studies. In the IR spectra of 
proteins, the secondary structure is most clearly reflected by the amide I and II bands, 
particularly the former (Elliot and Ambrose, 1950; Timasheff et al., 1967); the amide 
I band absorbs at 1657 cm"1 (mainly a C=0 stretch), and the amide II band absorbs at 
1542 cm'1 (C-N stretching coupled with N-H bending modes) (Elliot and Ambrose, 
1950; Timasheff et al., 1967). It has also been reported that, for a native protein, the 
amide I component for the a helical structure locates at 1656 ± 2 cm"1 and the band 
components for the p-sheet structure should locate between 1622 and 1642 cm'1 
(Elliot and Ambrose, 1950; Timasheff et al., 1967). Fig. 31 shows the spectra of the 
native lectin alone and co-iricubated with oxidizing agent and lactose at 37° C. The 
major peak at 1635 cm*1 as shown by native lectin is consistent with the presence of 
large extent of P-pleated sheet. The presence of lactose did not cause any significant 
change in the peak position, whereas the presence of 5 mM H2O2 caused a major 
transition of peak from 1635 cm'ho 1652 cm"1 (characteristic of a-helix). Oxidation 
induced peak shift from P-pleated to a-helical regions of lactose treated BBL was less 
as compared to H2O2 treated native BBL. 
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Figure 27. Far- UV-CD spectra of native BBL in the presence of lactose. 
The spectra of native BBL (0.250 mg/ml) in 10 raM PBS pH 7.2 was 
recorded between 200-250 nm using path length of 0.1 cm, in the absence 
(a); and presence of 0.1 M lactose (b). 
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Figure 28. Far-UV-CD spectra of native BBL in the presence of H202. 
The spectra of BBL (0.250 mg/ml) in 10 mM PBS pH 7.2 was recorded 
between 200-250 nm using path length of 0.1 cm. in the presence and 
absence of oxidizing agent, (a) native BBL; (b) oxidized BBL (by adding 5 
mM H202 in the absence of 0-ME ); and (c) oxidized BBL pre-incubated 
with 0.1 M lactose. 
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ure 29. Near- UV-CD spectra of native BBL in the presence of lactose. 
The spectra of BBL (lmg/ml) in 10 mM PBS, pH 7.2 was recorded in the 
absence (a) and presence (b) of 0.1M lactose between 250-350 nm using 
0.1 cm path length. 
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ure 30. Near- UV-CD spectra of native BBL in the presence of H2O2. 
The spectra of native BBL (1 mg/ml) in 10 raM PBS pH 7.2 (a); oxidized 
BBL (by adding 5 mM H202 in the absence of P-ME ) (b); and oxidized BBL 
pre-incubated with 0.1 M lactose (c), was recorded between 250-350 nm 
using path length of 0.1 cm. 
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Figure 31. FTIR spectra of BBL. 
The spectra of BBL (0.15 mg/ml) in 10 mM PBS pH 7.2 were recorded in 
the presence and absence of lactose/ H2O2. a. native BBL; b. BBL with 
lactose,; c. oxidized BBL (by adding 5 mM H2O2 in the absence of P-ME ) 
d oxidized BBL pre-incubated with 0.1 M lactose. 
89 
£Re&u46> 
Effect of denaturants on the activity and structure of lectin 
Activity 
Effect of denaturants like GdnHCl, urea and thiourea on the hemagglutinating activity 
of the native lectin was monitored at varying concentration of the denaturants (0-8 M) 
followed by incubation for four hours at 37°C. Both GdnHCl and urea caused a 
significant loss in the titre value with decrease of 50% at 3.0 M concentration, while 
thiourea reduced the lectin activity to 50% at 4.0 M. There was a leveling of activity 
of lectin at lower concentration of urea and GdnHCl (Fig. 32). 
Conformational change 
The denaturation of lectin was also monitored by differential fluorescent behaviour in 
the presence of varying amounts of denaturants at 37 °C after an incubation period of 
four hours. The emission spectra were recorded between 300-400 nm wavelengths by 
exciting the protein at 280 nm. Complete denaturation of protein was observed at 6 M 
GdnHCl with a 40% decrease in fluorescence intensity and shift of emission maxima 
from 340 to 357 nm (Fig. 33). Fluorescence intensity profile of BBL in the presence 
of urea depicted an increase in intensity, and complete unfolding was observed at 8 M 
urea with a 30.8 % increase in fluorescence intensity and shift of emission maximum 
from 337 to 355 nm (Fig.34). Thiourea caused a similar increase in the fluorescence 
intensity with a 25.8 % increase in fluorescence intensity with a red shift from 337 nm 
to 360 nm (Fig. 3 5). 
Deglycosylation of lectin and its effect on its stability 
Deglycosyfation 
The method applied for the deglycosylation completely removed the carbohydrate 
moiety from the native glycosylated BBL which was confirmed by phenol-sulphuric 
acid method (Dubois et al., 1956). The extent of deglycosylation was also monitored 
by means of SDS-PAGE (Fig. 3 6) where the migration of native BBL was compared to 
deglycosylated protein We found that periodate treatment of glycosylated lectin 
resulted in complete removal of sugar residues as the mobility of deglycosylated 
protein has increased and molecular weight was decreased to 14.0 kDa (Fig. 36). The 
effect of deglycosylation on the molecular weight of lectin was also investigated by gel 
filtration analysis. 
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Figure 32. Effect of increasing concentration of denaturants on the activity of 
BBL. 
BBL (125 fig/ ml) with initial titre value of 256 (100% activity) was incubated 
with varying concentration (0-8 M) of GdnHCI, urea and thiourea in 75 mM 
of PBS, pH 7.2 containing 5 mM P-ME at 37°C for four hours. The residual 
activity was measured by microtitre plate assay. The initial activity (100%) 
refers to the hemagglutinating activity of the unincubated protein. 
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Figure 33. Effect of increasing concentration of GdnHCl on fluorescent spectra 
of BBL. 
BBL (45ng/ml) was incubated with varying concentrations (0-8 M) of 
GdnHCl in 75 mM of PBS, pH 7.2 at 37°C for four hours. The emission 
spectra were measured in the range of 300-400 nm after excitation of protein 
at 280 nm. 
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Figure 34. Effect of increasing concentration of urea on fluorescent spectra of 
BBL. 
BBL (45ug/ml) was incubated with varying concentrations (0-8 M) of urea in 
75 mM of PBS pH 7.2 at 37°C for four hours. The emission spectra were 
measured in the range of 300-400 nm after excitation of protein at 280 nm. 
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Figure 35. Effect of increasing concentration of thiourea on fluorescent spectra 
of BBL. 
BBL (45ng/ml) was incubated with varying concentrations (0-8 M) of 
thiourea in 75 mM of PBS pH 7.2 at 37°C for four hours. The emission spectra 
were measured in the range of 300-400 nm after excitation of protein at 280 
nm. 
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The deglycosylated lectin was eluted later than the native form of protein. The 
delayed elution may reflect a contraction in molecular size due to the removal of 
carbohydrate moiety The molecular weight and stokes radius of deglycosylated lectin 
corresponded to 27.7 kDa and 24 A respectively, thus depicting a negligible change 
upon deglycosylation (Fig 37, 38). 
Effect of temperature 
The deglycosylated form retained its full activity till 40°C unlike the native form 
which was fully active till 45°C (Fig. 39). A sudden decrease in titre value was 
observed when both the forms of BBL were heated between 45" to 65°C with 
deglycosylated BBL displaying less stability against heat in comparison to the 
glycosylated BBL. Moreover, native BBL exhibited 12.5 % activity at 70° C in 
comparison to negligible 3.125 % of original activity of deglycosylated BBL. At 
60°C, the native and deglycosylated lectin showed 25% and 12.5 % of initial activity, 
respectively. Glycosylated protein was significantly more stable than 
non-glycosylated preparation when incubated at 60°C for different time intervals. The 
native protein retained 12.5 % of initial activity after 1 hour of incubation at 60°C 
whereas the deglycosylated form exhibited 6.25 % of residual activity under similar 
conditions (Fig. 40). 
Effect of pH 
There was no difference in pH optima of glycosylated and deglycosylated lectin. Both 
forms exhibited similar pH optima between 7.0-7.5, with deglycosylating lectin 
showing less activity than the native form at pH values other than pH optima 
(Fig. 41). 
Effect of denaturants 
Effect of GdnHCl, urea and thiourea on deglycosylated forms at different 
concentrations has been shown in Fig. 42, 43, and 44, respectively. There was not 
much difference in the activity of native BBL and deglycosylated form after its 
incubation with 1.5 M GdnHCl for four hours. The hemagglutinating activity showed a 
considerable decrease from 2.5 M GdnHCl to 8.0 M GdnHCl. Native BBL showed a 
50% decrease in its activity at 3.0 M GdnHCl, whereas deglycosylated form lost 75 % 
of its original activity at 3.0 M GdnHCl under similar conditions. Incubation with 
higher (6-8 M) concentrations of denaturants resulted in a complete loss in the 
agglutinating activity of both the forms of protein. 
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Figure 36. SDS-PAGE of native and deglycosylated forms of BBL 
Electrophoresis of both native and deglycosylated BBL was performed on 
12.5 % acrylamide gel in reducing condition. The relative mobilities (Rm) 
were plotted against their molecular weight using least square analysis of the 
data. Molecular weight of native and deglycosylated BBL is indicated by an 
arrow 1 and 2, respectively. Inset shows the electrophoretic pattern of native 
and deglycosylated BBL: Lane a: molecular weight standards in the 
descending order; Phosphorylase b (97.4 kDa), BSA (68 kDa), ovalbumin (45 
kDa), Carbonic anhydrase (29 kDa), Soyabean trypsin inhibitor (20.1 kDa), 
Lysozyme (14.4 kDa), Lane b: 35u.g of purified native protein. Lane c: 35 ug 
of deglycosylated protein. Gel was stained using coomassie brilliant blue 
R-250 dye. 
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Figure 37. Molecular weight determination of deglycosylated BBL using 
Sephadex G-100 gel filtration chromatography. 
Native and deglycosylated BBL was applied on a column of sephadex G.ioo 
(1.8 x 45 cm) and eluted with 75 mM PBS containing 5 mM 0-ME and 30 
mM lactose, pH 7.2 at a flow rate of 15 ml/hr in the form of 1.5 ml fractions. 
The molecular weight markers used were bovine serum albumin (BSA, 68 
kDa), ovalbumin (OA, 45 kDa), soyabean trypsin inhibitor (STI, 20.1 kDa) 
and cytochrome c (CC, 12.4 kDa). The elution position of the native and 
deglycosylated lectin is indicated by arrow 1 and 2, respectively. Inset shows 
the elution profile of native and deglycosylated BBL from sephadex G-100 
column. 
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Figure 38. Determination of Stokes radius of the deglycosylated BBL by Laurent 
and Killander plot. 
The deglycosylated lectin was subjected to gel filtration on sephadex G.JOO 
column. The Kav values were computed from the elution volumes of marker 
proteins. Stokes radii for the marker proteins were bovine serum albumin 
(BSA, 35.5 A), ovalbumin (27.3 A), soyabean trypsin inhibitor (22.6 A), and 
Cytochrome C (16.4 A). Stokes radii of native and deglycosylated BBL is 
indicated by arrows 1 and 2, respectively. 
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Figure 39. Effect of temperature on native and deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) in 75 mM sodium phosphate 
buffer, pH 7.2 containing 0.15 M NaCl and 5 mM p-ME were incubated at 
various temperatures (30°C-70°C) for 30 min., chilled in crushed ice and 
hemagglutinating activity was assayed by microtitre plate assay. Initial activity 
refers to the activity of the proteins at 37°C. 
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Figure 40. Thermal denaturation profile of native and deglycosylated BBL at 
60° C. 
Native and deglycosylated protein (125 ug/ ml) were taken in 75 mM sodium 
phosphate buffer, pH 7.2 containing 0.15 M NaCl and 5 mM 0-ME, chilled in 
crushed ice and hemagglutinating activity was assayed by microtitre plate 
assay at 60 °C after different time intervals. Initial activity refers to the activity 
of the unincubated proteins. 
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Figure 41. Effect of pH on native and deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated in various 
buffers (0.1 M sodium acetate/sodium phosphate/Tris-HCl/ glycine NaOH) of 
different pH values (3.5-11.5) at 4°C for 24 hours. Hemagglutinating activity 
was assayed by microtitre plate assay. Initial activity refers to the activity of 
both the proteins in normal saline containing 5 mM p-ME. 
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Similar denaturation curve was obtained in the presence of urea, but with a 
pronounced decrease in case of deglycosylated form. There was a reduction of 
66.66% of the initial activity of deglycosylated BBL at 3.0 M urea as compared to 50 
% loss in the activity of glycosylated lectin. 
Thiourea also abolished the activity of modified form but at a lower concentration than 
the native form. 
Effects of detergents 
In the presence of increasing concentration of SDS (Fig. 45) the activity of both 
glycosylated and deglycosylated lectins showed a decrease with a pronounced trend for 
deglycosylated form. 
Similarly, pre-incubation of both forms of lectin with Tween-20 at 37°C for 1 hour 
resulted in a greater loss of activity (Fig. 46) for deglycosylated BBL than for the 
glycosylated lectin. Native lectin retained 50 % of its initial activity at a concentration 
of 5 % (v/v) of Tween-2P, whereas the deglycosylated preparation lost nearly 75% of 
activity under similar concentration and conditions. The effect of increasing 
concentration of Triton X-100 (0.5-5.0 %, (v/v)) is illustrated in Fig. 47. The 
hemagglutinating activity of native and deglycosylated form was decreased at all 
concentrations, with native protein retaining higher activity as compared to the 
deglycosylated form. At 5.0 % (v/v) concentration of Triton X-100, native exhibited 
66.6 % of the initial activity, whereas only 33.3 % of initial activity was retained by 
deglycosylated form. 
Spectrophotometric properties 
UV spectra of both deglycosylated and native lectins showed maxima at 282 nm 
(Fig. 48), with slightly higher absorbance for deglycosylated BBL. Moreover, 
fluorescent spectra for deglycosylated form displayed a higher fluorescent intensity 
profile (Fig. 49) with similar maximum emission wavelength at 335 nm as that for 
native protein. Similarly, circular diochroism spectra of deglycosylated BBL did not 
show any appreciable change with respect to the spectra of native BBL, thus 
suggesting no alteration in the secondary structure of lectin upon removal of sugar 
moiety (Fig. 50) 
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Figure 42. Effect of increasing concentration of GdnHCI on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated in various 
concentration of GdnHCI (0-8 M) in 75 mM of PBS, pH 7.2 containing 
5 mM P-ME at 37°C for four hours. Hemagglutinating activity was assayed 
using microtitre plate assay and the initial activity refers to the activity of 
unincubated protein. 
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Figure 43. Effect of increasing concentration of urea on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated in various 
concentration of urea (0-8 M) in 75 mM of PBS, pH 7.2 containing 
5 mM p-ME at 37°C for four hours. Hemagglutinating activity was assayed 
using microtitre plate assay; the initial activity refers to the activity of 
unincubated protein. 
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Figure 44. Effect of increasing concentration of thiourea on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated in various 
concentration of thiourea (0-8 M) in 75 mM of PBS, pH 7.2 containing 
5 mM p-ME at 37°C for four hours. Hemagglutinating activity was assayed 
using microtitre plate assay and the initial activity refers to the activity of 
unincubated protein. 
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Figure 45. Effect of increasing concentration of SDS on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated at various 
concentration of SDS (0.1-2 mg/ml) in 75 mM of PBS, pH 7.2 containing 
5 mM P-ME at 37°C for one hour. Hemagglutinating activity was assayed 
using microtitre plate assay and the initial activity refers to the activity of 
unincubated protein. 
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Figure 46. Effect of increasing concentration of Tween-20 on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated at various 
concentration of Tween-20 (0.5-5 %) in 75 mM of PBS, pH 7.2 containing 
5 mM P-ME at 37°C for one hour. Hemagglutinating activity was assayed 
using microtitre plate assay and the initial activity refers to the activity of 
unincubated protein. 
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Figure 47. Effect of increasing concentration of Triton X-100 on native and 
deglycosylated BBL. 
Native and deglycosylated protein (125 ug/ ml) were incubated at various 
concentration of Triton X-100 (0.5-5%) in 75 mM of PBS, pH 7.2 containing 
5 mM p-ME at 37"C for one hour. Hemagglutinating activity was assayed 
using microtitre plate assay and the initial activity refers to the activity of 
unincubated protein. 
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Fluorescence studies of Denaturant treated native and deglycosylated form 
Fig. 51 demonstrates the unfolding pathway of glycosylated and deglycosylated BBL 
in the presence of increasing concentration of GdnHCl. There was a gradual decrease 
in the fluorescence intensity of both forms of lectin till 6 M GdnHCl with a 
pronounced red shift from 335 to 357 nm (for BBL). A slight increase in the intensity 
was observed at higher concentrations with no change in the emission maxima. 
However, in case of deglycosylated BBL, higher fluorescence intensity was observed 
than the native lectin with a greater red shift at all concentration of GdnHCl. 
Fig. 52 and 53 depicts the fluorescent profile for both the forms of lectin at different 
concentrations of urea and thiourea, respectively. Complete unfolding of protein was 
observed at 8 M urea with an increase in fluorescence intensity and shift of emission 
maximum from 335 to 355 nm. Thiourea caused a similar increase in the fluorescence 
intensity with a red shift from 335 nm to 360 nm. The deglycosylated buffalo brain 
lectin in the presence of urea and thiourea, again exhibited higher fluorescence 
intensity with a greater red shift as compared to the glycosylated native lectin. The 
difference in the fluorescence intensity of native and deglycosylated form was less 
between 1 to 2 M concentrations of denaturants, but became significantly higher at 
higher concentration of urea and thiourea. 
Immunological studies 
Evalution of antibody response 
Lectin obtained from buffalo brain was highly immunogenic in rabbits as it readily 
gave a single line of identity when tested by double immunodiffusion indicating the 
homogeneity of protein preparation. Direct binding ELISA was performed to 
characterize the immune response in rabbits using pure buffalo brain lectin as 
antigen. The antiserum showed a high titre > 128000 (Figure 54) suggesting the high 
immunogenic nature of BBL. Preimmunized serum served as negative control and 
did not show any appreciable binding to buffalo brain lectin. 
Antigenic cross reactivity with other brain lectins 
Immunodiffusion studies show that anti-BBL antibodies recognized both goat and 
sheep brain lectins, but comparatively faint precipitin lines were observed with 
respect to buffalo brain lectin indicating that antibody was not highly specific to 
sheep and goat lectin as compared to buffalo lectin (Fig. 55). The specificity of the 
induced antibodies and sharing of common antigenic determinants between lectins 
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Figure 48. Ultra violet spectra of native and deglycosylated BBL. 
Native and deglycosylated BBL (150[ig/ml) were prepared in 75 mM PBS, pH 
7.2 containing 5 mM P-ME. The spectra were recorded between wavelength 
220-320 nm. 
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Figure 49. Intrinsic fluorescence of native and deglycosylated BBL. 
Native and deglycosylated BBL (45^g/ml) were prepared in 75 mM PBS, pH 
7.2. The intrinsic fluorescence spectra were recorded by exciting the protein at 
280 nm and the emission wavelength were taken between 300-400 nm. 
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Figure 50. Far- UV-CD spectra of native and deglycosylated BBL 
The spectra of native BBL (a) and deglycosylated BBL (b) (0.250 mg/ml) in 
10 mM PBS pH 7.2 were recorded between 200-250 nm using path length 
of 0.1 cm. 
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Figure 51. Effect of increasing concentration of GdnHCI on fluorescence 
intensity of glycosylated and deglycosylated forms of BBL. 
Native and deglycosylated BBL (40ng/ ml) were incubated in 0-8 M 
concentration of GdnHCI 75 mM of PBS pH 7.2 at 37°C for four hours. The 
proteins were excited at 280 nm and emission wavelengths were taken 
between 300-400 nm. 
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Figure 52. Effect of increasing concentrations of urea on fluorescence intensity of 
glycosylated and deglycosylated forms of BBL. 
Native and deglycosylated proteins (40^g/ ml) were incubated in 0-8 M 
concentration of urea in 75 mM of PBS pH 7.2 at 37°C for four hours. The 
proteins were excited at 280 nm and emission wavelengths were recorded 
between 300-400 nm. 
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Figure 53. Effect of increasing concentrations of thiourea on fluorescence 
intensity of glycosylated and deglycosylated forms of BBL. 
Native and deglycosylated proteins (40ng/ ml) were incubated in 0-8 M 
concentration of thiourea in 75 mM of PBS, pH 7.2 at 37°C for four hours. 
The proteins were excited at 280 nm and emission wavelengths were taken 
between 300-400 nm. 
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Figure 54. ELISA of anti buffalo brain lectin. 
Pre-immunized and BBL immunized rabbit anti-sera tested by direct binding 
ELISA at different dilutions (1:100, 1:200, 1:400, 1:800, 1:1600, 1:3200, 
1:6400, 1:12800). The wells were coated with a solution containing 20 ug/ml 
buffalo brain lectin. The negative logarithm of serum dilution versus the 
absorbance at 450 nm for both pre-immunized and immunized sera are 
plotted. 
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was further ascertained by competition ELISA, using purified sheep, goat, and 
buffalo brain lectins as competitors. The induced antibodies showed a high degree of 
specificity for buffalo brain lectin (immunogen), however, the extent of binding was 
slightly slightly lower for sheep and goat lectins. The buffalo brain lectin inhibited 
the anti buffalo antibody binding to solid phase bound antigen by 87%, while the 
inhibition of goat and sheep lectin was 53% and 62%, respectively (Fig. 56) The 
antibodies were quite specific for the immunogen, since only 5 ug/ml of BBL was 
required for achieving 50% inhibition. (Table VII). Anti buffalo lectin antibody 
displayed full cross reactivity with goat and sheep brain lectin with concentrations 
required to achieve 50% inhibition corresponded to 18 and 9.5 ug/ml, respectively 
and the relative affinities for sheep and goat lectins were found to be 60.91% and 
71.26% respectively (Table VII). 
The antiserum was also tested against various tissue homogenates like heart, liver 
and lung by dot blot analysis (Fig. 57). It was found that antibodies reacted strongly 
with all of them. 
Membrane studies 
Effect of BBL mediated agglutination on the RBC osmofragility 
Extent of hemolysis of erythrocytes in the presence and absence of buffalo brain 
lectin is depicted in Fig. 58. Erythrocytes exhibited a decrease in hemolysis when 
exhibited to a range of hypotonic to isotonic NaCl solutions. Lectin agglutinated cells 
displayed a significant (P<0.001) lysis at 0.55 % and 0.65% NaCl concentration with 
72.22 and 70.03% hemolysis respectively, depicting a 47.7 and 112.53 % increase 
with respect to lysis in untreated RBCs. In the absence of BBL, there was only 48.89 
and 32.95% hemolysis at similar concentration of hypotonic solution. A significant 
(P< 0.001) 41.77% hemolysis of RBCs is observed at isotonic NaCl concentration 
showing pronounced lectin binding to RBC membrane. 
Effect of increasing concentration of buffalo brain lectin on hemolysis of 
erythrocytes 
The fragility of RBCs in the presence of increasing concentration of brain lectin in 75 
mM PBS pH 7.4 at 37°C is shown in Fig. 59.There was a concentration dependent rise 
in the hemolysis of erythrocytes with maximum lysis corresponding to 81.25 % 
at 100 n.g of lectin concentration, while negligible hemolysis was observed in control 
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Figure 55. Comparison of antigenicity of lectin preparation from goat, sheep 
and buffalo brain by Ouchterlony immunodiffusion. 
Well 'a' contains rabbit antiserum raised against buffalo brain lectin. Wells 
'b ' , ' c \ 'd' contain lectin (250ug/ml) from buffalo, sheep and goat brain, 
respectively. 
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Figure 56. Competitive ELISA of anti buffalo brain lectin antibody by different 
lectins as inhibitors 
For the antigenic specificity inhibition studies, varying amounts (0-20 ug/ml) 
of inhibitors like purified buffalo brain lectin (•), sheep brain lectin (A), 
goat brain lectin (•) were taken with a constant amount of antiserum (1:100), 
raised against BBL as described in 'methods' section. 
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Table VII. 
Relative binding affinity of anti-buffalo antibodies to various brain lectins 
Inhibitor 
Buffalo brain lectin 
Goat brain lectin 
Sheep brain lectin 
Cone . for 50% 
inhibition (ug/ml) 
5 
18 
9.5 
Maximum % 
inhibition at 20 
ug/ml 
87 
53 
62 
% Relative 
Affinity 
100 
60.91 
71.26 
Each value represents the mean of three independent experiments performed in 
triplicates. 
e/teta/A 
Figure 57. Dot Blot analysis using anti buffalo lectin antiserum. 
Tissue homogenates from buffalo brain, heart, lung and liver were loaded on 
nitrocellulose membrane sheet which was stained with rabbit antiserum 
raised against buffalo brain lectin (1:50 dilution). The spots a, b, c, d and e 
correspond to control (75 mM PBS), brain, lung, heart and liver tissue 
homogenates (2 |ig), respectively. 
121 
&lt»4i4U 
—•— Absence of BBL 
—•— Presence of BBL 
- I • 1 1 1 1 1 • 1 . 1 1 1 
0.3 0.4 0.5 0.6 0.7 0.8 0.9 
NaCI concentration (%) 
Figure 58. Effect of BBL on hemolysis of trypsinized erythrocytes at varying 
concentration of hypotonic solution. 
Trypsinized rabbit erythrocytes at different NaCI concentrations in the absence 
and presence of BBL (50 ug/ml) after 4 hours of incubation. Values shown are 
the mean ± S.D obtained from three observations. 
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Figure 59. Effect of different concentration of BBL on hemolysis of trypsinized 
rabbit erythrocytes. 
The incubation of 10 % RBC suspensions with different concentration of 
lectin (lOug-lOOug/ml) was carried out for 4 hours at 37° C. Samples were 
centrifuged and RBC lysates were analysed at 540 nm. Values shown are the 
mean ± S.D obtained from three observations. 
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Effect of temperature, pH and incubation time on the lectin mediated hemolysis 
ofRBCs 
The lectin-induced hemolysis at increasing temperature is depicted in Fig. 60. A 
temperature dependent gradual increase in percent hemolysis was observed, with 
maximum and significant (P < 0.001) hemolysis of 83.79% at 40°C in BBL treated 
erythrocytes as compared to negligible hemolysis in unagglutinated cells. 
Preincubation of erythrocytes with BBL in various buffers of pH range (3.5-9.5) 
revealed a sharp enhancement of percent hemolysis with a maximum of 80.19 % at 
pH 7.5 (Fig. 61). 
The extent of hemolysis increased with incubation period showing maximum lysis of 
83.84% for BBL treated RBCs, while only 1.633% for unagglutinated erythrocytes 
after a time lapse of 4 hours (Fig. 62). 
Effect of osmotic colloids on the hemolysis of erythrocytes in the presence and 
absence of brain lectin 
The ability of non-electrolytes to protect lectin-induced lysis of red blood cells was 
assessed after incubation with different sugars in 75 mM PBS pH 7.4 for 4 hours. 
Lectin agglutinated cells exhibited about 72.65 % hemolysis (P< 0.001) in PBS 
(Fig. 63) as compared to 2.33 percent hemolysis of unagglutinated cells. The presence 
of 30 mM lactose and sucrose provided the maximum protection, with hemolysis of 
about 10.75 and 16.11 % respectively, while addition of galactose (39.47 % hemolyis) 
and glucose (60.96 % hemolysis) did not inhibit lysis. The presence and absence of 
colloidal osmotic media did not show any appreciable effect on hemolysis of 
unagglutinated cells. 
Effect of brain lectin on susceptibility of erythrocytes membrane to free radical 
damage by pyragallol 
When RBC treated with lectin for 1 and 4 hour were exposed to oxyradical shock, a 
release of 26.13 and 33.39 uM of oxyhemoglobin was observed respectively, whereas 
only 1.74 uM of oxyhemoglobin was released when untreated erythrocytes were 
exposed to free radicals (Fig. 64). Almost no release of oxyhemoglobin was observed 
in erythrocytes, which were neither treated with lectin nor exposed to oxidative 
damage (control), or lectin treated cells but not exposed to oxyradical shock. 
Effect of lectin on hypochlorous acid induced hemolysis 
The oxidizing action of HOC1 was monitored in the presence of BBL in terms of 
percent erythrocytes hemolysis. As evident in Fig. 65, the extent of cell hemolysis 
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Figure 60. Effect of temperature on BBL induced hemolysis of trypsinized rabbit 
erythrocytes. 
The erythrocytes treated with lectin at a concentration of lOOug/ml in 75 mM 
PBS pH 7.4, were incubated at different temperatures for 4 hours. Values 
shown are the mean ± S.D obtained from three observations. 
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Figure 61. Effect of pH on BBL induced hemolysis of trypsinized rabbit 
erythrocytes. 
Trypsinized erythrocytes treated with lectin (lOOug/ml) in 75 mM PBS pH 
7.4, were incubated in various buffers (0.1 M sodium acetate/sodium 
phosphate/Tris-HCl/ glycine NaOH) of varying pH values (3.5-9.5) at 37T 
for 4 hours. Values shown are the mean ± S.D obtained from three 
observations. 
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Figure 62. Effect of incubation time on buffalo lectin induced hemolysis of 
trypsinized rabbit erythrocytes. 
The erythrocytes treated with lectin (lOOug/ml) in 75 mM PBS pH 7.4, were 
incubated for different time intervals (0.5-4 hours) at 37°C. Values shown are 
the mean ± S.D obtained from three observations. 
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was directly proportional to HOG concentrations. Prior agglutination of erythrocytes 
with BBL resulted into significant (P<0.001) enhancement of hemolysis as compared 
to untreated cells in the presence of varying concentration of HOC1. At 350 uM 
NaOCl concentration the BBL agglutinated erythrocytes showed 47.46 % hemolysis 
which was 42.99% more than the non-agglutinated cells (33.19 % hemolysis). 
Differential hemolytic action of lectin towards erythrocytes of cancerous patients 
Lectin-mediated agglutination of erythrocytes of cancer patients showed a differential 
pattern of hemolytic activity when compared to healthy control. Hemolysis was 
considerably increased (5.0.58%) in the presence of lectin in RBCs from normal 
healthy control (2.11%) (Fig.66). The extent of hemolysis in BBL treated erythrocytes 
from pre-operated (breast cancer) samples did not show an appreciable increase 
(30.33 %), whereas, there was a significant (P < 0.001) increase of 41.5 % in the 
% hemolysis in post-operated breast cancer RBCs. 
In case of prostate cancer patients, agglutination with BBL displayed an increase in 
% hemolysis in both pre-operated (75.4%) and post-operated (54.90%) erythrocytes 
with respect to unagglutinated pre-operated (55.96 %) and post-operated (13.05 %) 
RBCs (Fig. 67). 
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Figure 63. Osmotic protection against BBL induced lysis by various 
carbohydrates. 
The hemolysis of erythrocytes was measured in the presence of 30 mM of 
various sugars in 75 mM PBS pH 7.4. Phosphate buffered saline (PBS), 
Lactose (Lac), Galactose (Gal), Glucose (Glu), Sucrose (Sue). The 
measurements were performed in triplicates with 10% rabbit erythrocytes and 
100u.g/ml buffalo brain lectin in PBS pH 7.4. Values shown are the mean ± 
S.D obtained from three observations. 
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Figure 64. Measurement of OxyHb concentration under various conditions in the 
hemolysates of a; erythrocytes exposed to superoxide radicals, b; erythrocytes 
exposed to superoxide radicals in the presence of BBL after 1 hour, c; 
erythrocytes exposed to superoxide radicals in the presence of BBL after 4 
hours. Values shown are the mean ±S.D obtained from three observations. No 
oxyHb was released in the erythrocytes (absence /presence of BBL) not 
exposed to superoxide radicals. 
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Figure 65. Effect of BBL on hypochlorous acid induced hemolysis. 
The erythrocytes treated with lectin (50ug/ml) were incubated at different 
concentration of NaOCI in 75 mM PBS pH 7.4. Values shown are the mean ± 
S.D obtained from three observations. 
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Figure 66. Hemolysis of human erythrocytes of normal, pre-operated and post-
operated breast cancer patients in the presence and absence of BBL (50 
ug/ml). 
The degree of hemolysis was calculated by comparing with identical volume 
of erythrocytes mixed with distilled water which represented 100% lysis. 
Results are reported as mean of six independent readings ± S.D. 
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Figure 67. Hemolysis of human erythrocytes of normal, pre-operated and 
post-operated prostate cancer patients in the presence and absence of 
BBL (50 ug/ml). 
The degree of hemolysis was calculated by comparing with identical volume 
of erythrocytes mixed with distilled water which represented 100% lysis. 
Results are reported as mean of six independent readings ± S.D. 
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DISCUSSION 
Lectins are characterized by their non-immunoglobulin origin and specific 
carbohydrate binding property that does not display any enzymatic activity towards 
the recognized sugar moiety. Soluble P-galactoside binding lectins have been isolated, 
studied and characterized from variety of sources ranging from C. elegans 
(Hirabayashi et al., 2002) to various mammalian species, expressed in an array of 
different tissues like muscles (Child and Feizi, 1979), heart (Waard et al.,1976) lungs 
(Waard et al., 1976) skin (Bols et al., 1986) and brain (Caron et al., 1990). Several 
workers have investigated and characterized the presence of P-galactoside binding 
lectins from neural tissues of different mammals (Kuchler et al., 1989, Caron et al., 
1990, Zanetta et al., 1992, Jaison and Appukuttan, 1999; Ola et al., 2001; Shahwan et 
al., 2004) where they reside in a subpopulation of dorsal root ganglion, primary 
sensory neurons, motor neurons, astrocytes, perivascular cells and microvessels 
(Joubert et al., 1989; Hynes et al., 1990; Horie et al., 2004; Stillman et al., 2005; 
Stillmanetal.,2006). 
The present work is a comprehensive study which describes the purification and 
characterization of soluble lectin having affinity for P-galactoside residues from the 
nervous tissue of water buffalo (Bubalus Bubalis). The brain tissue extract rapidly 
agglutinated trypsinized rabbit erythrocytes, thus displaying the presence of lectins. 
The present scheme of purification involves a combination of ammonium sulphate 
precipitation and gel filtration chromatography on Sephadex G50-80 column. The 
ammonium sulphate fractionation resulted in partial purification and enrichment of 
specific activity of brain lectin. Moreover, gel permeation on sephadex G50-80 was 
quite effective in complete purification of protein as a single peak with high fold 
purification, thus making the entire procedure rapid, simple which gave a comparable 
yield of 0.04 % with others workers (Caron et al., 1987; Bladier et al., 1991; Ola et 
al., 2001). 
The purified lectin migrated as a single band in non-denaturing PAGE as well as 
SDS-PAGE under reducing conditions suggesting the homogeneity of the preparation. 
The subunit molecular weight of BBL corresponded to 14.5 kDa both in reducing as 
well as non reducing conditions, similar to the lectin isolated from bovine, rat and 
human nervous tissue (Caron et al., 1987, Bladier et al., 1991). Moreover, in size 
exclusion chromatography the native lectin behaved as a globular protein with 
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molecular weight of 28.5 kDa suggesting that it is presumably a homodimeric protein 
with two identical subunits held together by non-covalent interactions. These results 
were consistent with the values obtained for the lectin from nervous tissue of other 
mammalian species (Cerra et al., 1985; Caron et al., 1987; Bladier et al., 1991). 
The dimeric structure was further confirmed by the Scatchard analysis, which 
indicated the presence of two carbohydrate binding sites per native molecule of lectin. 
This result was quite comparable to that obtained for bovine spleen galectin (Ahmed 
et al., 1996). Association constant (Kass) for the binding of lactose to BBL was 
approximately 6.66* 103 M"1 which is slightly lower than that of electrolectin (Levi 
and Teichberg, 1981). The dimeric form of P-galactoside binding lectins provides 
them the potential to bind to glycoconjugates. It is reported that galectin-1 also causes 
biphasic modulation of cell growth (Stillman et al., 2005). The positive and negative 
effects of galectin-1 on cell growth might be influenced by both dose and the relative 
distribution of monomeric versus dimeric form (Camby et al., 2006; Stillman et al., 
2006). 
Most P-galactoside binding lectins display affinity towards lactose and 
N-acetyllactosamine with subtle differences in their carbohydrate specificities (Oda et 
al., 1993; Ahmed and Vasta, 1994; Leffler et al., 2004; Vasta et al., 2004; Rabinovich 
et al., 2007). Therefore, a number of simple sugars and complex saccharides were 
screened for sugar specificity of BBL by hemagglutination inhibition assay. BBL 
displayed its carbohydrate specificity profile similar to the known brain lectins from 
bovine, rat, goat, sheep and human (Leffler and Barondes, 1986; Caron et al., 1987, 
Bladier et al., 1991, Ola et al., 2001, Shahwan et al., 2004) with greater affinity for 
disaccharides, in particular for lactose. The minimum inhibitory concentration 
required for other saccharides was also different, suggesting that the BBL has its own 
unique and fine specificity (Sparrow et al., 1987; Solis et al., 1996, Kasai and 
Hirabayashi, 1996; Rabinovich et al., 2007). Lectin obtained from buffalo brain was 
maximally inhibited by lactose, suggesting its specificity for carbohydrate moieties in 
(5-glycosidic linkages. Thus, hemagglutination inhibition assay clearly demonstrated 
that BBL is specific for saccharides bearing non-reducing terminal galactose linked in 
a P-configuration. This result was further confirmed by weak binding of BBL to 
methyl-a-D-galactopyranoside and p-nitrophenyl- a-D-galactopyranoside as 
compared to methyl-|3-D-galactopyranoside and p-nitrophenyl-P-D-
galactopyranoside. In addition, nitrophenylated galactose was a more effective 
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inhibitor of BBL activity than galactose or methyl-P-D-galactopyranoside, suggesting 
the involvement of hydrophobic interaction in the saccharide binding (Ali and 
Salahuddin, 1989; Ola et al., 2001). Moreover, D-galactose and D-galactosamine 
inhibited the hemagglutination reaction, indicating the significance of free hydroxyls 
or a free amino group at C-2 in monosaccharides to cause inhibition of BBL binding 
to erythrocytes (Ola et al., 2001; Shahwan et al., 2004). The hemagglutinating activity 
was unaffected by the presence of sugars like mannose, sucrose, melibiose, fucose 
and fructose. However, the inability of glucose or glucosamine to cause inhibition 
sheds light on the importance of C-4 configuration. The extended like geometry of 
carbohydrate recognition domain of BBL is suggested due to its high affinity for 
lactose in comparison to galactose which gets only partially occupied upon galactose 
binding (Loris, 2002; Rabinovich et al., 2004). This is quite consistent with the X-ray 
crystallographic studies using small disaccharides which predicted the 4-OH and 
6-OH groups of galactose and 3-OH group of glucose comprising lactose structure are 
critically important for high affinity binding (Lee et al., 1990; Liao et al., 1994; Loris 
et al., 2002). 
Gal-1 is a non-covalent homodimeric protein composed of 14.5 kDa subunits 
consisting of two identical conserved carbohydrate recognition domains. Thus, BBL 
isolated in the present study is a (J-galactoside binding protein resembling the Gal-1 
family in functional and structural respects, but inclusion of this lectin in the 
galectin-1 family still awaits the sequence analysis for the presence of sequence 
similarity in CRD domains. 
BBL readily agglutinates all types of native human erythrocytes apart from 
agglutination of trypsin treated human blood cells. It agglutinated equally both blood 
group A and O erythrocytes, probably mediated by the polylactosaminoglycans found 
on the surface of human erythrocytes (Fukuda, 1985; Ola et al., 2001). 
It is a well established fact that almost all the known p-galactoside binding lectins 
require reducing agents for the hemagglutination activity and stability (Cerra et al., 
1985; Southan et al., 1987; Horie et al., 2004). BBL also strictly requires reducing 
agents such as {3-ME to show activity for longer period of time. The chemical analysis 
of BBL also revealed the presence of 2.8 thiol groups per mole of BBL. Thus in order 
to investigate whether free thiol groups were necessary to maintain lectins in their 
active form, the native BBL was alkylated by iodoacetate and iodoacetamide. This led 
to a wide range in rates at which thiol groups were alkylated and resulted in 
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inactivation of hemagglutination activity, suggesting the need for free thiol groups for 
the maintenance of BBL in the active form. Thus, the loss in the lectin activity could 
be due to a possible conformational change that occurred during modification of 
cysteine residues (Clerch et al., 1988), whereas the slow rate of inactivation reflects 
that the cysteine residues could be partially buried inside the protein and possibly not 
involved directly in carbohydrate binding but present at a relatively distant site 
(Whitney et al., 1986; Shahwan et al., 2004). It is also surprising to observe the ready 
inactivation of buffalo lectin by iodoacetamide contrary to the absence of inactivation 
or display of higher activity in the presence of iodocetamide by other lectins (Whitney 
et al., 1986; Clerch et al., 1988; Shahwan et al., 2004). 
In addition, BBL was irreversibly inactivated by exposure to high temperature during 
a relatively short period of time in contrast to bovine galectin which was found to be 
more resistant to thermal inactivation as it retained 6% of total activity even at 100°C 
for 30 min (Ahmed et al., 1996). The BBL was quite stable between pH 6.5-9.5 and 
overlapped with that of natural physiological environment as reported earlier for 
human spleen galectin (Ahmed et al., 1990; Ahmed et al., 1996). 
The functional and structural integrity of BBL was assayed in the presence of 
various detergents in order to highlight the susceptibility of brain proteins towards 
different denaturing media. SDS is a well known ionic detergent which denatures 
proteins by ordering protein water molecule around them and also by intercalating 
into hydrophobic protein clefts with its long hydrocarbon chain (Lanio et al., 2003). 
Thus, the present study too demonstrated the denaturing effect of SDS on BBL even 
at a very small concentration. Tween-20 and Triton X-100 being neutral detergents 
were less inhibitory on BBL as they do not bind with lectins in detectable amount 
and were not very efficient in breaking non-covalent bonds which are responsible 
for the quaternary structure of multimeric proteins (Helenius and Simons, 1972). 
However, detrimental action of detergents was largely prevented by the presence of 
lactose which possibly excludes detergents from BBL sites susceptible to 
denaturation and proteolysis (Doyle et al., 1973; Jollifes et al., 1980; Denson and 
Doyle, 1998). 
Interestingly, our findings also showed that mammalian P-galactoside binding lectins 
are potent inducers of mammalian brain cell aggregation. It is important to note that 
lectin carbohydrate binding need not be the only or even the main determinant of 
specificity in brain cell interaction. A requirement for dual recognition involving other 
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sets of complementary molecules is consistent with the lectin recognition hypothesis 
(Caron et al., 1987). This result may also imply the involvement of the brain galectins 
in neurotransmission process and neuronal cell differentiation (Stillman et al., 2005). 
The spectroscopic analysis of BBL showed that lectin fluoresces at 335 nm and has 
its UV maximum at 282 nm, confirming the presence of aromatic residues 
particularly tryptophan moiety in a hydrophobic environment. The Far-UV CD 
spectra of native BBL corresponds to that of a protein with a high content of (3-sheet 
with a minimum around 217 nm, typical to other P-galactoside binding lectins as 
confirmed by X ray crystallography (Liao et al., 1994; Horie and Kadoya, 2004; 
Houzelstein et al., 2004). An FTER spectrum also correlates with CD analysis, 
consistent with the presence of large extent of P-sheet structure as suggested by 
maximum absorbance peak at 1635 cm" . 
Nearly all known P-galactoside binding lectins with few exceptions require reducing 
agents for their activity (Southan et al., 1987; Ola et al., 2001; Kadoya et al., 2005; 
Rabinovich et al., 2007). Buffalo brain lectin also shows hemagglutination activity 
only in the presence of reducing agents such as P-mercaptoethanol. Purified lectin 
showed no detectable loss of activity when kept for up to 3 months in PBS containing 
0 3 M lactose at 4°C, thus, suggesting that lactose maintains the purified protein in the 
active form even in the absence of a reducing agent, possibly by preventing oxidative 
inactivation due to formation of intra-sulphide linkages (Cho and Cummings, 1995). 
Since these lectins remain in active conformation in the presence of a reducing agent, it 
led us to believe that they contain an oxidizable residue whose integrity is quite crucial 
for its activity. Our results clearly demonstrate that the exposure of lectin to an oxidant 
causes a decrease in its activity which can be due to the oxidation of either cysteine or 
tryptophan residue. Oxidation of cysteine residue can be possibly ruled out as UV 
absorption maxima in the presence of an oxidant showed a sharp decline from 282 nm 
to 250 nm, typical to that of an oxidized Trp residue (Patchornik et al., 1960). 
Oxidation of Trp residue was further confirmed by quenching of the intrinsic 
fluorescence of the protein in the presence of 5 mM H2O2 with a slight blue shift. In 
addition, the decrease in the fluorescence of BBL was quite concomitant with the loss 
of activity at different time intervals. Apparently, H2O2 did induce subtle changes in 
lectin conformation in such a way that fluorophor is transferred to less polar 
environment and also led to the oxidation of tryptophan residue to form an oxindole. 
Moreover, the finding that lactose increased the fluorescence of lectin and prevented 
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the deleterious effect of H202 indicated that the emitting fluorophore is located within 
the lactose-binding site (Levi and Teichberg, 1981). Since, the tryptophan fluorescence 
is quenched by H2O2, the loss of lectin activity can be accounted for by the oxidation 
of the tryptophan residue present in the lactose-binding site, whereas, in the presence 
of lactose, oxidation of the tryphtophan residue and formation of oxindole is prevented. 
Thus, due to high susceptibility of brain lectins to oxidation they are often advised to 
be stored in lactose solution. These findings suggests the importance of reducing 
environment which is probably needed to reduce molecular oxygen normally present in 
solution and prevent it from oxidizing tryptophans (Levi and Teichberg, 1981). 
Although, there is no direct evidence that tryptophan is crucial for hemagglutination 
activity in case of buffalo lectin, but it may play some possible role in maintenance of 
the carbohydrate binding site of the lectin molecule as several workers based on X-ray 
studies on bovine spleen galectin have shown that Trp-68, a highly conserved amino 
acid in (3-galactoside binding lectins is found to make stacking interaction with 
galactose moiety (Abbot and Feizi, 1991; Hirabayashi and Kasai, 1991; Rini and 
Lobsanov, 1999; Vasta et al., 2004). 
The effect of oxidant was also monitored by circular diochroism and FTIR analysis. 
The native secondary structure of BBL underwent a major transition from (3-pleated 
form into a more open and enriched a-helix conformation (as evident by a shift in CD 
spectra and FTIR spectra), suggesting the reason for the loss of activity upon oxidation 
(Pande et al., 2003; Kadoya et al., 2005). An increase in a-helix content has also been 
reported for galectin in the presence of H202 (Pande et al., 2003; Shahwan et al., 
2004), which owing to disulfide bond formation possibly locks the protein into a new 
inactive conformation that cannot form the usual secondary structure, thereby, losing 
its potential to bind saccharides (Clerch et al., 1988; Pande et al., 2003; Horie and 
Kadoya, 2004). This suggests that the regular secondary structure is vital for 
maintaining the active conformation of lectin. 
Near-UV CD spectra of BBL captured under the same conditions showed a significant 
change in the tri-dimensional structure of the protein, indicating a non-native structure 
and Trp spatial disposition in BBL as discussed previously by fluorescence studies. In 
particular, the data obtained shows a total loss of tertiary structure which is compatible 
with a more open conformation. 
Presence of lactose does not bring any significant change in secondary and tertiary 
topology of BBL as revealed by CD and FTIR analysis. Slight changes in spectras (CD 
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and FTIR) may be contributed by the alterations in the tryptophan residues. However, 
lactose does play a preventive role against deleterious effect of H2O2. Far-UV CD and 
FTER analysis of BBL pre-incubated with lactose in oxidizing conditions showed a 
slight protection against the secondary conformational change. However, near-UV 
analysis displayed a significant difference between the lactose treated BBL and 
untreated BBL in the presence of H202. These striking augmentations correlate with 
the earlier fluorescence studies where lactose prevented the exposure of tryptophan 
residue to oxidizing media. Probably, a stable conformational state is achieved in the 
presence of specific sugars, which involves the masking of tryptophan residue or the 
provocation of some conformational changes in the lectin resulting in the 
internalization of tryptophan residue (Khan et al., 2001). 
The exact biological action of 14-kDa lectin in brain is not yet known. Recent 
evidences indicate that the brain lectins are involved in the potentiation of neuropathic 
pain in the dorsal horn of rat olfactory system (Puche and Key, 1995; Kadoya et al., 
2005; Stillman et al., 2006). However, it has been demonstrated that oxidized 
P-galactoside binding lectin enhances axonal regeneration in the peripheral nervous 
system but does not posses hemagglutinating properties (Inakaki et al., 2000; Horie 
and Kadoya, 2004; Stillman et al., 2005; Stillman et al., 2006). Our studies also 
demonstrate that oxidized form is totally inactive thus, proving that oxidized 
functional lectin in the nervous tissue may just acts as an autocrine or paracrine factor, 
functioning more like a cytokine or chemokine than as lectin. Thus, this information 
opens new insights into the functions of galectins in mammalian nervous system. 
The denaturation of BBL by various chaotropic denaturants (Guanidine HC1 
(GdnHCl), urea and thiourea) indicated that its globular nature is possibly stabilized 
mainly by hydrogen binding and hydrophobic interactions (Nelson and Cox, 2001). 
The conformational changes induced by different denaturants were also monitored by 
fluorescence spectroscopy. The fluorescence emission spectrum of BBL in the 
presence of increasing concentrations of GdnHCl showed a decrease in the 
fluorescence intensity indicating that the tryptophan residue in native protein is 
located near an intra-molecular quenching group and the denaturation of the protein 
increases this interaction. These changes were also accompanied by a red shift from 
340 to 357 nm at different concentrations of GdnHCl. This shift results from the 
extent of exposure of the Trp residue to bulk solvent. Higher denaturant 
concentrations, up to 6 M GdnHCl had no effect on the position of the maximum but 
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a slight increase in fluorescence intensity was observed. In contrast, the fluorescence 
emission spectrum of BBL in the presence of increasing concentrations of urea and 
thiourea showed an increase in the fluorescence intensity suggesting the exposure of 
tryptophan residue to a more polar environment. In particular, the increase observed at 
various concentrations of denaturants could reflect an unfolding of the protein, 
thereby, preventing the quenching of the fluorescence by the polar solvent 
(Friedfelder, 1935). Increase in fluorescence intensity was also accompanied by a red 
shift at different concentrations of urea and thiourea. Thus, in all, BBL undergoes a 
denaturants-induced alteration in its conformation that involves a modification of the 
environment of the Trp residues (Freidfelder, 1935; Iglesias et al., 2003). 
Although galectins are often reported to be present on cell surfaces or in extracellular 
matrix, they lack recognizable secretion signal sequences and do not pass through the 
standard endoplasmic reticulum/Golgi pathway (Hughes, 1999), with the possible 
exceptions of a sponge galectin (Miarons and Fresno, 2000). As a result most of the 
isolated galectins have characteristics typical of cytoplasmic proteins, such as an 
acetylated N-terminus, free sulfhydryls and lack of glycosylation (Hughes, 1999). 
Thus, P-galactoside binding lectins are usually non-glycosylated proteins but 
interestingly, carbohydrate analysis of BBL revealed the presence of 3.3 % sugar 
moiety of the total mass of the lectin. Till date, all the mammalian brain lectin isolated 
are found to be devoid of any carbohydrate moiety (Bladier et al., 1989; Caron et al., 
1990; Ola et al., 2001; Shahwan et al., 2004). Therefore, it was interesting to study the 
role of glycosylation on the structure and functions of lectin by a cooperative analysis 
of its activity and structural stability in both glycosylated and deglycosylated forms 
over a wide range of temperature, pH, and in the presence of various denaturing 
agents. 
The addition of large glycan structures to the protein backbone can dramatically alter 
the structure, and consequently the function of the polypeptide architecture to which 
they are attached (Sinha and Surolia, 2007). Linked glycans can affect protein 
structure in two capacities; firstly addition of the carbohydrate to the partially folded 
nascent polypeptide can have an impact on, or facilitate the protein-folding process. 
Secondly, the carbohydrate can stabilize the mature protein (Wang et al., 1996; Sinha 
and Surolia, 2007). Therefore, in order to study the role of carbohydrate residue on 
soluble lectin, we removed the sugar residues using periodate oxidation method. This 
method completely removed the sugar moieties which were confirmed by the Dubois 
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analysis and the difference in the mobility of the native and modified protein on 
SDS-PAGE. Consistent with other workers (Wang et al., 1996, De Koster and 
Robertson, 1997), thermal stability of native lectin proved to be higher than its 
deglycosylated form over a wide range of temperature. The thermal denaturation of 
both forms of BBL at 60°C for various time intervals showed greater retention of 
hemagglutination activity for glycosylated native lectin. Thus, presence of 
carbohydrate residues to the protein backbone clearly indicates a protective role in 
thermal melting of proteins (Wang et al., 1996; Arnold and Hoffman, 1997). 
There was not any change in the pH optima of glycosylated and deglycosylated forms 
when their activity was tested as a function of pH, however, a decreased activity 
profile was observed for deglycosylated lectin. Thus, the presence of carbohydrate 
moiety protected the protein from extreme conditions of pH (Wang et al., 1996; 
Rasheedietal.,2003). 
Deglycosylated lectin showed lower hemagglutinating activity as compared to the 
native glycosylated BBL when treated with different concentrations of various 
denaturants and detergents. Earlier reports have already shown the role of 
carbohydrate residue in imparting resistance to denaturants mediated inactivation 
(Rasheedi et al., 2003; Fatima and Hussain, 2007). 
The deglycosylated form exhibited higher fluorescence intensity as removal of 
carbohydrate residues resulted in a greater exposure of the flurophore, concomitant 
with earlier reported studies relating to fluorescent behavior of glycosylated and 
nonglycosylated proteins (Rasheedi et al., 2003; Jafari-Aghdam et al., 2005; Fatima 
and Hussain, 2007). The fluorescence studies with different denaturants revealed the 
unfolding of the native and deglycosylated form. The fluorescence emission spectrum 
of BBL in the presence of increasing concentrations of GdnHCl showed a decrease in 
the fluorescence intensity indicating that the tryptophan residue in native protein is 
located near an intramolecular quenching group and the denaturation of the protein 
increases this interaction. The decrease was observed till 6 M concentration above 
which there was a slight increase in the fluorescence intensity. These changes were 
also accompanied by a red shift from 335 nm to 357 nm which resulted from the 
extent of exposure of the Trp residue to bulk solvent. At each concentration of 
GdnHCl, the deglycosylated lectin exhibited higher fluorescence intensity and a 
greater red shift as compared to the native BBL. Thus, carbohydrate moieties due to 
steric hindrances play a significant role in shielding the trytophan residues of native 
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lectin from more polar microenvironment (Fatima and Hussain, 2007). 
While, in the presence of urea and thiourea there was an increase in the fluorescence 
intensity with a pronounced red shift for both forms of lectin, with the deglycosylated 
lectin exhibiting higher intensity as compared to its native glycosylated form. This 
again highlights the importance of the glycan residues attached to the native protein 
which stabilizes its structure and protects the unfolding of the protein. Glycosylation 
has been reported to increase the stability of a number of molecules against different 
denaturating agents (Khan et al., 2003; Rasheedi et al., 2003; Sinha and Surolia, 2007) 
and increased resistance against protease degradation (Van Berkel et al., 1995). Thus, 
there was an overall change in the structure of both the forms and a reorientation of 
the tryptophan residues in the presence of different denaturants, which was more 
pronounced in deglycosylated form. Based on these studies, it can be predicted that 
glycosylation influences the conformational dynamics of nascent polypeptides and 
confers their biological activity. 
To the best of our information, as no mammalian glycosylated lectin has been 
reported so far (Bladier et al., 1989; Caron et al., 1990; Ola et al., 2001; Shahwan et 
al., 2004), the study of this glycosylated lectin may prove to shed some light on the 
significance of sugar residues on soluble lectin and ultimately enhance knowledge of 
the already growing repertoire of mammalian lectins. 
In view of the possible role of brain lectins, it was of interest to see whether the 
isolated lectin is phylogenetically/structurally related to other brain lectin or is a 
distinct protein sharing only a similar saccharide-binding specificity. Lectin obtained 
from buffalo brain was highly immunogenic in rabbits as it readily gave a single line 
of identity when tested by double immunodiffusion indicating the homogeneity of 
protein preparation. Direct binding ELISA was performed to characterize the 
immune response in rabbits using pure buffalo brain lectin as an antigen. The 
antiserum showed a high titre > 128000 again suggesting the high immunogenic 
nature of BBL. Preimmunized serum served as negative control and did not show 
any appreciable binding to buffalo brain lectin. 
Antigenic crossreactivity between buffalo, sheep and goat lectins by 
immunodiffusion studies show that anti BBL antibodies recognized both goat and 
sheep brain lectins, but comparatively faint precipitin lines were observed with 
respect to buffalo brain lectin indicating that antibody was not highly specific to 
sheep and goat lectin as compared to buffalo lectin. The specificity of the induced 
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antibodies and sharing of common antigenic determinants between lectins was 
further ascertained by competition ELISA using purified sheep, goat and buffalo 
brain lectins as competitors. The induced antibodies showed a high degree of 
specificity for buffalo brain lectin (immunogen), however, the extent of binding was 
lower for sheep and goat lectins. The buffalo brain lectin inhibited the anti buffalo 
antibody binding to solid phase bound antigen by 87%, while the inhibition of goat 
and sheep lectin was 53% and 62%, respectively, depicting that buffalo brain lectin 
has a slightly low degree of antigenic similarity or conformational homogeneity with 
sheep and goat brain lectins. The antibodies were quite specific for the immunogen 
(BBL), since, only 5 ug/ml of BBL was required for achieving 50% inhibition. A 
low level of cross reactivity of anti-buffalo lectin antibody with goat and sheep was 
again confirmed as concentration required to achieve 50% inhibition corresponded 
to 18 ug/ml and 9.5 ug/ml for goat and sheep lectins, respectively and the relative 
affinities for goat and sheep lectins were found to be 60.9 % and 71.26 %, 
respectively. Thus, the overall results indicate that lectins from different species 
share only few common antigenic determinants or epitopes. Antigenic reactivity 
between the sheep and goat brain lectins corroborates with the earlier findings and is 
consistent with the results for species which are phylogenetically related (Ola et al., 
2001; Shahwan et al., 2004). These observations on the cross reactivity between 
brain lectins of different species suggest a taxonomic variation in structure and 
function of these lectins analogous to that observed with cytochrome C (Dickerson 
and Geis, 1969; Beyer et al., 1979). 
To check the possible structural similarity of buffalo brain with similar lectins 
present in other organs of buffalo, the antiserum was tested against various tissue 
homogenates like heart, liver and lung by dot blot analysis. It was found that 
antibodies reacted strongly with all of them. These results indicated the antigenic 
similarity between buffalo brain lectins and similar lectins from other organs of the 
same specie (Beyer et al., 1979). 
The exact biological function of brain lectin is still obscure, yet recent reports 
suggest that they have a specific role in nerve degeneration (Kadoya et al., 2005; 
Camby et al., 2006) and development of brain carcinoma (Stillman et al., 2005; 
Stillman et al., 2006). However, the localization of lectins in different tissues has 
also brought up the suggestion that the endogenous lectin may play different roles in 
different organs (Beyer et al., 1979). It seems more likely that they play a common 
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role in different cell types as recognition molecules for cellular moieties containing 
carbohydrate structure with terminal P-galactosyl residues (Beyer et al., 1979). Our 
results showing antigenic cross reactivity between lectins from different tissues and 
different species are certainly in line with the idea that all the p-galactoside binding 
lectins in animal tissues have a common fundamental biological role that has been 
preserved through evolution (Levi and Teichberg, 1982; Ola et al., 2001). 
Proteins with hemolytic or in general with cytolytic activites have been of much 
interest to membrane biologists, since, the study of the mode of action of such 
cytolytic agents has contributed considerably to the understanding of complexities of 
biomembrane organization and function. Interestingly, (3-galactoside binding lectin 
from buffalo brain also exhibited hemolytic activity towards rabbit and human 
erythrocytes. Lytic actions of some proteins have been ascribed to enzymatic activity 
(Hittelet et al., 2002), perturbation of the activities of membrane associated enzymes 
(Lowe and Marth, 2003), or pore formation in the membranes (Yu et al., 2002). Thus, 
we examined the interaction of BBL with the erythrocyte membrane in order to 
elucidate the mechanism of hemolysis by BBL using rabbit erythrocytes as a model 
system. The study showed that BBL agglutinated RBCs were significantly hemolysed 
in comparison to unagglutinated RBCs, suggesting that lectin by virtue of its glycan 
binding property creates pores or leaks in the cellular membranes and thereby disrupts 
its function as a selective cell barrier. Thus, due to an imbalanced colloid-osmotic 
pressure of intracellular solutes (Devticke et al., 1986) uptake of water and salts rises, 
causing an increase in hemolysis in lectin agglutinated cells. Similar results have also 
been obtained for plant and animal lectins where they interact with membrane 
glycoconjugates and penetrate the lipid bilayer, thereby disturbing its integrity and 
fluidity (Hajela et al., 1997; Pande et al., 1998; Gupta et al., 2006). Lectins, upon 
contact with cell surface glycans like laminin, fibronectin and lysosyme associated 
proteins, oligomerize into dynamic complexes that have high on or off rates of 
interaction with the lipid bilayer, which ultimately results in substantial reorganization 
of membrane components (Surolia et al., 1997). Contact point of lipid bilayer and 
membrane integrated proteins is tightly intact and any displacement of membrane 
proteins due to the lectin binding may disturb the sealed interaction, thus, establishing 
an aqueous pore (Israelachivilli, 1977). Aqueous trans-membrane channels with 
hydrophobic protein domain coated walls may also form with a cluster of aggregated 
and displaced proteins (Pande et al., 1998; Gupta et al., 2006). 
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A rise in temperature increases the rate of electrolyte diffusion through the pore; this 
may be the reason for increase in percent hemolyis with temperature. The hemolysis 
of the erythrocytes in the presence of lectin showed a sharp rise with the increasing 
pH upto 7.5 and became constant till pH 9.5. This might reflect the presence of some 
ionizable group of amino acid residues of lectin with a pKa in the range of pH 7.5-9.5, 
which is involved in the hemolytic activity. 
Presuming that the increased hemolysis of lectin agglutinated erythrocytes is due to 
the formation of ion permeable leaks formed in the membrane, as with some cytolytic 
proteins (Hatakayema et al., 1994; Hatakayema et al., 1995), attempts were made to 
prevent the colloid osmotic lyses by addition of non-electrolytes to the extra cellular 
medium, which may counter-balance the osmotic pressure exerted by intracellular 
macromolecules (Hoekstra and Duzgunes, 1989). The disaccharides like lactose and 
sucrose showed remarkable (85.2% and 77.8 % decrease, respectively with respect to 
hemolysis in PBS alone) osmotic protection against lysis, whereas, other sugars being 
low molecular weight molecules easily penetrated through the pores, thus, causing no 
effect. While lactose and sucrose being large weight carbohydrates could not pass 
through the leak, and therefore could protect the lysis maximally. In addition lactose 
may have also competed with lectin's active sites, thus, contributing more to the 
decrease in the lysis of erythrocytes. 
The effect of lectin induced agglutination on the rate of oxidative damage to the cell 
membrane revealed that lectin induced perturbations in cell membrane makes it more 
vulnerable to oxidative attack. The leaks or pores formed in the lipid bilayer 
facilitated the superoxide ions to seep through the hydrophobic cellular membrane 
which was earlier impervious to these ions. 
It is a well established fact that hypochlorous acid (HOC1) is an extremely toxic 
oxidant that can react with a variety of cellular components (Vissers and Winterboum, 
1991; Zavodnick et al., 2002). It has also been confirmed that HOC1 causes red blood 
cell lysis through lipid modification, membrane cross linking, K+ leakage and cell 
swelling (Vissers and Winterboum, 1995; Zavodnick et al., 2002). Therefore, the 
effect of lectin on (HOC1) induced membrane perturbations was also studied. An 
additive effect on the increase in percent hemolysis of erythrocytes is observed by 
BBL on HOC1 induced cell damage, thus, suggesting that lectin may be an active pore 
forming agent together with hypochlorite, thereby, making the membrane components 
more susceptible to oxidative assault. Brain lectin is a homodimeric protein with two 
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binding sites which can crosslink identical ligands on the cell surface or to the 
extracellular matrix inducing conformational changes in membrane proteins and 
altering lipid fluidity, and thus may increase the accessibility of HOC1 to RBC 
components. As the average number of pores formed by HOC1 per cell is less than 
1.00 (Zavodnick et al., 2002), prior agglutination with lectin possibly increases the 
number of short lived pores in plasma membrane. This suggests the possibility of the 
role of P-galactoside binding lectin in HOC1 induced neutrophil-mediated cellular 
damage, which may have direct implications in various inflammatory conditions of 
nervous tissues where increased expression of galectin has been reported (Rorive et 
al., 2001). 
In addition, the peroxidant injury in any cell is greatly enhanced if its membrane 
integrity and fluidity is compromised (Hoekstra and Duzgunes, 1989). This has been 
confirmed as cells from pathological conditions with some membrane defects like 
sickle cell anaemia and thalassemia are more prone to oxidative assault than normal 
cells (Chin et al., 1982) Overall, our findings may also highlight the possible role of 
brain lectin as a triggering agent to enhance nervous tissue damage during oxidative 
stress by enabling the oxidant to penetrate inside cells due to the increased membrane 
permeability. 
Thus, BBL exhibiting hemolytic and cytolytic functions might be involved in the 
defense mechanism of mammalian nervous system, not only neutralizing foreign 
substances by binding to their carbohydrate moieties, but also acting directly as a 
toxic protein to invading microorganisms. Thus, lectin's interaction with membranes 
acts as perturbing tool causing a change in membrane topology and assembly which 
may play important role under physiological demands or pathological conditions in 
mammalian nervous system. 
The antigenic determinants present on the exterior surface of erythrocytes and other 
cell are carried by both glycolipids and glycoproteins, however; soluble blood group 
substances are strictly glycoprotein in nature (Carrilho et al., 2000; Connor et al., 
2000; Hasija 2002; Hasija, 2004; Toivanen et al., 2008). 
A number of glycoconjugates expressed on the erythrocyte and cell membrane are 
altered in primary cancerous and metastatic diseases. Alterations in serum 
glycoconjugates have been reported in patients with various cancers including head, 
oral and neck cancer (Baxi et al., 1991; Patel et al., 1997; Manoharan et al., 2004; 
Hernandez et al., 2006). Thus, altered glycoconjugates can be excellent indicators for 
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diagnosis, staging, prognostication, treatment monitoring and detecting early 
recurrence of cancer in patients with malignant neoplasm (Manoharan et al., 2004; 
Hasija, 2004; Hernandez et al., 2006). Lectins owing to their multivalent sugar 
binding property have been excellent tools for detection of aberrant glycosylation 
related to various carcinomas and may provide useful diagnostic or prognostic 
information, thus, contributing directly to cancer biology (Dennis et al., 1999; Hasija, 
2004; Hernandez et al., 2006). Thus, p-galactoside binding lectin from buffalo brain 
was used to detect the change in the P-galactoside expression pattern in erythrocyte 
membrane from human donors suffering from prostrate and breast cancer. In case of 
erythrocytes from pre-operated breast cancer patients no change was observed in the 
hemolysis upon lectin binding, whereas, significant increase was observed in normal 
healthy controls and post-operated samples. This observation may be attributed to the 
decrease in the expression of (M- 4 linked glycans on the surface of the RBC 
membrane in breast cancer patients, and their re-expression after surgery. Hemolysis 
of the lectin untreated RBCs from breast cancer patients displayed an increase as 
compared to the healthy controls owing to the pathological condition of the disease 
(Abou-Seif et al., 2000; Kolanjiappan et al., 2002). It has been observed that changes 
in binding qualities of blood group substances with lectins occur with the change in 
glycol-moieties of the glycoproteins (Hasija, 2004; Hernandez et al., 2006). 
Alterations in cell surface carbohydrates occur during malignancy which involves the 
blood antigens (Baxi et al., 1991; Hasija, 2004). 
In contrast, an increase in hemolysis of BBL agglutinated RBCs was observed in 
prostrate cancer patients, suggesting no change in glycosylation with respect to BBL 
specific sugars in erythrocytes of these patients. As lectins or agglutinins are proteins 
that bind specifically to saccharide moieties present in glycoproteins or glycolipids on 
the cell surface without modifying them chemically (Nagae et al., 2008), they could 
be excellent tools to detect the changes in the glycosylation pattern during 
malignancy, which can be a more convenient method than taking the biopsy samples 
in certain cases (Hasija, 2002; Hasija, 2004). 
To conclude, the purpose of the present work was not only to look for lectins, which 
display specific sugar specificity, but also to start a comprehensive study, which will 
contribute for the understanding biological functions of lectins. 
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SUMMARY 
Depending on the requirement of calcium for their hemagglutination activity, the 
animal lectins have been divided into two major types, the S type (calcium-
independent) and C type (calcium-dependent). The S-type lectins are soluble, 
(3-galactoside-specific, evolutionarily conserved proteins widely distributed in nature 
from lower invertebrates to mammals. In addition, they require the presence of thiol 
reducing reagents to retain their carbohydrate-binding activity. So far, (3-galactoside 
binding proteins or galectins have been implicated in various fundamental processes 
such as embryonic development, cell-cell interactions, cell migration, immune 
regulation and organization of nervous system. Moreover, these proteins are very well 
expressed in mammalian nervous system but its exact role is still obscure. 
[3-galactoside binding lectin from buffalo brain was purified to homogeneity by using 
a combination of 40-70% ammonium sulphate fractionation and gel filtration 
chromatography on sephadex G50-80 column. The purification resulted in 1716 fold 
enrichment of specific activity with a yield of 0.04 %. The molecular weight of 
buffalo brain lectin (BBL) as determined by SDS-PAGE under reducing and non-
reducing conditions was 14.5 kDa, however, with gel filtration under native 
conditions, it was 28.5 kDa, revealing the dimeric form of the protein. The stokes 
radius calculated from gel filtration data was 25 A and diffusion coefficient 
corresponded to 8.91 ><10"15 cm2/s. 
The neutral sugar content of the soluble lectin was estimated to be 3.3 %, whereas 
thiol analysis indicated the presence of 3 sulphydryl groups per mole of BBL. 
Alkylation of sulphydryl groups of brain lectin by iodoacetate and iodoacetamide 
resulted in inactivation of hemagglutinating activity, suggesting the need of reducing 
agent to maintain BBL in its active form. The specificity of BBL for various 
saccharides was determined by hemagglutination inhibition assay. BBL displayed 
affinity for lactose and other sugar moieties in glycosidic form, suggesting it to be a 
(3-galactoside binding lectin. Moreover, BBL preferentially agglutinated trypsinized 
human type A as well 0 erythrocytes. The temperature and pH activity profile 
displayed the maximum hemagglutination activity of BBL between a temperature 
range of 30-45 °C and a pH range of 7-7.5. Binding parameters of BBL for lactose 
was determined by equilibrium dialysis, with 6.6 * 103 M*1 association constant (Kass) 
and two binding sites per lectin molecule. 
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The effect of various denaturing agents like GdnHCl, urea and thiourea on BBL was 
studied and it was found that BBL considerably lost its activity at 6 M concentration 
of denaturants. Similarly, SDS also abolished the lectin activity but at very low 
concentration, while non-ionic detergents like Tween-20 and Triton X-100 exhibited a 
mild inhibitory behavior against BBL. However, pre-incubation of BBL with lactose 
largely prevented the detergent induced denaturation of the protein. 
The purified lectin was investigated for its brain cell aggregation properties by testing 
its ability to agglutinate cells isolated from buffalo and goat brains. Rate of 
aggregation of buffalo brain cells by purified protein was more than the goat brain 
cells. 
The treatment of BBL with oxidizing agent (H2O2) abolished its agglutination activity 
and shifted its UV absorption maxima from 282 to 250 nm, suggesting the oxidation 
of tryptophan residue present in BBL. In addition, conformational changes in BBL 
induced by H2O2 were also monitored by fluorescence, circular dichroism and FTIR 
spectroscopy. Fluorescence spectra of BBL in presence of oxidizing agent displayed a 
quenching in the fluorescence intensity profile, confirming the oxidation of aromatic 
acid residues. However, the presence of lactose was protective against oxidative 
structural perturbations as the fluorescence intensity of BBL pre-incubated with 
lactose displayed a lesser degree of H2O2 induced quenching. Similarly, circular 
dichroism and FTIR analysis revealed that the presence of oxidizing agent completely 
destroyed the native conformation of BBL. Far UV and FTIR spectra of oxidized 
BBL suggested the loss of secondary state, thereby changing the f}-pleated (native) 
into a-helical structures, whereas the near-UV spectra confirmed the oxidant induced 
perturbations in the native tertiary structure of BBL. However, pre-incubation of BBL 
with lactose did not bring any change in the native conformation of BBL both at 
secondary and tertiary levels. Moreover, a protective effect of lactose against 
oxidizing action of H202 on BBL was also demonstrated by both CD and FTIR 
spectroscopy. 
The purified lectin from buffalo brain revealed the presence of 3.3 % sugar residues. 
Thus, the possible role of carbohydrate moiety in the stabilization of the protein was 
investigated by deglycosylating the lectin using periodate oxidation method. 
Deglycosylated and glycosylated forms of brain lectin were subjected to a 
comparative analysis using protein activity and fluorescence as probes over a wide 
range of temperature, pH and in the presence of various detergents and chaotropic 
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agents. The native form of lectin retained greater fraction of hemagglutinating activity 
against various physical and chemical denaturants. The unfolding of both the forms of 
lectin in the presence of GdnHCl, urea and thiourea studied by fluorescence indicated 
greater perturbations in the conformation of deglycosylated lectin than the native 
protein. The different properties examined thus indicated that glycosylation plays an 
important role in the stabilization of native conformation of protein against the 
inactivation caused by various denaturants. 
Antibodies raised against pure BBL gave a single precipitin band with BBL and the 
titre determined by direct binding ELISA was found to be more than 12800 
suggesting the high immunogenic nature of the protein. Moreover, anti-BBL 
antibodies also cross reacted with purified goat and sheep brain lectins, displaying 
antigenic relationship between them. Dot blot analysis revealed the presence of 
similar lectin in lung, heart and liver of buffalo which cross reacted with antibodies 
raised against buffalo brain lectin. 
The effect of soluble (3-galactoside specific lectin from buffalo brain on the fragility 
and permeability of bio-membranes was examined using erythrocyte as model. 
Osmotic fragility of erythrocytes was considerably enhanced in the presence of BBL. 
The lytic activity of BBL was temperature, pH and incubation period dependent with 
maximum activity displayed between 30-40°C, pH 6.4-7.5 and 6 hours, respectively. 
Modulation of membrane integrity under oxidative stress in the presence and absence 
of (3-galactoside binding protein was also investigated. Exogenous brain lectin 
considerably enhanced the susceptibility of erythrocyte membranes to free radical 
injury and hypochlorous acid induced oxidative assault, indicating the property of 
lectin to affect membrane dynamics and functions by overall reorganization of 
membrane components and making it more vulnerable to toxic assaults. 
BBL was also used as a diagnostics tool to reveal the expression pattern of 
P-galactoside residues on the erythrocyte membranes of prostate and breast cancer 
patients. It was found that breast cancer causes a marked decrease in the expression of 
P-galactoside residues whereas, no change in the sugar moieties was exhibited in 
patients with prostate cancer. 
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Abstract Lectins are carbohydrate-binding proteins 
jresent in a wide variety of plants and animals, which serve 
various important physiological functions. A soluble 
8-galactoside binding lectin has been isolated and purified 
to homogeneity from buffalo brain using ammonium sul-
phate precipitation (40-70%) and gel permeation 
:hromatography on Sephadex G50-«o column. The molec-
ular weight of buffalo brain lectin (BBL) as determined by 
SDS-PAGE under reducing and non-reducing conditions 
was 14.2 kDa, however, with gel filtration it was 28.5 kDa, 
revealing the dimeric form of protein. The neutral sugar 
content of the soluble lectin was estimated to be 3.3%. The 
BBL showed highest affinity for lactose and other sugar 
moieties in glycosidic form, suggesting it to be a 
0-galactoside binding lectin. The association constant for 
lactose binding as evidenced by Scatchard analysis was 
6.6 x 103 M - 1 showing two carbohydrate binding sites per 
lectin molecule. A total inhibition of lectin activity was 
observed by denaturants like guanidine HC1, thiourea and 
urea at 6 M concentration. The treatment of BBL with 
oxidizing agent destroyed its agglutination activity, abol-
ished its fluorescence, and shifted its UV absorption 
maxima from 282 to 250 nm. The effect of H202 was 
greatly prevented by lactose indicating mat BBL is more 
stable in the presence of its specific ligand. The purified 
lectin was investigated for its brain cell aggregation prop-
erties by testing its ability to agglutinate cells isolated from 
buffalo and goat brains. Rate of aggregation of buffalo 
brain cells by purified protein was more than the goat brain 
cells. The data from above study suggests that the isolated 
S. Rizvi • N. Banu (El) 
Department of Biochemistry, Faculty of Life Sciences, 
A.M. University, Aligarh, UP 202002. India 
e-mail: naheedbanu7@yahoo.com 
lectin may belong to the galectin-1 family but is glycos) 
lated unlike those purified till date. 
Keywords Buffalo brain lectin • 
Ammonium sulphate precipitation • Gel filtration • 
Oxidation • Fluorescence • UV spectra • 
Equilibrium dialysis • Brain cell aggregation 
Introduction 
The galectins are a phylogenetically conserved family < 
animal lectins that recognize sugar residues present 
cellular glycoproteins or glycolipids [1] and show a si. 
nificant sequence similarity in their carbohydra 
recognition domain (CRD). This class of proteins is wide 
distributed in the animal kingdom ranging from nematod 
to human beings. Till date 15 members of galectin fami 
have been identified in a variety of animal tissues Hi 
muscles, intestines, heart, lung and liver [2-4]. Accordii 
to their structure they have been classified by Hirabayas 
and Kasai [5] into prototype galectins (galectin-1, -2, -5, -
-10, -11 and -13), existing as monomers or non-covale 
homodimers, chimera type lectin (galectin-3) consisting 
a non-lectin domain linked to a CRD, and tandem repe 
type (galectin-4, -6, -8, -9 and -12) composed of two d. 
tinct CRDs in a single polypeptide chain. Unlike ott 
proteins that are typically targeted to single cellular loc 
tions, galectins are found at many sites within and outsi 
the cells. They are produced as cytosolic proteins, but c 
localize to the nucleus or associate with mitochondr 
membranes [1]. In addition, galectin-9 can even insert ir 
plasma membrane where it acts as a urate transporter 
renal epithelium [6]. Apart from their cell adhesi 
potential, galectins also modulate cell proliferatic 
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apoptosis, RNA splicing, inflammation, atherosclerosis and 
diabetic vascular nephropathy [7]. Thus galectins have an 
overwhelming variety of essential functions and serve as 
important biological tools. 
In 1973 Rosen et al. first reported galectin expression in 
mammalian brain extract [8]. Since then galectins from 
mammalian nervous tissues have been an interesting target 
for active research and exploration. This galactoside-bind-
ing protein is localized in central nervous system in 
developing animals but its distribution is restricted to the 
peripheral nervous tissues in adults [9, 10]. In animal 
models galectin-1 (Gal-1) is expressed in a subpopulation of 
dorsal root ganglia neurons, primary sensory neurons, and 
motor neurons as well as astrocytes, perivascular cells and 
microvessels [10, 11]. Role of galectin in mammalian ner-
vous tissue is little known. However, Gal-1 is involved in 
rodent olfactory system in neurite outgrowth and synaptic 
connectivity [12]. Recently, it has also been demonstrated 
that oxidized galectin enhances axonal regeneration in the 
rat dorsal root ganglion and may also contribute to the 
establishment of neuropathic pain after peripheral nerve 
injury [13]. By directly regulating the balance between cell 
survival and cell death, modulating cell motility, and 
impacting signalling through the Ras pathway, galectins 
may play important roles in the development and the 
potential treatment of brain tumours [14]. Although Gal-1 is 
widely expressed in mammalian brains but its exact func-
tion is still obscure. It has been purified and characterized 
from brain tissues of various mammals like rat, cow, 
human, goat, buffalo and sheep [15-19]. In view of the fact 
that the physicochemical properties of buffalo brain lectin 
(BBL) have not been fully investigated, we have initiated a 
detailed study of this soluble lectin, as it is available in large 
amounts, hoping that the intimate knowledge of this protein 
may help in understanding its physiological functions. In 
the present paper we have purified lectin having an affinity 
for 0-galactosides from water buffalo (Bubalus bubalis) 
brain by gel permeation technique. Its detailed physico-
chemical properties have been sketched down and an 
attempt has been made to observe the changes in the 
function and structure of purified lectin in the presence of 
oxidative assault in order to elucidate the role of reducing 
agents to maintain its active form. Thus the overall aim of 
this work contributes to the existing repertoire of the 
diversity, structure, and biological role of brain lectins. 
Materials and methods 
Materials 
Molecular weight marker proteins, trypsin, bisacrylamide, 
acrylamide, sephadex Gioo, sephadex Gio-m were 
purchased from Sigma Chemical Co., St. Louis, MO, USA. 
Saccharides used were from Sisco Research Laboratories, 
Bombay, India. All other chemicals were of analytical 
grade. Fresh buffalo brain tissues were obtained from the 
local slaughterhouse and used immediately. 
Methods 
Purification of buffalo brain lectin {BBL) 
Purification of lectin from buffalo brain was achieved by a 
slight modification of the earlier method [18]. Fresh ner-
vous tissue (150 g) was properly cleaned, minced and 
homogenized in 75 mM phosphate buffered saline (PBS) 
pH 7.2 containing 0.15 M NaCl, 0.15 M lactose, 5 mM 
/j-mercaptoethanol (/J-ME), 0.02% (w/v) sodium azide and 
10 mM EDTA. Homogenate was clarified by passing 
through several folds of cheesecloth and centrifugation at 
10,000 rpm at 4°C. Supernatant was further sedimented at 
40,000 rpm for 1 h to pellet out any insoluble matter. The 
brain extract (supernatant) was then fractionated between 
40 and 70% ammonium sulphate saturation. The precipi-
tated protein after dialysis against 75 mM PBS containing 
40 mM lactose was applied on sephadex G5o_8o column. 
The fractions of protein peak were again dialyzed against 
75 mM PBS with 5 mM /J-ME to remove lactose and 
tested for hemagglutination activity. Samples showing 
maximum activity were pooled and concentrated for study. 
The protein content was quantitated by Folin's phenol 
reagent by the method of Lowry et al. [20]. 
Determination of hemagglutination activity 
The agglutination assays of BBL were performed with 
trypsinized rabbit erythrocytes to a final concentration of 
100 ug/mL of RBC suspension according to the method of 
Lis and Sharon [21]. 
Hemagglutination activity was performed using 'U' 
shaped microtitre plates where twofold serial dilutions of 
50 uL samples were made in 50 uL of operating buffer. 
RBC suspension in PBS (50 uL of 4% (v/v)) were added to 
each well, mixed by shaking and left at room temperature. 
The agglutinating titre (reciprocal of the highest dilution 
giving a visible hemagglutination) was noted after 1 h. 
Carbohydrate specificity 
Twofold serial dilutions of various sugars and their deriv-
atives were made in 50 uL of operating buffer. Purified 
lectin solution (4 agglutinating unit) was added to each 
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well followed by the addition of 4% (v/v) trypsinized 
erythrocytes suspension. Agglutination was noted after 1 h. 
Highest dilution of the test sugars required for complete 
inhibition were recorded. 
Molecular weight determination 
SDS-PAGE of protein samples and molecular weight 
standards were performed in 12.5% acryl amide gel in both 
reducing and non-reducing conditions. Molecular weight of 
the native lectin was reconfirmed by size exclusion chro-
matography on sephadex G.ioo gel column. Standard 
molecular weight markers used were in the range of 
96,000-14,500 Da. The linear plot between Ve/Vo and 
log M was used for calculating the molecular weight of the 
lectin. Stokes radius of the lectin was also determined 
using gel nitration data. 
Chemical analysis 
Carbohydrate content of the purified lectin was determined 
using the phenol sulphuric acid reaction described by 
Dubois et al. [22]. 
Effect of detergents and metal ions on lectin induced 
hemagglutination 
The effect of denaturants on lectin activity was determined 
by incubating protein (125 ug/mL) with urea, guanidine HC1 
(GnHCl) and thiourea in the concentration range of 0.5-
8.0 M. Lectin sample in PBS served as control. Titre value of 
each sample was determined using microplate assay. 
To examine the effect of divalent cation on lectin 
activity demetallization of purified lectin was carried out 
using 0.1 M EDTA followed by remetallization of the 
sample with 0.1 M CaCl2 and MnCl2. Hemagglutination 
activity of each sample was tested using rabbit RBCs. 
Equilibrium dialysis 
The binding of lactose to BBL was quantitatively studied in 
75 mM PBS pH 7.2 containing 0.15 M NaCl and 5 mM 
/?-ME by equilibrium dialysis in a dialysis bag (3.0 mL 
capacity) made from Sigma cellulose membrane. The 
dialysis bag containing 100 uM of the lectin solution was 
placed in plastic vials containing 1.0 mL of lactose solu-
tion in the range of 40-400 uM. After equilibrating for 
24 h at 37°C, a portion was taken from the protein free 
compartment and estimated for its carbohydrate content by 
the method of Dubois et al. [22]. The amount of lactose 
bound per mole of lectin was calculated according to 
Scatchard analysis. 
Treatment of lectin with hydrogen peroxide 
Lectin with a titre value of 256 was incubated with H202 
(5 mM) in 75 mM PBS pH 7.2 in the absence of 0-ME for 
2 h at room temperature. Titre value of the incubated 
protein was determined. 
Optical properties 
Absorption spectroscopy. UV absorption spectra of native 
lectin in 75 mM PBS pH 7.2 containing 5 mM /?-ME and 
oxidized lectin (by adding 5 mM H202) in the absence of 
/3-ME was measured on Beckman DU-640 Spectropho-
tometer in the range of 220-320 nm. 
Fluorescence spectroscopy. Intrinsic fluorescence of 
native protein was measured at 25°C in a Hitachi F-200 
spectrofluorometer (Hitachi, Tokyo, Japan) equipped with 
a DR3 recorder. The protein was selectively irradiated 
using an excitation wavelength of 280 nm with 10 nm 
band pass. Emission spectra were measured in the range of 
300-400 nm. Change in the intrinsic fluorescence in the 
presence of 5 mM of H2C«2 and 0.1 M lactose solution was 
also recorded. Appropriate controls containing the oxidiz-
ing agent used for the treatment were run and correction 
made wherever necessary. Each spectrum was the average 
of three scans. 
Brain cell aggregation assay 
The brain cell aggregation activity was determined using 
dissociated cells from goat and buffalo brain without any 
chemical treatment. One-gram tissue was isolated from the 
telencephalon of each brain and mechanically dissolved 
into separate cells using a dissociation chamber containing 
a magnetic stirrer. The cell suspension was fixed in 4% (v/ 
v) glutaraldehyde in 75 mM PBS pH 7.2 containing 
0.15 M NaCl. After 1 h, the cells were washed in PBS, 
rinsed twice in 0.2 M glycine, and dissociated again. Iso-
lated cells were finally suspended at 6.25 x 105 cells/mL 
of PBS pH 7.2 containing 75 mM NaCl. One hundred |jL 
of purified lectin (10 ^g/mL) was added to tubes contain-
ing 100 uL of a suspension of isolated fixed cells. After 
rotation at 70 rpm for 60 min, small aliquots were carefully 
removed and the number of particles (single cells and 
clumps) per unit volume was determined using a Maleuzz 
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hematocytometer. The rate of agglutination was expressed 
as the % decrease in particle number [23]. 
Brain cell aggregation activity of galectin was also 
measured as a function of pH and temperature by microti tre 
plate assay. 
Results 
Isolation of buffalo brain lectin 
A lectin that displays affinity towards galactoside residues 
was purified by the combination of ammonium sulphate 
fractionation and gel permeation chromatography on 
Sephadex GJO-RO column. Ammonium sulphate fraction-
ation resulted in about 18% yield of the total active protein 
with fivefold purification. The high salt content was 
removed by extensive dialysis against 75 mM PBS pH 7.2 
containing 30 mM lactose and 5 mM 0-ME. Lactose was 
added to the dialyzed sample before loading on to the 
column to inhibit the lectin and Sephadex gel interaction. 
The yield of the purified protein was around 560 ug (from 
1,350 mg) with fold purification 1,715.59 (Table 1). Upon 
SDS-PAGE of the fraction showing the maximum activity, 
a single band was observed, suggesting homogeneity of the 
preparation (Fig. la). 
Molecular weight determination 
Fig. 1 a SDS-Gel electrophoresis of buffalo brain lectin during 
various stages of purification: SDS-PAGE was performed on 12.5% 
acrylamide gel under reducing conditions. Lane (a) soluble brain 
extracts (30 ug); Lane (b) 40-70% ammonium sulphate fraction 
(30 ug); Lane (c) purified protein (40 ug). b Molecular weight 
determination of BBL: samples were separated by 12.5% SDS-PAGE 
under reducing condition and non-reducing conditions. Lane (a) 
purified protein (25 ug) under reducing conditions; Lane (b) molec-
ular weight markers under reducing conditions; Lane (c) purified 
protein (25 ug) under non-reducing conditions; Lane (d) molecular 
weight markers under non-reducing conditions. The molecular weight 
markers are in the descending order; Phosphorylase b (97.4 kDa), 
BSA (68 kDa), ovalbumin (45 kDa), Carbonic anhydrase (29 kDa), 
Soyabean trypsin inhibitor (20.1kDa), Lysozyme (14.4 kDa) 
Agglutination properties and stability of buffalo brain 
lectin 
The lectin purified from buffalo brain gave a single poly-
peptide band corresponding to ~ 14.5 kDa as assessed by 
SDS-PAGE under reducing and non-reducing conditions 
(Fig. lb). This result was on the basis of three independent 
SDS-PAGE studies. Using size exclusion chromatography, 
the native protein appeared as a single peak corresponding 
to 28.5 kDa, suggesting that it is composed of two identical 
non-covalently linked 14.5 kDa subunits. The stokes radius 
computed using the gel filtration data was found to be 
~25 A0 (data not provided). 
Some agglutination properties of the pure lectin towards 
trypsinized erythrocytes have been investigated. The 
extracted lectin showed maximum activity only in the 
presence of a reducing agent like 5 mM /? mercaptoethanol 
and 4 mM dithiothreitol. The hemagglutination titre was 
not affected up to a temperature range of 45°C, and the 
most suitable pH for the protein to remain in active con-
formation is in the range of pH 6.0-9.0. Purified lectin 
showed no detectable loss of activity when kept for up to 
3 months in PBS containing 0.3 M lactose and 5 mM 
Table 1 Purification table of Bufl 
Step fraction 
Brain extract 
40-70% cut 
Gel chromatography 
alo brain lectin 
Total volume 
(ml) 
180 
20 
2 
Total protein 
(mg)' 
1350 
24(1 
0.560 
Total activity 
(titre)b 
il
l 
Specific acti 
(titre/mg) 
10.66 
53.33 
18285.71 
yity Purification 
(fold) 
1 
5.00 
1715.35 
Recovery 
(%) 
100 
88.88 
71.11 
Yield 
(%) 
100 
17.77 
0.041 
Values are means of tilree different preparations from 150 g fresh tissue 
* Determined by the method of Lowry et al 
b
 The titre of the tested lectin is expressed as the reciprocal of the highest dilution showing agglutination of trypsinized rabbit erythrocytes 
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0-ME at 4°C. Carbohydrate specificity of the BBL was 
determined at room temperature by the hemagglutination 
inhibition assay. Lactose was found to be the most potent 
inhibitor of hemagglutination activity giving complete 
inhibition at 0.78 mM followed by />-nitrophenyl-/5-r> 
galactopyranoside at concentration of SO mM suggesting 
that the active sites of the lectin have high specificity for 
carbohydrates with glycosidic linkages (Table 2). 
Effect of denaturants and metal ions 
Denaturants like urea and GnHCl at 3.0 M concentration 
while thiourea at 4.0 M reduced the lectin activity to 50%. 
The denaturation of lectin was also monitored by fluores-
cence spectroscopy at 340 run (Fig. 2) in the presence of 
increasing concentration of GnHCl. Complete unfolding of 
protein was observed at 6 M GnHCl with a 40% decrease 
in fluorescence intensity and shift of emission maximum 
from 340 to 357 nm. EDTA treatment or addition of metal 
cations showed no effect on lectin activity suggesting that 
lectin activity was not dependent on metal ions. 
| 500 
•5 450 
I 400-
I 
300 
0 1 2 3 4 5 6 
concentration of GnHCl 
Fig. 2 Effect of growing concentrations of GnHCl on fluorescence 
intensity of native BBL at 340 nm. Protein concentration was 125 ug/ 
mL in 75 mM PBS, 0.15 M NaCl, pH 7.2 containing 5 mM /JME. 
The denaturation was monitored by fluorescence intensity at 340 nm 
since no carbohydrate could be detected in the sample of 
goat brain lectin purified under the same conditions as 
BBL. 
Chemical analysis Equilibrium dialysis 
Sugar analyses performed on samples of lectin reveal that 
lectin contains 3.3% carbohydrate, which would corre-
spond to four residues of carbohydrate per lectin molecule. 
To confirm the glycosylated form of BBL, it was assured 
that sugar residues were not contaminants remaining from 
the gel chromatography or originating from the dialysis bag 
Table 2 Effect of various sacchrides on the hemagglutinating 
activity of buffalo brain lectin 
Carbohydrates 
Lactose (100 mM) 
Galactose (200 mM) 
Methyl-/)-D-galactopyranoside 
(200 mM) 
p-nitrophenyl-/J-D-galactopyranoside 
(200 mM) 
/7-nitrophenyl-x-D-galactopyranoside 
(200 mM) 
D-galactosamine (200 mM) 
Metbyl-a-D-galactopyranoside 
(200 mM) 
Glucose (200 mM) 
Minimum concentration 
of sugar giving complete 
hemagglutination inhibition 
0.78 
100 
100 
50 
Nil 
>100 
100 
Nil 
The following sacchrides were also tested and bad no inhibitory 
activity at 200 mM: />-nitrophenyl-a-D-galactopyranoside, o-man-
nose, L-fucose, sucrose, melibiose, and D-fructose 
The Scatchard plot of the equilibrium dialysis data of BBL 
in 75 mM PBS buffer containing 0.15 M NaCl and 5 mM 
0-ME (pH 7.2) with lactose at 37°C is shown in Fig. 3. A 
linear plot was obtained, the slope of which gave the 
binding constant K,,, as 6.66 x 10^  M_ l . The number of 
binding sites calculated from the X intercept was found to 
be 1.7 per lectin dimer suggesting the presence of two 
binding site per protein molecule. 
Spectroscopic properties of lectin 
Purified protein presents a UV spectrum (Fig. 4) with 
maxima at 282 nm corresponding to the presence of single 
tryptophan residue and a large number of other aromatic 
residues. When excited at 280 nm, the native lectin shows 
a fluorescence emission spectrum with a maximum at 
335 nm, typical of that of a tryptophan group in a hydro-
phobic environment as shown in Fig. 5. 
Functional and conformational modification of lectin in 
the presence of H2O2 and lactose 
H2O2 caused a remarkable decrease in hemagglutination 
activity of buffalo brain lectin with time. Activity was 
completely abolished after 40 min. The presence of an 
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Fig. 3 Scatchard plot for the binding of lactose to BBL. A fixed 
concentration of BBL (100 uM) in 75 mM phosphate buffer pH 7.2 
containing 0.15 M NaCl in a dialysis bag was incubated with 40-
400 uM of lactose in the same buffer at 37°C for 24 h. After the 
attainment of equilibrium the decrease in lactose concentration was 
estimated in the dialysate. Analysis of results yielded the value of 
association constant and the number of sugar binding sites 
1.0-
0.6 
0.6-
0.4-
0.2-
0.0 
— I — 
220 240 
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260 280 
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— i — 
300 
— I — 
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Fig. 4 Ultraviolet spectra of native and oxidized buffalo brain lectin. 
Spectra of native buffalo brain lectin (ISO ug/mL) in 75 mM sodium 
phosphate buffer. pH 7.2 containing 0.15 M NaCl and 5 mM 
/j-mercaptoethanol (•) and after adding 5 mM H202 in absence of 
-^mercaptoethanol (•) 
oxidant also shifted the absorption maxima of BBL from 
282 to 250 nm (Fig. 4). The fluorescent profile of the 
oxidized protein (Fig. 5) showed a remarkable quenching 
in the fluorescence intensity accompanied with a blue shift 
from 335 to 342 nm. When fluorescence experiments of the 
native protein were carried out in the presence of 0.1 lac-
tose solution a large enhancement in the fluorescence 
320 340 360 380 
Wavelength (nm) 
400 
Fig. 5 Fluorescence spectra of native and oxidized buffalo brain 
lectin. Experiments were performed with BBL (45 ug/mL) in 75 mM 
sodium phosphate buffer pH 7.2. The spectra of native BBL alone 
(•), in die presence of 0.1 M lactose (D), oxidized BBL alone (by 
adding 5 mM H202) (•) and oxidized BBL in the presence of 0.1 M 
lactose (o) were measured at 300-400 nm 
intensity was observed. Moreover, exposure of lectin to 
5 mM H 20 2 in the presence of 0.1 M lactose showed less 
decrease of fluorescence intensity as compared to the 
decrease in the absence of lactose solution. 
Brain aggregation assays 
The purified BBL preferentially agglutinated buffalo brain 
cells (75%; 45 x 104 cells/mL) than goat brain cells (63%; 
38 x 104 cells/mL) (Fig. 6). Optimum pH and temperature 
for brain cell aggregation activity of BBL was found to be 
7.5 and 40°C, respectively. 
Discussion 
In this study we have described the purification of lectin 
from the nervous tissue of buffalo on the basis of gel fil-
tration technique. The present rapid and simple scheme of 
purification involving ammonium sulphate precipitation 
and gel filtration chromatography on Sephadex G5(v_s«) 
column gave a better yield as compared to our earlier 
method [18]. The lectin was electrophoretically homoge-
nous in SDS-PAGE and migrated as a single band 
corresponding to a molecular weight of 14.5 kDa similar to 
the lectin isolated from bovine, rat and human nervous 
tissue [15, 16]. In size exclusion chromatography, the 
native lectin behaved as a globular protein with molecular 
weight of 28.5 kDa suggesting that it is presumably 
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Fig. 6 Brain cell aggregation by BBL. Lectin induced aggregation of 
brain cells from adult buffalo (•) and goat (•) were detected by 
measuring the decrease in the number of total free particles by 
bematocytometer 
composed of two identical subunits. These results were 
consistent with the values obtained for the lectin from 
nervous tissue of other mammalian species [15, 16, 24]. 
The dimeric structure was further confirmed by the Scat-
chard analysis, which indicated the presence of two 
carbohydrate binding sites per native molecule of lectin. 
This result is quite comparable to that obtained for bovine 
spleen galectin [25]. Association constant (K,,,) for the 
binding of lactose to BBL was ~6.66 x 103 M~', which is 
slightly lower than that of electrolectin [26]. The purified 
lectin is a glycoprotein containing 3.3% carbohydrate 
unlike other brain lectins purified in our laboratory 
[17-19]. This sheds light on the significance of glycosyl-
ation, which is one of the most important posttranslational 
modifications for newly synthesized proteins [27]. BBL 
being a glycosylated protein opens further avenues for 
future studies in understanding the role of glycosylation in 
protein function. Lectin obtained from buffalo brain was 
maximally inhibited by lactose, suggesting that it has an 
affinity for carbohydrate moieties in glycosidic forms. Gal-
1 is a non-covalent homodimeric protein composed of 
14.5 kDa subunits consisting of two identical conserved 
CRDs [7]. Thus BBL isolated in the present study is a 
/?-galactoside binding protein resembling the Gal-1 family 
in functional and structural respects, but inclusion of this 
lectin in the Gal-1 family still awaits the sequence analysis 
for the presence of sequence similarity in CRD domains. 
The spectroscopic analysis of BBL showed that lectin 
fluoresces at 335 nm and its UV maxima are 282 nm 
confirming the presence of aromatic residues particularly 
tryptophan moiety in a hydrophobic environment. The 
denaturation of BBL by various denaturants indicated its 
globular nature stabilized mainly by hydrogen binding and 
hydrophobic interactions [28]. The fluorescence emission 
spectrum of BBL in the presence of increasing concentra-
tions of GnHCl showed a decrease in the fluorescence 
intensity indicating that the tryptophan residue in native 
protein is located near an intra-molecular quenching group 
and the denaturation of the protein increases this interac-
tion. These changes were also accompanied by a red shift 
from 340 to 357 nm at different concentrations of GnHCl. 
Higher denaturant concentrations, up to 6 M GnHCl, had 
no effect on the position of the maximum. This shift results 
from the extent of exposure of the Trp residue to bulk 
solvent. In all, these data show that BBL undergoes a 
guanidine-induced alteration in its conformation that 
involves a modification of the environment of the Trp 
residues [29]. 
Nearly all known galectins with few exceptions require 
reducing agents for their activity [30]. Buffalo brain lectin 
also shows hemagglutination activity only in the presence 
of reducing agents such as /J-ME. Stability studies also 
demonstrated that lactose maintains the purified protein in 
the active form even in the absence of a reducing agent, 
possibly by preventing oxidative inactivation due to for-
mation of intra-sulphide linkages [31]. Since these lectins 
remain in active conformation in the presence of a reducing 
agent, it led us to believe that they contain an oxidizable, 
residue whose integrity is quite crucial for its activity. The 
exposure of lectin to an oxidant causes a decrease in its 
activity, which can be due to the oxidation of either cys-
teine or tryptophan residue. Oxidation of cysteine residue 
can be possibly ruled out as UV absorption maxima in the 
presence of an oxidant showed a sharp decline from 282 to 
250 nm, typical to that of an oxidized tryptophan residue 
[32]. It was further confirmed by quenching of the intrinsic 
fluorescence of the protein in the presence of 5 mM H202 
with a slight blue shift. Apparently, H2O2 did induce subtle 
changes in lectin conformation in such a way that fluoro-
phor is transferred to less polar environment and also led to 
the oxidation of tryptophan residue to form an oxindole. 
The findings that lactose increases the fluorescence of 
lectin and prevents the deleterious effect of H202 indicate 
that the emitting fluorophore is located within the lactose-
binding site [26]. Since the tryptophan fluorescence is 
quenched by H202, the loss of lectin activity can be 
accounted for by the oxidation of the tryptophan residue 
present in the lactose-binding site. In the presence of lac-
tose, oxidation of the tryphtophan residue and formation of 
oxindole is prevented. Thus these findings suggest the 
importance of reducing environment which is probably 
needed to reduce molecular oxygen normally present in 
solution and prevent it from oxidizing tryptophans [26]. 
Thus, due to high susceptibility of brain lectins to oxidation 
they are often advised to store in lactose solution. 
fi Springer 
Neurochem Res (2008) 33:468-476 475 
The exact biological action of 14-kDa lectin in brain has 
not yet been known. Recent evidence indicates that the 
brain lectins are involved in the potentiation of neuropathic 
pain in the dorsal horn of rat olfactory system [12]. How-
ever, it has been demonstrated that oxidized galectins also 
enhances axonal regeneration in the peripheral nervous 
system but does not posses lectin properties [33]. Our 
studies also demonstrated that oxidized form is totally 
inactive thus proving that oxidized functional lectin in the 
nervous tissue may just acts as an autocrine or paracrine 
factor, functioning more like a cytokine or chemokine than 
as lectin. Thus this information opens new insights into the 
functions of galectins in mammalian nervous system. 
Interestingly, our findings also showed that mammalian 
galectins are potent inducers of mammalian brain cell 
aggregation. It is important to note that galectin carbohy-
drate binding need not be the only, or even the main 
determinant of specificity in brain cell interaction. A 
requirement for dual recognition involving other sets of 
complementary molecules is consistent with the lectin 
recognition hypothesis [23]. This result may also imply the 
involvement of the brain galectins in neurotransmission 
process and neuronal cell differentiation. 
To conclude, the purpose of this study was not only to 
look for lectins, which display specific sugar specificity, 
but also to start a comprehensive study, which will con-
tribute for the understanding biological functions of lectins. 
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